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Abstract
Introduction: Physical fitness training after stroke is recommended in guidelines 
across	 the	 world,	 but	 evidence	 pertains	 mainly	 to	 ambulatory	 stroke	 survivors.	
Nonambulatory	 stroke	 survivors	 (FAC	 score	≤2)	 are	 at	 increased	 risk	 of	 recurrent	
stroke due to limited physical activity. This systematic review aimed to synthesize 
evidence	regarding	case	fatality,	effects,	experiences,	and	feasibility	of	fitness	train-
ing for nonambulatory stroke survivors.
Methods:	Eight	major	databases	were	searched	for	any	type	of	study	design.	Two	
independent	reviewers	selected	studies,	extracted	data,	and	assessed	study	quality,	
using published tools. Random- effects meta- analysis was used. Following their sepa-
rate	analysis,	qualitative	and	quantitative	data	were	synthesized	using	a	published	
framework.
Results:	Of	13,614	records,	33	studies	involving	910	nonambulatory	participants	met	
inclusion	criteria.	Most	studies	were	of	moderate	quality.	 Interventions	comprised	
assisted	walking	(25	studies),	cycle	ergometer	training	(5	studies),	and	other	training	
(3	studies),	mainly	in	acute	settings.	Case	fatality	did	not	differ	between	intervention	
(1.75%)	and	control	(0.88%)	groups	(95%	CI	0.13–3.78,	p	=	0.67).	Compared	with	con-
trol	interventions,	assisted	walking	significantly	improved:	fat	mass,	peak	heart	rate,	
peak	oxygen	uptake	and	walking	endurance,	maximum	walking	speed,	and	mobility	
at	 intervention	 end,	 and	 walking	 endurance,	 balance,	 mobility,	 and	 independent	
walking	at	follow-	up.	Cycle	ergometry	significantly	improved	peak	heart	rate,	work	
load,	peak	ventilation,	peak	carbon	dioxide	production,	HDL	cholesterol,	fasting	in-
sulin	 and	 fasting	 glucose,	 and	 independence	 at	 intervention	end.	 Effectiveness	of	
other	training	could	not	be	established.	There	were	insufficient	qualitative	data	to	
draw	conclusions	about	participants’	experiences,	but	those	reported	were	positive.	
There	were	few	intervention-	related	adverse	events,	and	dropout	rate	ranged	from	
12	to	20%.
Conclusions:	Findings	suggest	safety,	effectiveness,	and	feasibility	of	adapted	fitness	
training for screened nonambulatory stroke survivors. Further research needs to 
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1  | INTRODUC TION
Fitness is often considerably reduced in stroke survivors compared 
with	sedentary	healthy	controls,	with	marked	reductions	in	muscle	
strength,	 power	 (Ivey,	 Macko,	 Ryan,	 &	 Hafer-	Macko,	 2005),	 and	
oxygen	 uptake	 capacity	 (Saunders	 et	al.,	 2016;	 Smith,	 Saunders,	
&	 Mead,	 2012).	 Fitness	 is	 impaired	 along	 the	 entire	 stroke	 jour-
ney	(Bernhardt,	Chan,	Nicola,	&	Collier,	2007;	Egerton,	Maxwell,	&	
Granat,	 2006;	 Kerr,	 Rowe,	 Esson,	 &	 Barber,	 2016;	 Kunkel,	 Fitton,	
Burnett,	 &	 Ashburn,	 2015;	 Moore	 et	al.,	 2013),	 with	 ambulatory	
stroke	 survivors	 spending	 on	 average	 81%	of	 their	 day	 sedentary	
in	their	first	year	after	stroke	(Tieges	et	al.,	2015).	Reduced	fitness	
after stroke is compounded by the increased energy cost of many 
activities;	for	example,	walking	typically	requires	around	three	times	
more	energy	than	in	healthy	age-	matched	controls	(Platts,	Rafferty,	
&	 Paul,	 2006)	 because	 of	 motor	 impairments	 (Kramer,	 Johnson,	
Bernhardt,	 &	 Cumming,	 2016).	 These	 compound	 other	 problems	
(Morris,	Oliver,	Kroll,	Joice,	&	Williams,	2015,	2017;	Morris,	Oliver,	
Kroll,	&	Macgillivray,	2012;	Nicholson	et	al.,	2013,	2014)	that	make	it	
difficult for stroke survivors to regain and maintain a level of fitness 
necessary	 for	 basic	 mobility	 (Macko	 et	al.,	 2001)—a	 phenomenon	
known	as	“diminished	physiological	fitness	reserve	(McArdle,	Katch,	
&	 Katch,	 1996).”	 Reduced	 fitness	 adversely	 affects	 vascular	 risk	
factor	profiles	(Ivey,	Hafer-	Macko,	&	Macko,	2006;	Saunders	et	al.,	
2016),	disability,	 and	participation	after	 stroke	 (Mayo	et	al.,	1999).	
One	of	the	top	research	priorities,	selected	by	stroke	survivors,	car-
ers,	and	health	professionals,	is	to	investigate	the	potential	of	fitness	
training to reduce recurrent stroke risk and improve function and 
quality	of	life	(Pollock,	St	George,	Fenton,	&	Firkins,	2012).
What is known already is that fitness training facilitates second-
ary	prevention	of	cardiovascular	morbidity	(Garber	et	al.,	2011),	re-
duces	disability,	and	improves	walking	(Saunders	et	al.,	2016),	quality	
of	life	(Carin-	Levy,	Kendall,	Young,	&	Mead,	2009),	psychosocial	func-
tioning	 (Carin-	Levy	et	al.,	2009),	and	adaptation	to	 life	after	stroke	
(Reed,	Harrington,	Duggan,	&	Wood,	2010).	This	evidence	underpins	
guidelines	for	community-	based	exercise	after	stroke	services	in	the	
UK	 (Best	et	al.,	2010;	Poltawski	et	al.,	2013)	and	clinical	guidelines	
across	 the	world	 (Billinger	 et	al.,	 2014;	MacKay-	Lyons	 et	al.,	 2013;	
Royal	 College	 of	 Physicians	 Intercollegiate	 Stroke	 Working	 Party,	
2016;	 Scottish	 Intercollegiate	 Guidelines	 Network,	 2008,	 2010;	
Stroke	Foundation,	2017).	These	guidelines	mainly	pertain	to	ambu-
latory	stroke	survivors,	however.	There	appears	to	be	comparatively	
little research on fitness training for nonambulatory stroke survivors 
(Billinger	et	al.,	2014;	Saunders	et	al.,	2016;	i.e.,	those	unable	to	walk	
at	all	or	without	physical	assistance	from	at	least	one	other	person),	
who	make	 up	 approximately	 20%	of	 the	 stroke	 population	 (Kwah,	
Harvey,	Diong,	&	Herbert,	2013;	Veerbeek,	Van	Wegen,	Harmeling-	
Van	der	Wel,	&	Kwakkel,	2011);	53	of	the	58	studies	in	the	Cochrane	
systematic	 review	 on	 fitness	 training	 after	 stroke	 (Saunders	 et	al.,	
2016)	 involved	 ambulatory	 stroke	 survivors.	 Fitness	 training	 after	
stroke	often	involves	walking	(Saunders	et	al.,	2016)	and	is	therefore	
not	suitable	for	most	nonambulatory	stroke	survivors,	who	are	thus	
disadvantaged by the lack of evidence- based physical fitness train-
ing	that	is	adapted	to	their	mobility	restrictions.	As	nonambulatory	
stroke survivors are inevitably more sedentary than their ambulatory 
counterparts,	their	risks	associated	with	prolonged	sitting	(Rezende,	
Rodrigues	Lopes,	Rey-	López,	Matsudo,	&	Luiz,	2014)	are	increased.
In	summary,	improving	fitness	in	nonambulatory	stroke	survivors	
is	a	top	priority,	but	there	is	a	dearth	of	evidence-	based	guidance	to	
inform	practice.	To	the	knowledge	of	the	authors,	there	is	no	published	
systematic	review	on	this	topic.	The	aim	of	this	mixed-	methods	system-
atic review and meta- analysis was to synthesize published literature on 
physical fitness interventions for nonambulatory stroke survivors and 
evaluate	the	evidence	for	their	effects	on	fitness,	function,	activity	and	
participation,	quality	of	life,	acceptability,	and	feasibility.
2  | MATERIAL S AND METHODS
2.1 | Design
This	 review	was	 designed	 as	 a	 mixed-	methods	 systematic	 review	
and	meta-	analysis.	The	framework	by	Thomas,	Ciliska,	Dobbins	and	
Micucci	(2004),	designed	for	synthesizing	quantitative	and	qualita-
tive	evidence,	was	used	to	comprehensively	 integrate	evidence	on	
case	fatality,	effects,	feasibility,	and	acceptability.	The	following	sec-
tions describe the study eligibility criteria for this review.
2.2 | Types of studies
Any	type	of	quantitative,	qualitative,	or	mixed-	methods	(i.e.,	compris-
ing	a	quantitative	and	qualitative	element)	study	was	included	(e.g.,	
randomized	and	nonrandomized,	 crossover,	 cohort,	 and	case	 stud-
ies).	For	the	analysis	of	case	fatality	and	feasibility,	data	from	all	in-
cluded	studies	were	used.	For	the	analysis	of	effects,	only	data	from	
randomized	controlled	trials	 (RCTs)	were	used,	given	the	 increased	
risk	of	bias	in	non-	RCTs;	for	the	analysis	of	acceptability,	data	from	
mixed-	methods	 and	 qualitative	 studies	 were	 used.	 Systematic	 re-
views	were	excluded;	however,	their	reference	lists	were	searched	to	
ensure all relevant studies were included. In order to have access to 
all	relevant	data,	articles	had	to	be	full	reports,	published	in	English.
investigate	the	clinical	and	cost-	effectiveness	as	well	as	experiences	of	fitness	train-
ing—especially	for	chronic	stroke	survivors	in	community	settings.
K E Y W O R D S
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2.3 | Types of participants
Only data pertaining to nonambulatory stroke survivors were in-
cluded,	as	generalizing	from	ambulatory	participants	was	considered	
inappropriate.	Nonambulatory	adult	stroke	survivors	(age	≥18	years)	
were	included,	regardless	of	type	and	time	since	stroke,	or	any	co-
morbidities. In studies where information about ambulatory status 
was	absent	or	unclear,	 authors	were	 contacted.	Where	 it	was	not	
possible to obtain data relating to nonambulatory stroke survi-
vors,	studies	were	excluded.	To	the	authors’	knowledge,	there	is	no	
standard	definition	for	“nonambulatory.”	The	Functional	Ambulation	
Category	(FAC;	Holden,	Gill,	Magliozzi,	Nathan,	&	Piehl-	Baker,	1984)	
is a validated and widely used tool to describe walking ability after 
stroke.	In	this	review,	“nonambulatory”	was	defined	as	an	FAC	score	
≤2,	ranging	from	being	completely	unable	to	walk	to	being	depend-
ent on continuous/intermittent physical assistance of at least one 
person	during	walking,	to	help	with	balance	or	coordination	(Holden	
et	al.,	1984).
2.4 | Types of interventions
Improving cardiorespiratory fitness is crucial for secondary stroke 
prevention	 (O’Donnell	 et	al.,	 2016)	 and	 therefore	 a	 key	 element	
in	 many	 fitness	 interventions	 after	 stroke	 (Saunders	 et	al.,	 2016).	
Studies were therefore included if published intervention descrip-
tions comprised structured activities aimed at improving health- 
related	fitness	(Garber	et	al.,	2011).	The	importance	of	skill-	related	
fitness	 was	 acknowledged;	 however,	 studies	 that	 focused	 exclu-
sively	 on	 the	 latter	 (e.g.,	mirror-	box	 training	 to	 improve	 dexterity)	
were	excluded.	Similarly,	voluntary	muscle	contraction	was	consid-
ered	a	key	intervention	ingredient.	Therefore,	studies	were	excluded	
if voluntary muscle contraction was not an essential component of 
the	 intervention	 (e.g.,	 passive	movement,	 electrical	 stimulation,	or	
diet).	Studies	comprising	only	unstructured	recreational	or	occupa-
tional	physical	activity	were	also	excluded,	as	extracting	information	
about dose would not be possible.
2.5 | Types of setting
Interventions	delivered	in	any	type	of	setting	(e.g.,	hospital,	labora-
tory,	community)	were	included,	but	they	had	to	be	land-	based.
2.6 | Types of comparisons
Studies	were	not	required	to	have	a	comparison,	but	those	that	did	
were only included if this provided information about the effects of 
the	fitness	 intervention,	that	 is,	 fitness	training	versus	placebo,	no	
intervention,	 usual	 care,	 or	 another	 intervention.	 Studies	where	 a	
health- related fitness intervention was compared to the same inter-
vention	plus	an	 intervention	not	requiring	active	voluntary	muscle	
contraction	 (e.g.,	 a	 diet)	were	 excluded.	Data	were	 compared	 be-
tween	baseline	and	end	of	intervention,	and	between	baseline	and	
follow-	up	(where	provided).
2.7 | Types of outcome measures
Quantitative studies were included if outcomes comprised at 
least	 one	 health-	related	 fitness	 component,	 as	 defined	 by	 the	
ACSM	 (American	 College	 of	 Sports	 Medicine,	 2013),	 specified	
below).	Studies	were	excluded	 if	 they	only	 reported	skill-	related	
fitness outcomes. Outcomes were categorized into International 
Classification of Disability and Functioning (ICF; World Health 
Organization,	2001)	domains	where	possible,	 to	enable	compari-
son	 to	 recommended	 stroke	 datasets	 (Geyh	 et	al.,	 2004;	 Silva	
et	al.,	2015).
Primary outcomes comprised the following:
1. Case fatality
2. Health-related	 fitness	outcomes	 (American	College	of	 Sports	
Medicine,	2013),	that	is,	measures	of	cardiovascular	endurance	
(e.g.,	 6-minute	 walk	 test),	 body	 composition	 (e.g.,	 fat	 mass),	
muscle	strength	(e.g.,	Motricity	Index)	and	endurance,	flexibil-
ity	 (e.g.,	 range	of	motion),	 and	measures	 of	 cardiorespiratory	
function	 (e.g.,	 blood	 pressure)	 and	 metabolic	 function	 (e.g.,	
blood	glucose).
Secondary outcomes comprised the following:
1. Skill-related	 fitness	 outcomes	 (ACSM,	 2013),	 that	 is,	 measures	
of	agility	(e.g.,	Rivermead	Mobility	Index),	coordination	(e.g.,	Fugl-
Meyer),	balance	(e.g.,	Berg	Balance	Scale),	power	(e.g.,	Nottingham	
power	 rig),	 reaction	 time,	 and	 speed	 (e.g.,	 walking	 speed).
2. Stroke-related	general	measures	of	function	(i.e.,	body	function	
(e.g.,	Canadian	Neurological	Scale),	sensory	function	(e.g.,	hemi-
spatial	neglect),	mobility	(e.g.,	Functional	Ambulation	Category),	
movement-related	 functions	 (e.g.,	 Trunk	 Control	 Test),	 mental	
functions	(e.g.,	Hospital	Anxiety	and	Depression	Scale)),	activi-
ties	and	participation	(e.g.,	Stroke	Impact	Scale),	and	quality	of	
life	(e.g.,	the	Stroke	and	Aphasia	Quality	of	Life	Scale).
3. Feasibility,	operationalized	as	the	number	of	patients	assessed	for	
eligibility and those randomized (or allocated otherwise to an in-
tervention),	attendance,	number	of	dropouts	and	adverse	events,	
and	acceptability	of	the	 intervention,	reported	by	study	partici-
pants.	Review	authors	extracted	data	on	dropouts	in	the	period	
between intervention start and end of study and then categorized 
these	 as:	 possibly	 intervention-related,	 general	 health-related,	
logistics-related,	 and	 refusal	 to	 participate—if	 this	 could	 be	 de-
duced	 from	 the	 text.	Otherwise,	 dropouts	were	 categorized	 as	
unknown	 or	 not	 reported.	 These	 data	 were	 extracted	 from	 all	
studies included in this review.
2.8 | Search terms and databases
A	 combination	 of	 controlled	 Medical	 Subject	 Headings	 (MeSH)	
and	 free-	text	 terms	 relating	 to	 the	 key	 search	 terms	 of	 “stroke,”	
“physical	 activity,”	 and	 “non-	ambulatory”	were	 used	 to	 search	 the	
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following	 electronic	 databases	 from	 inception	 until	 31	 July	 2016:	
AMED,	CINAHL	and	Medline	in	EBSCOhost,	PEDro,	Web	of	Science,	
Cochrane	Database,	PubMed,	and	Embase.	Search	terms	were	modi-
fied	for	each	database	(Table	1).
2.9 | Study selection
One	review	author	 (ML)	screened	all	citations	 identified,	using	the	
predetermined	inclusion	criteria	listed	above,	discarding	those	that	
were	clearly	not	relevant.	Two	review	authors	(ML	and	FvW)	inde-
pendently screened abstracts of all selected titles using the same 
criteria,	 retaining	those	that	were	clearly	or	possibly	relevant.	The	
same	process	was	undertaken	for	full-	text	articles.	A	third	review	au-
thor	(DS)	was	available	to	facilitate	agreement	if	required.	Reference	
lists of studies included and relevant reviews identified in the search 
were also screened.
2.10 | Data collection process and data items
Data	 from	 the	 included	 studies	 were	 extracted	 independently	 by	
two	 review	authors	 (ML	and	FvW)	and	cross-	checked	 for	any	dis-
crepancies.	A	third	review	author	(DS)	was	available	if	required.	Data	
extracted	 covered	 the	 ACSM	 FITT	 principles	 (ACSM,	 2013)	 and	
CERT	criteria	 (Slade	et	al.,	2016)	and	 included	the	following:	study	
design,	 inclusion/exclusion	criteria,	 age,	 time	poststroke,	 interven-
tion	 frequency,	 intensity,	 type,	 time,	 materials,	 provider,	 delivery,	
setting,	dosage,	adherence,	motivational	strategies,	home	program,	
tailoring,	dropouts	and	adverse	events,	 and	outcomes	and	experi-
ences of the intervention.
2.11 | Quality assessment
Quantitative	 studies	 were	 assessed	 using	 the	 Effective	 Public	
Health	Practice	Project	(EPHPP)	tool	(Thomas	et	al.,	2004),	which	is	
designed	for	randomized	and	nonrandomized	studies	(Deeks	et	al.,	
2003)	 and	 has	 content	 and	 construct	 validity	 (Jackson	 &	Waters,	
2005;	Thomas	et	al.,	2004),	“fair”	 interrater	agreement	for	singular	
domains,	and	“excellent”	agreement	for	final	ratings	 (Armijo-	Olivo,	
Stiles,	Hagen,	 Biondo,	&	Cummings,	 2012).	 The	 overall	 global	 rat-
ing	 (“strong,”	 “moderate,”	 or	 “weak”)	 is	 based	 on	 the	 tally	 of	 indi-
vidual	 component	 scores.	 Mixed-	methods	 studies	 were	 assessed	
using	 the	Mixed	Methods	 Appraisal	 Tool	 (MMAT;	 Pluye,	 Gagnon,	
Griffiths,	&	Johnson-	Lafleur,	2009;	Pluye	et	al.,	2011).	Its	interrater	
reliability	ranges	from	moderate	to	perfect;	however,	its	validity	has	
not	been	assessed	yet	 (Pace	et	al.,	2012).	Scores	are	given	 for	 the	
number	of	criteria	met	per	domain,	while	an	overall	score	is	given	at	
the level of the lowest domain score. Qualitative studies were to be 
assessed	with	the	critical	review	form	developed	by	the	McMaster	
University	Occupational	Therapy	Evidence-	Based	Practice	Research	
Group	 (version	 2.0;	 Letts	 et	al.,	 2007).	 Each	 study	 was	 assessed	
independently	 by	 two	 review	 authors	 (ML	 and	 FvW),	 after	which	
findings	were	discussed.	A	third	review	author	(DS)	was	available	as	
arbitrator.	As	the	aim	of	this	review	was	to	synthesize	all	published	
quantitative	and	qualitative	data	from	a	body	of	literature	that	was	
anticipated	to	be	limited,	no	studies	were	excluded	on	the	basis	of	
their	methodological	quality.	However,	 study	quality	 informed	 the	
discussion	on	 the	strength	of	 the	evidence,	and	 recommendations	
for further research and implementation.
2.12 | Data analysis and synthesis
Only data pertaining to nonambulatory stroke survivors were in-
cluded	in	this	review,	as	generalizing	from	ambulatory	participants	
was considered inappropriate. In studies where data on nonambula-
tory	stroke	survivors	had	to	be	extracted	from	mixed	populations,	
TABLE  1 Search	strategy	for	PubMed	(adapted	for	each	
database)
PubMed (PubMed Central)
((((((((((((((((“stroke/brain”[All	Fields]	OR	“stroke/cerebral”[All	Fields])	
OR	“stroke/cerebrovascular”[All	Fields])	OR	“stroke/cerebrovascu-
lar	accident”[All	Fields])	OR	“stroke/cva”[All	Fields])	OR	“stroke/
edema”[All	Fields])	OR	“stroke/embolism”[All	Fields])	OR	“stroke/
hemiparesis”[All	Fields])	OR	“stroke/hemiplegia”[All	Fields])	OR	
“stroke/infarcted”[All	Fields])	OR	“stroke/infarction”[All	Fields])	OR	
“stroke/ischemia”[All	Fields])	OR	“stroke/ischemic”[All	Fields])	OR	
“stroke/rehabilitation”[All	Fields])	OR	“stroke/therapy”[All	Fields])	
OR	(“stroke”[MeSH	Terms]	OR	“stroke”[All	Fields]))	AND	
(((((((((((((((((((((((((((((((((((((“physical	activity”[All	Fields]	OR	“physical	
activity/exercise”[All	Fields])	OR	“physical	activity/fitness”[All	
Fields])	OR	“physical	activity/increased”[All	Fields])	OR	“physical	
activity/participation”[All	Fields])	OR	“physical	activity/
rehabilitation”[All	Fields])	OR	“physical	activity/sport”[All	Fields])	
OR	(“motor	activity”[MeSH	Terms]	OR	(“motor”[All	Fields]	AND	
“activity”[All	Fields])	OR	“motor	activity”[All	Fields]	OR	
(“physical”[All	Fields]	AND	“activity”[All	Fields])	OR	“physical	
activity”[All	Fields]))	OR	“chair	based”[All	Fields])	OR	“chair	based	
yoga”[All	Fields])	OR	(chair[All	Fields]	AND	based[All	Fields]))	OR	
“exercise”[All	Fields])	OR	“exercise/activities”[All	Fields])	OR	
“exercise/activity”[All	Fields])	OR	“exercise/aerobic”[All	Fields])	OR	
“exercise/circuit”[All	Fields])	OR	“exercise/fitness”[All	Fields])	OR	
“exercise/fitness	programs”[All	Fields])	OR	“exercise/group”[All	
Fields])	OR	“exercise/leisure”[All	Fields])	OR	“exercise/muscle”[All	
Fields])	OR	“exercise/muscle	contraction”[All	Fields])	OR	“exercise/
physical”[All	Fields])	OR	“exercise/physical	activity”[All	Fields])	OR	
“exercise/physical	therapy”[All	Fields])	OR	“exercise/
rehabilitation”[All	Fields])	OR	“exercise/rehabilitation	programs”[All	
Fields])	OR	“exercise/sport”[All	Fields])	OR	“exercise/sport	
activity”[All	Fields])	OR	“exercise/sports”[All	Fields])	OR	“exercise/
strength”[All	Fields])	OR	“exercise/strength	training”[All	Fields])	OR	
“exercise/stretch”[All	Fields])	OR	“exercise/stretching”[All	Fields])	
OR	“exercise/therapy”[All	Fields])	OR	“exercise/therapy	
interventions”[All	Fields])	OR	“exercise/therapy	programs”[All	
Fields])	OR	“exercise/treatment”[All	Fields]))	AND	((((((((((((“non	
ambulatory”[All	Fields]	OR	“non	ambulatory	activities”[All	Fields])	
OR	“non	ambulatory	activity”[All	Fields])	OR	“non	ambulatory	
hemiparetic	patients”[All	Fields])	OR	“non	ambulatory	
individuals”[All	Fields])	OR	“non	ambulatory	participants”[All	
Fields])	OR	“non	ambulatory	persons”[All	Fields])	OR	“non	
ambulatory	status”[All	Fields])	OR	“non	ambulatory	stroke”[All	
Fields])	OR	“non	ambulatory	stroke	patients”[All	Fields])	OR	“chair	
bound”[All	Fields])	OR	“chair	bound	patients”[All	Fields])	OR	“chair	
bound	persons”[All	Fields])
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review	 authors	 (ML,	 FvW)	 independently	 extracted	 and	 analyzed	
data,	analyzed	additional	data	supplied	by	study	authors,	or	included	
additional	data	analyzed	by	study	authors,	as	required	(as	indicated	
in	Tables	4–7).	Given	the	small	sample	sizes	of	such	subgroups,	only	
descriptive data were presented in this review. Interventions were 
grouped into clinically relevant categories of assisted walking train-
ing,	cycle	ergometer	training,	or	“other”	training.
For	 the	 analysis	 of	 intervention	 effects,	 only	 data	 from	 RCTs	
were	used,	as	this	type	of	design	yields	the	highest	quality	evidence.	
Randomized	 crossover	 studies	were	 also	 included—but	 only	 up	 to	
and including the point of crossover. Data from non- RCTs were ana-
lyzed	descriptively	only.	For	a	comprehensive	overview,	data	from	all	
included	studies	are	reported	in	the	data	tables	(Tables	4–7).	For	the	
meta-	analysis,	only	outcomes	used	 in	 two	or	more	RCTs	were	en-
tered;	outcomes	used	in	one	study	only	are	described	in	the	text	and	
presented	in	the	tables.	To	synthesize	quantitative	data	from	RCTs,	
RevMan	 5.3	 software	 (RevMan	 2014)	was	 used	 for	meta-	analysis	
purposes	(Cochrane	Collaboration,	2014).	Where	studies	used	vary-
ing	subscales	of	the	same	outcome	measure	(e.g.,	the	full	Fugl-	Meyer	
or	 its	 lower	 limb	subscale	only),	 the	standardized	mean	difference	
(SMD)	was	used	instead	of	the	mean	difference	(MD).	Only	data	re-
ported as standard deviation were entered in the meta- analysis; data 
presented as standard error were converted to standard deviation 
before	 being	 entered.	 Data	 reported	 as	 medians	 and	 (interquar-
tile)	 ranges,	which	did	not	 allow	 their	 distribution	 to	be	examined	
for	skewness,	were	not	included	in	meta-	analysis	(Higgins	&	Green,	
2011).	In	cases	where	multiple	baseline	assessments	were	reported	
that	were	not	significantly	different,	the	last	baseline	measure	was	
used. Final values at the end of intervention and at follow- up (where 
included)	were	used.	To	establish	the	odds	of	regaining	independent	
walking,	an	odds	ratio	(OR)	was	computed.	Variability	was	assessed	
with	the	Chi-	square	test	for	statistical	heterogeneity	and	the	I2 sta-
tistic	for	inconsistency	across	studies,	which	are	both	included	in	the	
RevMan	forest	plots.	However,	as	the	Chi-	square	test	has	low	power	
in meta- analyses when the sample size is small or when the number 
of	events	is	small,	the	significance	level	was	set	at	0.10	rather	than	at	
0.05,	and	a	random-	effects	model	was	used	(Higgins	&	Green,	2011).	
These processes also ensured comparability with the Cochrane sys-
tematic review on physical fitness training after stroke by Saunders 
et	al.	(2016).
For	 the	 analysis	 of	 feasibility,	 relevant	 data	on	 adverse	 events	
and	dropouts	 from	all	studies	were	 included.	For	case	fatality,	 the	
number of deaths in each group and the total number of participants 
in each group were entered into the meta- analysis as dichotomous 
outcomes	and	the	odds	ratios	(OR)	were	computed.
For	 the	analysis	of	acceptability	of	 interventions,	 the	plan	was	
to	use	a	thematic	synthesis	of	qualitative	data.	However,	no	qualita-
tive	studies	and	only	two	mixed-	methods	studies	could	be	included,	
which	had	very	little	qualitative	information	pertaining	to	nonambu-
latory	participants,	and	this	is	presented	narratively.
Following	 the	 separate	 analysis	 of	 quantitative	 and	 qualitative	
data,	the	framework	proposed	by	Thomas	et	al.	(2004)	was	used	to	
synthesize these data.
3  | RESULTS
3.1 | Study selection
Thirty-	four	 reports,	 representing	 33	 studies	 (Batcho,	 Stoquart,	 &	
Thonnard,	2013;	Chang,	Kim,	Huh,	Lee,	&	Kim,	2012;	Cho,	Park,	Lee,	
Park,	 &	 Kim,	 2015;	 Dean	 et	al.,	 2010;	 Demers	 &	 McKinley,	 2015;	
Franceschini	 et	al.,	 2009;	 Hesse,	 Bardeleben,	 Werner,	 &	 Waldner,	
2012;	 Hesse,	 Bertelt,	 Schaffrin,	 Malezic,	 &	 Mauritz,	 1994;	 Hesse,	
Waldner,	 &	 Tomelleri,	 2010;	 Hesse	 et	al.,	 1995;	 Husemann,	 Muller,	
Krewer,	Heller,	&	Koenig,	2007;	Lennon,	Carey,	Gaffney,	Stephenson,	&	
Blake,	2008;	Leroux,	2005;	Mayr	et	al.,	2007;	Mehrholz,	Rutte,	&	Pohl,	
2006;	Morone	et	al.,	2011;	Ng,	Tong,	&	Li,	2008;	Ochi,	Wada,	Saeki,	&	
Hachisuka,	2015;	Plummer	et	al.,	2007;	Potempa	et	al.,	1995;	Richards	
et	al.,	1993;	Rosendahl	et	al.,	2006;	Shea	&	Moriello,	2014;	Stoller	et	al.,	
2015;	Teixeira	da	Cunha	Filho	et	al.,	2001,	2002;	Tong,	Ng,	&	Li,	2006;	
Tsaih,	Shih,	&	Hu,	2012;	Vidoni,	Tull,	&	Kluding,	2008;	Wang,	Wang,	Fan,	
Lu,	&	Wang,	2014a;	Wang,	Wang,	Fan,	Wenjun,	et	al.,	2014b;	White,	
Bynon,	Marquez,	Sweetapple,	&	Pollack,	2013;	Yagura,	Hatakenaka,	&	
Miyai,	2006;	Yang	et	al.,	2014),	were	included	in	the	review	(Figure	1).
3.2 | Study types
Of	the	33	studies	included,	31	were	quantitative,	of	which	18	were	
RCTs	(Chang	et	al.,	2012;	Dean	et	al.,	2010;	Franceschini	et	al.,	2009;	
Husemann	et	al.,	2007;	Lennon	et	al.,	2008;	Morone	et	al.,	2011;	Ng	
et	al.,	2008;	Ochi	et	al.,	2015;	Potempa	et	al.,	1995;	Richards	et	al.,	
1993;	Rosendahl	et	al.,	2006;	Stoller	et	al.,	2015;	Teixeira	da	Cunha	
Filho	et	al.,	2001,	2002;	Tong	et	al.,	2006;	Tsaih	et	al.,	2012;	Wang	
et	al.,	 2014a,	 2014b;	 Yagura	 et	al.,	 2006),	 three	 were	 randomized	
crossover	 studies	 (Cho	 et	al.,	 2015;	Mayr	 et	al.,	 2007;	 Yang	 et	al.,	
2014),	 four	were	 cohort	 studies	 (Batcho	 et	al.,	 2013;	Hesse	 et	al.,	
1994;	Leroux,	2005;	Plummer	et	al.,	2007),	and	five	were	case	stud-
ies	(Hesse	et	al.,	1995,	2010;	Mehrholz	et	al.,	2006;	Shea	&	Moriello,	
2014;	Vidoni	et	al.,	2008).	Hesse	et	al.	(2012)	did	not	describe	study	
design,	 which	 was	 a	 controlled	 trial	 where	 participants	 were	 as-
signed	consecutively	to	one	of	two	groups.	White	et	al.	(2013)	used	
a	mixed-	methods	design.	Demers	&	McKinley	(2015)	presented	their	
study	as	a	descriptive	qualitative	study;	however,	review	authors	felt	
the	inclusion	of	quantitative	data	rendered	this	a	mixed-	methods	co-
hort design.
3.3 | Quality assessment
Of	the	31	quantitative	studies,	nine	(29%)	were	classified	as	“strong”	
(Chang	et	al.,	2012;	Franceschini	et	al.,	2009;	Hesse	et	al.,	2012;	Ng	
et	al.,	2008;	Ochi	et	al.,	2015;	Stoller	et	al.,	2015;	Wang	et	al.,	2014a,	
2014b;	Yang	et	al.,	2014)	and	14	(45%)	as	“moderate”	(Batcho	et	al.,	
2013;	Cho	et	al.,	2015;	Dean	et	al.,	2010;	Hesse	et	al.,	1994,	1995;	
Husemann	 et	al.,	 2007;	 Lennon	 et	al.,	 2008;	 Leroux,	 2005;	 Mayr	
et	al.,	 2007;	 Mehrholz	 et	al.,	 2006;	 Morone	 et	al.,	 2011;	 Plummer	
et	al.,	 2007;	 Rosendahl	 et	al.,	 2006;	 Teixeira	 da	 Cunha	 Filho	 et	al.,	
2001,	2002),	while	eight	 (26%)	were	 rated	as	 “weak”	 (Hesse	et	al.,	
2010;	Potempa	et	al.,	1995;	Richards	et	al.,	1993;	Shea	&	Moriello,	
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2014;	Tong	et	al.,	2006;	Tsaih	et	al.,	2012;	Vidoni	et	al.,	2008;	Yagura	
et	al.,	2006;	Table	2).	Of	the	18	RCTs,	11	used	an	intention-	to-	treat	
(ITT)	analysis	(Dean	et	al.,	2010;	Franceschini	et	al.,	2009;	Husemann	
et	al.,	2007;	Lennon	et	al.,	2008;	Morone	et	al.,	2011;	Ng	et	al.,	2008;	
Ochi	 et	al.,	 2015;	 Rosendahl	 et	al.,	 2006;	 Stoller	 et	al.,	 2015;	 Tong	
et	al.,	2006;	Wang	et	al.,	2014b)	and	six	did	not	(Chang	et	al.,	2012;	
Richards	et	al.,	1993;	Teixeira	da	Cunha	Filho	et	al.,	2001,	2002;	Tsaih	
et	al.,	2012;	Wang	et	al.,	2014a;	Yagura	et	al.,	2006),	while	reporting	
was	unclear	in	one	RCT	(Potempa	et	al.,	1995).
The	 quality	 of	 the	 two	 mixed-	methods	 studies	 (Demers	 &	
McKinley,	2015;	White	et	al.,	2013)	was	rated	as	 low,	as	 the	over-
all	score	is	the	lowest	score	of	the	study	components	(Pluye	et	al.,	
2011;	Table	3).
3.4 | Participants
A	total	of	910	nonambulatory	stroke	participants	were	 randomized	
or	 allocated	 otherwise	 in	 the	 33	 included	 studies.	 Between	 rand-
omization	and	intervention	start,	29	dropped	out,	leaving	894	(range	
1–126	per	study)	participating	 in	 the	 interventions	 (Table	4).	Of	 the	
33	studies,	18	 included	participants	 less	 than	6	months	poststroke,	
comprising	719	(80%)	participants	in	this	review	(Chang	et	al.,	2012;	
Dean	 et	al.,	 2010;	 Demers	 &	 McKinley,	 2015;	 Franceschini	 et	al.,	
2009;	 Hesse	 et	al.,	 2010,	 2012;	 Husemann	 et	al.,	 2007;	 Mehrholz	
et	al.,	 2006;	Morone	et	al.,	 2011;	Ng	et	al.,	 2008;	Ochi	 et	al.,	 2015;	
Richards	et	al.,	1993;	Stoller	et	al.,	2015;	Teixeira	da	Cunha	Filho	et	al.,	
2001,	 2002;	 Tong	 et	al.,	 2006;	Wang	 et	al.,	 2014a,	 2014b;	 Yagura	
et	al.,	2006).	Eight	studies	involved	participants	in	the	chronic	stage	
(≥6	months)	 poststroke	 (Batcho	 et	al.,	 2013;	 Lennon	 et	al.,	 2008;	
Leroux,	2005;	Plummer	et	al.,	 2007;	 Shea	&	Moriello,	 2014;	Vidoni	
et	al.,	2008;	White	et	al.,	2013;	Yang	et	al.,	2014)	and	four	 included	
participants	 across	 different	 stages	 poststroke	 (Cho	 et	al.,	 2015;	
Hesse	et	al.,	1994,	1995;	Mayr	et	al.,	2007),	while	 three	studies	did	
not	report	time	since	stroke	 (Potempa	et	al.,	1995;	Rosendahl	et	al.,	
2006;	Tsaih	et	al.,	2012).
3.5 | Interventions
Intervention	 details	 are	 presented	 in	 Table	5.	 Most	 studies	 (25/33)	
were characterized as assisted walking training (using electromechani-
cal	and	other	devices)	and	included	730/894	(82%)	of	all	participants	
(Batcho	et	al.,	2013;	Chang	et	al.,	2012;	Cho	et	al.,	2015;	Dean	et	al.,	
2010;	Franceschini	et	al.,	2009;	Hesse	et	al.,	1994,	1995,	2010,	2012;	
Husemann	 et	al.,	 2007;	 Leroux,	 2005;	 Mayr	 et	al.,	 2007;	 Mehrholz	
F IGURE  1 PRISMA	flow	diagram
Records idenfied through database 
searching
(n = 13,320)
Addional records idenfied through 
other sources
(n = 294)
Total number of records idenfied
(n = 13,614)
Total number of records 
aer duplicates removed
(n =12,184)
Duplicates removed
(n = 1,430 )
Titles aer screening
(n = 993)
Titles removed
(n = 11,191)
Records aer screening 
abstracts
(n = 384)
Records included aer 
screening full text
(n = 33)
Abstracts excluded
(n=609)
Full-text arcles excluded
(n = 351)
Reasons for exclusion:
- Protocol only (n=5)
- Not a full publicaon (n=1)
- Parcipants:
- not adults (n=1)
- not stroke survivors (n=4)
- not non-ambulatory (n=159)
- Data for non-ambulatory stroke 
parcipants: not available (n=81)
- Intervenon:
- not land-based (n=1)
- not for health-related fitness (n=45)
- Study did not explore effects/ experiences 
of a health-related fitness intervenon 
(n=3)
- Outcomes did not include any health-
related fitness outcome (n=51)
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TABLE  2 Quality	assessment	of	quantitative	studies	included	in	the	review
References Selection bias Study design Confounders Blinding
Data 
collection 
method
Withdrawals 
and dropouts Global rating
Batcho	et	al.	
(2013)
M M N/A M W M M
Chang et al. 
(2012)
M S S M S M S
Cho	et	al.	(2015) M S S M S W M
Dean et al. 
(2010)
W S S M S S M
Franceschini 
et	al.	(2009)
M S S M S S S
Hesse et al. 
(1994)
W M N/A M S S M
Hesse et al. 
(1995)
W M N/A M S S M
Hesse et al. 
(2010)
W W N/A M S S W
Hesse et al. 
(2012)
M M S M S S S
Husemann et al. 
(2007)
W S S M S S M
Lennon	et	al.	
(2008)
W S S M S S M
Leroux	(2005) W M N/A M S S M
Mayr	et	al.	
(2007)
W M N/A M S S M
Mehrholz	et	al.	
(2006)
W M N/A M S S M
Morone	et	al.	
(2011)
M S S M S W M
Ng	et	al.	(2008) M S S M S S S
Ochi et al. 
(2015)
M S S M S S S
Plummer et al. 
(2007)
W M N/A M S S M
Potempa et al. 
(1995)
W S S M S W W
Richards et al. 
(1993)
W S S M S W W
Rosendahl et al. 
(2006)
M S S M S W M
Shea and 
Moriello	(2014)
W W N/A M S S W
Stoller et al. 
(2015)
M S S M M M S
Teixeira	da	
Cunha Filho 
et	al.	(2001)
W S S M S M M
Teixeira	da	
Cunha Filho 
et	al.	(2002)
W S S M S S M
Tong et al. 
(2006)
W S M W S S W
(Continues)
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et	al.,	 2006;	Morone	 et	al.,	 2011;	 Ng	 et	al.,	 2008;	 Ochi	 et	al.,	 2015;	
Plummer	 et	al.,	 2007;	 Richards	 et	al.,	 1993;	 Rosendahl	 et	al.,	 2006;	
Stoller	 et	al.,	 2015;	 Teixeira	 da	Cunha	 Filho	 et	al.,	 2001,	 2002;	 Tong	
et	al.,	2006;	Tsaih	et	al.,	2012;	Vidoni	et	al.,	2008;	Yagura	et	al.,	2006).	
Five	studies	were	characterized	as	cycle	ergometer	training,	including	
154/894	(17%)	of	all	participants	(Lennon	et	al.,	2008;	Potempa	et	al.,	
1995;	Wang	et	al.,	2014a,	2014b;	Yang	et	al.,	2014).	Three	studies	com-
prised	“other	training,”	including	9/894	(1%)	of	all	participants,	that	is,	
dance	(Demers	&	McKinley,	2015),	Pilates	(Shea	&	Moriello,	2014),	and	
mixed	walking/cycling	and	health	education	 (White	et	al.,	2013)—but	
none	of	these	were	RCTs;	hence,	their	effects	could	not	be	analyzed.	
All	studies	reported	the	profession	of	staff	delivering	the	intervention,	
with	the	exception	of	Cho	et	al.	(2015)	and	Potempa	et	al.	(1995),	but	
exercises	were	supervised	in	all	studies.	Only	one	study	mentioned	a	
home	program	(Plummer	et	al.,	2007),	but	no	further	details	were	re-
ported.	Seventeen	of	33	studies	(52%)	indicated	that	participants	were	
given	 information	 to	aid	motivation,	but	none	appeared	 to	 include	a	
theory- based strategy.
3.5.1 | Assisted walking training
This category comprised overground functional/task- oriented as-
sisted	walking,	“brisk”	walking,	modified	jump	training,	body	weight-	
supported	 treadmill	 training	 (BWSTT),	 robot-	assisted	 walking,	 and	
stair climbing. Functional overground walking training was used in 
three	RCTs	(Richards	et	al.,	1993;	Rosendahl	et	al.,	2006;	Tsaih	et	al.,	
2012)	and	one	cohort	study	(Leroux,	2005).	Frequency	ranged	from	
2	×		per	day	 (Richards	et	al.,	1993)	to	2	×		per	week	(Leroux,	2005).	
Intensity of strength training as part of the high- intensity functional 
exercise	program	was	“high”	(i.e.,	8–12	repetition	maximum	[RM])	in	
one	study	(Rosendahl	et	al.,	2006),	“somewhat	strong”	to	“strong”	in	
another	study	(Leroux,	2005),	and	not	clearly	reported	in	two	studies	
(Richards	et	al.,	1993;	Tsaih	et	al.,	2012).	Intensity	was	monitored	in	
one	study	only	(Leroux,	2005).	Session	duration	ranged	from	30	min	
(Tsaih	et	al.,	2012)	to	1.74	±	0.15	hr	 (Richards	et	al.,	1993).	Program	
duration	 ranged	 from	 4	weeks	 (Tsaih	 et	al.,	 2012)	 to	 3	months	
(Rosendahl	et	al.,	2006).	The	number	of	sessions	varied	between	12	
(Tsaih	et	al.,	2012)	and	50	(Richards	et	al.,	1993).	Progression	was	de-
scribed	in	three	studies	(Leroux,	2005;	Rosendahl	et	al.,	2006;	Tsaih	
et	al.,	2012),	but	not	in	Richards	et	al.	(1993).	Brisk	walking	was	used	
in	one	cohort	study	(Batcho	et	al.,	2013),	but	how	this	was	adapted	for	
nonambulatory	participants	was	not	explained.	Modified	jump	train-
ing	was	used	in	one	case	series	(Mehrholz	et	al.,	2006).	Intensity	was	
set	by	the	patient	and	therapist,	but	was	not	described.	Two	studies	
monitored	 cardiovascular	 responses	 (Batcho	et	al.,	 2013;	Mehrholz	
et	al.,	2006).
BWSTT	 was	 used	 in	 four	 RCTs	 (Dean	 et	al.,	 2010;	 Franceschini	
et	al.,	2009;	Teixeira	da	Cunha	Filho	et	al.,	2001,	2002;	Yagura	et	al.,	
2006)	and	four	other	studies	(Hesse	et	al.,	1994,	1995;	Plummer	et	al.,	
2007;	Vidoni	et	al.,	2008;	Table	6).	Session	frequency	ranged	from	3	×		
(Plummer	et	al.,	2007;	Yagura	et	al.,	2006)	to	5	×		per	week	(Dean	et	al.,	
2010;	Franceschini	et	al.,	2009;	Hesse	et	al.,	1994,	1995;	Plummer	et	al.,	
2007;	Teixeira	da	Cunha	Filho	et	al.,	2001,	2002).	Intensity	was	not	de-
scribed	in	any	study;	Plummer	et	al.	(2007)	was	the	only	study	to	mon-
itor	heart	rate,	while	Vidoni	et	al.	(2008)	assessed	heart	rate	and	blood	
pressure	prior	to	each	session.	Session	duration	ranged	from	15	(Hesse	
et	al.,	1994)	to	30	min	(Dean	et	al.,	2010;	Hesse	et	al.,	1995;	Plummer	
et	al.,	 2007).	 Average	 program	 duration	 ranged	 from	 5	 (Franceschini	
et	al.,	2009;	Hesse	et	al.,	1994)	to	16	weeks	(Plummer	et	al.,	2007).	In	
other	studies,	 the	 intervention	ended	when	participants	achieved	 in-
dependent	walking	(Dean	et	al.,	2010)	or	were	discharged	(Dean	et	al.,	
2010;	Teixeira	da	Cunha	Filho	et	al.,	2001,	2002).	The	number	of	ses-
sions,	where	stated,	ranged	from	18	(Yagura	et	al.,	2006)	to	45(Hesse	
et	al.,	1995).	Walking	was	assisted	by	one	or	more	therapists,	while	BWS	
did	not	exceed	50%	in	any	study.	Progression	was	described	in	all	stud-
ies,	which	was	achieved	by	reducing	BWS	and/or	increasing	speed.
References Selection bias Study design Confounders Blinding
Data 
collection 
method
Withdrawals 
and dropouts Global rating
Tsaih et al. 
(2012)
W S S M W M W
Vidoni	et	al.	
(2008)
W W N/A M S S W
Wang et al. 
(2014a)
M S S M S S S
Wang et al. 
(2014b)
M S S M S S S
Yagura	et	al.	
(2006)
W S W M S S W
Yang	et	al.	
(2014)
M S S M S S S
Note.	W,	weak;	M,	moderate;	S,	strong;	N/A,	not	applicable	to	studies	with	only	one	group.
TABLE  2  (Continued)
     |  9 of 55LLOYD et aL.
Robot-	assisted	walking	training,	using	a	total	of	four	different	devices	
across	studies,	featured	in	11	studies	(Chang	et	al.,	2012;	Cho	et	al.,	2015;	
Hesse	et	al.,	2010,	2012;	Husemann	et	al.,	2007;	Mayr	et	al.,	2007;	Morone	
et	al.,	2011;	Ng	et	al.,	2008;	Ochi	et	al.,	2015;	Stoller	et	al.,	2015;	Tong	et	al.,	
2006;	Table	5).	The	Lokomat	was	used	in	five	studies	(Chang	et	al.,	2012;	
Cho	et	al.,	2015;	Husemann	et	al.,	2007;	Mayr	et	al.,	2007;	Stoller	et	al.,	
2015).	The	G-	EO	Systems	Robot	was	used	in	two	studies	(Hesse	et	al.,	
2010,	2012)	and	the	Gait	Trainer	(GTII)	was	used	in	three	studies	(Morone	
et	al.,	2011;	Ng	et	al.,	2008;	Tong	et	al.,	2006),	while	the	Gait	Assistance	
Robot	(GAR)	was	used	in	one	study	(Ochi	et	al.,	2015).	Training	frequency	
ranged	from	1×	per	week	(Tong	et	al.,	2006)	to	2×	per	day	(Chang	et	al.,	
2012).	Intensity	was	not	specified	as	such	in	any	of	the	studies,	but	some	
monitored	 cardiovascular	 responses	 (Hesse	et	al.,	 2010,	2012;	 Stoller	
et	al.,	2015;	Tong	et	al.,	2006).	Session	duration	ranged	from	15	(Hesse	
et	al.,	2010,	2012)	to	30	min	net	training	time	(Husemann	et	al.,	2007),	al-
though	the	total	session	duration	in	Husemann	et	al.	(2007)	was	60	min.	
Program	duration	ranged	from	2	(Chang	et	al.,	2012)	to	9	(Mayr	et	al.,	2007)	
weeks,	but	in	Mayr’s	study	(Mayr	et	al.,	2007)	this	comprised	only	two,	
three-	week	blocks	of	Lokomat	training.	The	number	of	sessions	ranged	
from	4	(Tong	et	al.,	2006)	to	45	(Mayr	et	al.,	2007)	and	was	20	in	most	stud-
ies	(Chang	et	al.,	2012;	Hesse	et	al.,	2012;	Husemann	et	al.,	2007;	Morone	
et	al.,	2011;	Ng	et	al.,	2008;	Ochi	et	al.,	2015).	In	studies	using	BWS,	this	
was	set	at	a	maximum	of	50%	and	reduced	as	soon	as	possible	and	speed	
was increased while preserving an optimal gait pattern. Progression in the 
study	by	Ochi	et	al.	(2015),	who	did	not	use	BWS,	was	not	clearly	described.
3.5.2 | Cycle ergometer training
Four	RCTs	(Lennon	et	al.,	2008;	Potempa	et	al.,	1995;	Wang	et	al.,	2014a,	
2014b)	and	one	randomized	crossover	study	(Yang	et	al.,	2014)	used	cycle	
ergometer	 training,	 including	 lower	 limb	 cycling	 (Wang	 et	al.,	 2014a,	
2014b);	 Yang	 et	al.,	 2014)	 or	 upper/lower	 limb	 cycling	 (Lennon	 et	al.,	
2008),	while	Potempa	et	al.	(1995)	did	not	specify	the	type	of	cycling.	The	
study	by	Lennon	et	al.	(2008)	included	two	“life	skills”	classes.	Frequency	
ranged	from	2×	(Lennon	et	al.,	2008)	to	5×	per	week	(Yang	et	al.,	2014).	
Intensity	ranged	from	“low”	(Wang	et	al.,	2014a,	2014b)	to	“a	little	strenu-
ous”	(Borg	scale	13;	Yang	et	al.,	2014)	and	was	monitored	in	four	studies	
(Lennon	et	al.,	2008;	Wang	et	al.,	2014a,	2014b;	Yang	et	al.,	2014).	Session	
duration	ranged	from	30	(Lennon	et	al.,	2008;	Potempa	et	al.,	1995;	Yang	
et	al.,	2014)	to	40	min	(Wang	et	al.,	2014a,	2014b),	while	training	periods	
ranged	from	6	(Wang	et	al.,	2014a,	2014b)	to	10	(Potempa	et	al.,	1995)	
weeks.	The	number	of	sessions	varied	between	16	(Lennon	et	al.,	2008)	
and	30	(Potempa	et	al.,	1995).	Training	load	was	progressed	in	all	studies.
3.5.3 | Other training
Shea	 et	al.	 (Shea	&	Moriello,	 2014)	 delivered	 an	 adapted,	 classical	
Pilates	program	comprising	of	exercises	in	a	lying/seated	position	for	
9	months—the	longest	intervention	period	reported.	Exercises	were	
progressed,	 but	 intensity	 was	 not	 reported.	 Demers	 &	 McKinley	
(2015)	adapted	dance	techniques,	so	they	could	be	performed	in	sit-
ting.	 Improvisation	was	used	to	encourage	participants,	but	other-
wise	progression	was	not	clear.	Intensity,	which	was	moderate,	was	T
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TABLE  4 Demographic	data	and	inclusion/exclusion	criteria	of	included	studies
Author 
(year)
Number of 
non- 
ambulatory 
stroke 
participants 
(% of study 
participants)
Age (years) 
of study 
participants
Mean (SD) 
(unless stated 
otherwise)
Time since stroke 
of study 
 participants
Mean (SD) (unless 
stated otherwise) Inclusion criteria Exclusion criteria
Batcho	
(2013)a
Int.:	6	(12%) Int.:	60.5	
(45–85)b
Int.:	18.4	(13–44)	
monthsb
1.	Having	stroke	at	least	6	
months	prior	to	inclusion,	
2.	Minimal	ambulatory	
capacity with supervision 
and/or	assistive	device,	3.	No	
major cognitive deficit that 
could prevent completion of 
a	self-	reported	questionnaire	
(MMSE	score	≥24).
NR
Chang 
(2012)
Int.:	20	(100%)
Cont.: 17 
(100%)
Int.:	55.5	
(12.0)
Cont.:	59.7	
(12.1)
Int.:	16.1	(4.9)	days
Cont.:	18.2	(5.0)	
days
1.	First-	ever	stroke,	2.	Stroke	
onset	within	1	month,	
3.	Supratentorial	lesion,	
4.	Age	>20	years	and	
<65	years,	5.	FAC<	2,	
6.	Ability	to	cooperate	during	
exercise	testing.
1.	Absolute	and	relative	contraindica-
tions	to	exercise	testing	as	per	
ACSM,	2.	contraindications	for	
Lokomat	therapy,	3.	Musculoskeletal	
disease	involving	the	lower	limbs,	
e.g.,	severe	painful	arthritis,	
osteoporosis,	or	joint	contracture	
and other neurological diseases.
Cho  
(2015)
Group	1:	13	
(100%)
Group	2:	7	
(100%)
Group	1:	55.3	
(11.9)
Group	2:	55.4	
(15.3)
Group	1:	15.1	(8.7)	
months
Group	2:	13.4	(6.7)	
months
1. Time post stroke 
>6	months,	2.	FAC	<2,	
3. Independent ambulation 
before	stroke,	4.	Capability	
of understanding and 
executing	RAGT,	5.	An	
absence of other orthopaedic 
or neurological problems in 
the	lower	extremities.
1.	Weight	>120	kg.	2.	Femoral	length	
<35	cm	or	femoral	length	
>47	cm.	3.	History	of	lower	
extremity	fracture	after	
stroke.	4.	Instability	or	subluxation	
of	the	hip	joint.	5.	Pressure	ulcers	on	
hips	or	lower	extremities.	6.	Any	
underlying disease preventing 
execution	of	RAGT.
Dean  
(2010)
Int.:	64	(100%)
Cont.:	62	
(100%)
Int.:	70	(9)
Cont.:	71	(9)
Int.:	18	(8)	days
Cont.:	18	(7)	days	
1. Within 28 days of 1st 
stroke,	2.	Aged	50–85	years,	
3. Clinically diagnosed with 
hemiplegia	or	hemiparesis,	
4.	Non-	ambulatory,	defined	
as	Item	5	(walking)	score	0	or	
1	on	MAS.
1.	Clinically	evident	brainstem	signs,	
2. Severe cognitive and/or language 
deficits,	unable	to	follow	instruc-
tions,	3.	Unstable	cardiac	status,	
4.	Pre-	morbid	conditions	that	
precluded rehabilitation.
Demers 
(2015)c
Int.:	5	(31%) Int.: 71 
(47–74)b
Int.:	2	(1–4)	
monthsb
1.	Stable	medical	condition,	
regardless of co- morbidities 
or medication.
1.	Severe	motor	apraxia,	2.	Severe	
mixed	aphasia,	3.	Tetraplegia,	4.	Poor	
tolerance	to	group	setting,	
5.	Significant	behavioural	problems,	
6.	Unable	to	tolerate	at	least	2,	
45-	min	treatment	sessions	per	day.
Franceschini 
(2009)
Int.:	52	(100%)
Cont.:	45	
(100%)
Int.:	65.5	
(12.2)
Cont.: 70.9 
(11.8)
Int.:16.7	(9.8)	days
Cont.:	14.4	(7.3)	
days
1.	Time	post	stroke	<	45	days,	
2.	Able	to	control	sitting	
position on rigid surface with 
legs hanging freely and 
without arm support for at 
least	30	s,	3.	Able	to	control	
trunk in upright position even 
with	help	of	upper	extremi-
ties	gripping	a	fixed	support	
or	other	aid,	4.	No	LL	
spasticity	(Ashworth	scale	
≤1),	5.	Stable	cardiovascular	
condition with a low risk for 
vigorous	exercise	(ACSM	
Class	B).
1. Significant pre- stroke disability 
(modified	Rankin	Scale	≥2),	
2. Significant pre- stroke gait 
disability (Walking Handicap Scale 
≥2),	3.	Orthopaedic	or	other	
pre- stroke disorders causing a gait 
limitation,	4.	Mild	gait	impairment	at	
time of enrolment (ability to walk 
without aids for at least 3 m or for 
more	than	6	m	with	the	aid	of	a	cane	
or	tripod,.	5.	Previous	treadmill	
training,	6.	ACSM	Class	C	or	D	
exercise	risk	or	New	York	Heart	
Association	classification	system	
Class	III	or	IV	risk.
(Continues)
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Author 
(year)
Number of 
non- 
ambulatory 
stroke 
participants 
(% of study 
participants)
Age (years) 
of study 
participants
Mean (SD) 
(unless stated 
otherwise)
Time since stroke 
of study 
 participants
Mean (SD) (unless 
stated otherwise) Inclusion criteria Exclusion criteria
Hesse 
(1994)
Int.:	9	(100%) Int.:	56.7	
(31–79)
Int.: 129  
(54–414)	days
NR NR
Hesse 
(1995)
Int.:	7	(100%) Int.:	60.3	
(52–72)
Int.:	176.8	
(91–362)	days
NR 1.	Additional	neurological	and/or	
orthopaedic deficits that impaired 
ambulation,	2.	Heart	Failure	
classified	as	greater	than	New	York	
Heart	Association	grade	2.
Hesse 
(2010)
Case study:  
Int.:	1	(100%)
Case study: 
Int.: 72
Case study:  
Int.:	5	weeks
NR NR
Hesse 
(2012)
Int.:	15	(100%)
Cont.:	15	
(100%)
Int.:	63.7	(9.4)
Cont.:	66.4	
(11.9)
Int.:	5.7	(2.3)	
weeks
Cont.:	5.1	(1.6)	
weeks
1.	Age	<80	years,	2.	First-	time	
supratentorial stroke with 
time	post	stroke	<10	weeks,	
3. Wheelchair- mobilised and 
partially independent in basic 
activities	of	living	(Barthel	
Index	30–55	out	of	100),	
4.	Able	to	sit	at	edge	of	bed	
with hands holding on and 
feet placed on floor and able 
to stand for short period with 
hands	holding	on,	5.	Requiring	
continuous or intermittent 
help carrying weight and with 
balance	during	gait	(FAC	1–2),	
6.	No	severe	lower-	limb	
spasticity,	joints	must	reach	
neutral position in standing 
frame,	7.	No	severe	heart	
disease limiting participation 
according	to	cardiology	exam	
including	a	12-	lead	ECG,	
8. No other neurological or 
orthopaedic disease impairing 
repetitive	gait	practice,	9.	No	
severe cognitive or communi-
cative impairment.
NR
Husemann 
(2007)
Int.:	17	(100%)
Cont.:	15	
(100%)
Int.:	60(13)
Cont.:	57(11)
Int.:	79(56)	days
Cont.:	89(61)	days
1.	No	prior	stroke,	2.	No	other	
neurological or orthopaedic 
disorder,	3.	Independent	
ambulation	prior	to	stroke,	
4.	No	severe	medical	illness,	
5.	Severe	lower	extremity	
hemiparesis	(Lower	extremity	
muscle	strength	MRC	grade	
≤3	in	>2	muscle	groups),	
6.	FAC	≤1	7.	Time	post	stroke	
28–200	days.
NR
Lennon	
(2008)c
Int.:	4	(17%)
Cont.:	4	(17%)
Int.: 
59.0(10.3)d
Cont.: 
60.5(10.0)d
Int.:	237.3	(110.7)	
weeksd
Cont.:	245.3	
(169.8)	weeksd
1.	Time	post	stroke	>1	year,	
2.	Stroke	confirmed	by	MRI/	
CT	scan,	2.	Age	>18	years,	
3. Irrespective of ambulatory 
capacity.
1. O2	dependence,	2.	Angina,	
3.	Unstable	cardiac	conditions,	
4.	Uncontrolled	diabetes,	5.	Major	
medical	condition,	6.	Claudication,	
7.	Febrile	illness,	8.	Cognitive	
impairment,	9.	Beta	blocker	
medication.
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Author 
(year)
Number of 
non- 
ambulatory 
stroke 
participants 
(% of study 
participants)
Age (years) 
of study 
participants
Mean (SD) 
(unless stated 
otherwise)
Time since stroke 
of study 
 participants
Mean (SD) (unless 
stated otherwise) Inclusion criteria Exclusion criteria
Leroux	
(2005)
Int.:	20	(100%) Int.:	67.6	
(10.0)
Int.:	5.5	(6.3)	years 1. Stroke resulting in 
hemiplegia	or	hemiparesis,	
2.	Time	post	stroke	≥	
6	months,	3.	Fully	discharged	
from	rehabilitation,	
4.	Written	approval	from	
primary	care	physician,	
5.	Complete	the	CJCS	
physical	activity	question-
naire	(modified	Par-	Q	form).
1. Previous participation in the 
exercise	class	at	the	CJCS,	2.	Any	
medical conditions that would 
severely limit participation in the 
exercise	program	or	outcome	
assessments.
Mayr	
(2007)a
Int.	ABA:	7	
(88%)
Int.	BAB:	5	
(63%)
Int.	ABA:	65	
(44–87)b
Int.	BAB:	67	
(57–78)b
Int.	ABA:	2	(1–10)	
monthsb
Int.	BAB:	1.5	(1–5)	
monthsb
NR NR
Mehrholz	
(2006)
Int.:	6	(100%) Int.:	54.5	
(41–67)b
Int.:	6	(3–12)	
weeksb
1. Hemiparesis due to 1st 
stroke of middle cerebral 
artery or hemispheric 
haemorrhagic	stroke,	2.	Able	
to stand with assistance for at 
least	10s,	3.	Able	to	walk	15	m	
with	therapist,	4.	FAC=	2
1.	Osteoporosis,	2.	Ankle	contracture,	
3.	Modified	Tardieu	and	Ashworth	
Scale 2 +  (increased muscle tone 
ankle,	knee	or	hip),	4.Neurological	
symptoms	e.g.,	aphasia.
Morone	
(2011)
Int. 1: 12 
(100%)
Int. 2: 12 
(100%)
Cont. 1: 12 
(100%)
Cont. 2: 12 
(100%)
Int. 1: 
55.58	±	13.35
Int. 2: 
68.33	±	9.11
Cont. 1: 
60.17	±	9.59
Cont. 2: 
62.92	±	17.43
Int. 1: 
16.25	±	11.33	days
Int. 2: 
21.92	±	10.72	days
Cont. 1: 
20.00	±	12.76	days
Cont. 2: 
20.00	±	15.68	days
1. Hemiplegia/hemiparesis in 
the	subacute	phase,	
2. Significant gait deficits 
(FAC	<	3)	caused	by	a	
first-	ever	stroke,	3.	Lesions	
confirmed	by	CT	or	MRI,	
4.	Age	between	18–80	years.
1.	Subarachnoid	haemorrhage,	
2.	Sequelae	of	prior	stroke,	3.	Other	
chronic	disabling	pathologies,	
4.	Orthopaedic	injuries	that	could	
impair	locomotion,	5.	Spasticity	
limiting	lower	extremity,	i.e.,	ROM	
less	than	80%,	6.	Sacral	skin	lesions,	
7.	MMSE	score	<	24	8.	Hemispatial	
neglect.
Ng	(2008) Int. 1: 17 
(100%)
Int.	2:	16	
(100%)
Cont.: 21 
(100%)
Int.	1:	66.6	
(11.3)
Int.	2:	62.0	
(10.0)
Cont.:	73.4	
(11.5)
Int.	1:	2.7	(1.2)	
weeks
Int.	2:	2.3	(1.1)	
weeks
Cont.:	2.5	(1.2)	
weeks
1. Diagnosis of ischaemic brain 
injury or intracerebral 
haemorrhage	by	MRI	or	CT,	
2. Time post stroke 
<6	weeks,	3.	Sufficient	
cognition to follow simple 
instructions and understand 
study content and purpose 
(MMSE	>21),	4.	Ability	to	
stand	upright,	supported	or	
unsupported,	for	1	minute,	
5.	Significant	gait	deficit	(FAC	
<3),	6.	No	skin	allergy.
1. Recurrent stroke or other 
neurological deficit affecting 
ambulation	ability,	2.	Any	additional	
medical or psychological condition 
affecting ability to comply with 
study	protocol,	3.	Aphasia	or	a	
cognitive deficit with inability to 
follow two consecutive step 
commands,	4.	Severe	hip,	knee	or	
ankle contracture or orthopaedic 
problem affecting ambulation that 
would	preclude	passive	ROM	of	
paretic leg.
Ochi	(2015) Int.:	13	(100%)
Cont.: 13 
(100%)
Int.:	61.8	(7.5)
Cont.:	65.5	
(12.1)	
Int.:	22.9	(7.4)	days
Cont.:	26.1	(8.0)	
days
1. First- ever stroke with a 
unilateral cerebral hemi-
spheric lesion confirmed by 
CT	or	MRI,	2.	Age	
40–85	years,	3.	Time	post	
stroke	<	5	weeks,	4.	Severe	
paralysis	of	the	LL	
(Brunnstrom’s	stage	<	grade	
III,	5.	Non-	ambulator,	defined	
as	FAC	≤2,	6.	Independent	
walking before stroke. 
1.	Height	<145	or	>180	cm,	2.	Body	
weight	>100	kg,	3.	Marked	limitation	
in	LL	ROM,	4.	Severe	cardiovascular,	
respiratory,	renal,	or	musculoskeletal	
disease,	5.	Difficulty	communicating.
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Author 
(year)
Number of 
non- 
ambulatory 
stroke 
participants 
(% of study 
participants)
Age (years) 
of study 
participants
Mean (SD) 
(unless stated 
otherwise)
Time since stroke 
of study 
 participants
Mean (SD) (unless 
stated otherwise) Inclusion criteria Exclusion criteria
Plummer 
(2007)
Int.:	1	(14%) Int.: 73 Int.:	6	months 1. Time post stroke 
3–7	months,	2.	Residual	LL	
paresis,	3.	Able	to	sit	
unsupported	for	30	seconds,	
4.	Follow	a	3	step	command,	
5.	Able	to	walk	at	least	10	ft	
with	maximum	AO1,	
6.	Self-	selected	gait	speed	
<0.8 m/s.
1. Dependent in self- care/lived in 
nursing	home	prior	to	stroke,	2.	Unable	
to	ambulate	≥150	ft.	prior	to	stroke,	
3.	Serious	cardiac	conditions,	
4.	Serious	COPD,	5.	Supplemental	O2 
dependence,	6.	Severe	WB	pain,	
7.	Pre-	existing	neurological	disease,	
8.	Dementia,	9.	Previous	stroke	with	
existing	neurological	defi-
cits,10.	History	of	major	head	trauma,	
11.	LL	amputation,	12.	Non-	healing	LL	
ulcers,	13.	Renal	dialysis	or	end	stage	
liver	disease,	14.	Legal	blindness	or	
severe	visual	impairment,	15.	History	
of	significant	psychiatric	illness,	
16.	Life	expectancy	<1	year,	17.	Severe	
arthritis or orthopaedic problems 
limiting	LL	passive	ROM,	18.	History	of	
alcoholism	or	drug	abuse,	19.	History	
of	DVT	or	pulmonary	embolism	within	
6	months,	20.	Uncontrollable	diabetes	
with	recent	weight	loss,	21.	Diabetic	
coma	or	frequent	insulin	reactions,	
22. Severe sustained hypertension 
with	systolic	BP	>180	mmHg	and	
diastolic	BP	>100	mmHg.	
Potempa 
(1995)
Int.:	19	(100%)
Cont.: 23 
(100%)
Not reported 
as int/cont 
groups
NR 1.	Aged	21–77	years,	2.	Time	
post hemispheric stroke 
>6	months,	3.	Medically	
stable,	4.	Completed	
rehabilitation.
1.	Brain	stem	lesions,	2.	Disorders	
that	preclude	maximal	exercise	
testing or confound the measure-
ment	of	maximal	exercise	
parameters.
Richards 
(1993)
Int.:	10	(100%)
Cont. 1: 8 
(100%)
Cont. 2: 9 
(100%)
Int.:	69.6	(7.4)
Cont.	1:	67.3	
(11.2)
Cont. 2: 70.3 
(7.3)
0–7	days 1.	Live	within	50	km	of	study	
site,	2.	Age	40–80	years,	
3.	Time	post	1st	stroke	<7	days,	
4.	Clinically	identi	fiable	MCA	
syndrome of thromboembolic 
origin involving subcortical 
struc	tures	confirmed	by	CT,	
5.	Under	medical	supervision	
of study neurologist.
1.	Other	neurological	conditions,	
2.	Major	medical	problem	that	had	or	
would incapacitate functional 
capacity or interfere with 
rehabilitation.
Rosendahl 
(2006)a 
Int. 1: 
Exercise	+	diet	
supplement:	4	
(8%)
Cont. 1: 
Sitting + diet 
supplement: 7 
14%)
Int. 2: 
Exercise	+	
placebo: 8 
(18%)
Cont. 2: 
Sitting + 
placebo: 8 
(16%)
Int. 1: 
Exercise	+	diet	
supplement: 
82	(74–92)b
Cont. 1: 
Sitting + diet 
supplement: 
79	(65–86)b
Int. 2: 
Exercise	+	
placebo: 88 
(77–90)b
Cont. 2: 
Sitting + 
placebo:	84.5	
(68–90)b
NR 1.	Age	≥65	years,	
2. Dependent on assistance 
from	a	person	in	≥1	personal	
activity of daily living 
according	to	Katz	Index,	
3.	Able	to	stand	up	from	
chair with armrests with help 
from no more than one 
person,	4.MMSE	
≥10.	5.	Approval	from	
physician.
NR
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Author 
(year)
Number of 
non- 
ambulatory 
stroke 
participants 
(% of study 
participants)
Age (years) 
of study 
participants
Mean (SD) 
(unless stated 
otherwise)
Time since stroke 
of study 
 participants
Mean (SD) (unless 
stated otherwise) Inclusion criteria Exclusion criteria
Shea	(2014) Int.:	1	(100%) Int.:	67 Int.: 8 months NR NR
Stoller 
(2015)
Int.:	7	(100%)
Cont.:	7	(100%)
Int.:	57	(12)
Cont.:	63	(13)
Int.:	52	(42)	days
Cont.:	45	(30)	days
1. Clinical diagnosis of 
first-	ever	stroke,	2.	Time	post	
stroke	<	20w,3.	Age	>	
18	years,	4.	FAC	<3,	5.	Ability	
to understand procedures 
and provide informed 
consent.
1. Contraindications for cardiopulmo-
nary	exercise	testing	(ACSM),	
2. Contraindications for robot- 
assisted	treadmill	exercise	according	
to	device	manufacturer,	3.	Concurrent	
neurological	disease)	4.	Concurrent	
pulmonary	disease,	5.	Dementia.
Teixeira	da	
Cunha 
Filho 
(2001)
Int.:	6	(100%)
Cont.:	6	(100%)
Int.:	57.83	
(5.56)
Cont.:	59.67	
(13.58)
Int.:	15.67	(7.66)	
days
Cont.:	14.33	(6.06)	
days
1.	Time	post	stroke	<	6	weeks,	
diagnosis based on clinical 
presentation	or	MRI,	
2.	Significant	gait	deficit	i.e.,	
speed	≤36	m/min	and	FAC	
≤2,	3.	MMSE	≥21,	4.	Able	to	
stand with or without 
assistance	and	take	≥1	step	
with or without assistance.
1. Co- morbidity or disability other 
than hemiparesis that would 
preclude	gait	training,	2.	MI	within	
4	weeks,	3.	Uncontrolled	health	
condition that contraindicates 
exercise,	e.g.,	uncontrolled	diabetes,	
4.	Severe	lower	extremity	joint	
disease	or	rheumatoid	arthritis,	5.	
Body	weight	>110	kg,	6.	MMSE	<21.
Teixeira	da	
Cunha 
Filho 
(2002)
Int.:	6	(100%)
Cont.:	7	(100%)
Int.:	57.80	
(5.50)
Cont.:	58.90	
(12.90)
Int.:	15.70	(7.70)	
days
Cont.: 19.00 
(12.70)	days
See	Teixeira	da	Cunha	Filho	
(2001).	Also:	1.	Stable	
medical condition allowing 
participation	in	exercise
See	Teixeira	da	Cunha	Filho	(2001)	
Also:1.	Cardiac	bypass	surgery	with	
complications,	2.	History	of	bilateral	
stroke.
Tong	(2006) Int.	1:	15	
(100%)
Int.	2:	15	
(100%)
Cont.: 20 
(100%)
Int.	1:	66.1	
(9.9)
Int.	2:	61.8	
(10.8)
Cont.:	71.4	
(14.0)
Int.	1:	2.7	(1.3)	
weeks
Int.	2:	2.3	(1.0)	
weeks
Cont.:	2.7	(1.2)	
weeks
1. Diagnosis of ischaemic brain 
injury or intracerebral 
haemorrhage	by	MRI	or	CT,	
2.	Time	post	stroke<	6w,	
3. Sufficient cognition to 
follow simple instructions 
and understand the study 
(MMSE	>21),	4.	Able	to	stand	
upright,	supported/	
unsupported	for	1	minute,	
4.	Significant	gait	deficit	(FAC	
<3),	5.	No	skin	allergy	to	
electrical stimulation.
1. Recurrent stroke or other 
neurological deficit affecting 
ambulation,	2.	Any	additional	
medical or psychological condition 
affecting ability to comply with 
study	protocol,	3.	Aphasia	or	a	
cognitive deficit with inability to 
follow two consecutive step 
commands,	4.	Severe	hip,	knee	or	
ankle contracture that would 
preclude	LL	passive	ROM.
Tsaih 
(2012)a
Int.:	8	(32%)
Cont.:	7	(28%)
Int.:	72.5	
(45–90)b
Cont.:	75	
(54–89)b
Data not provided 
by authors
1.	Ambulation	challenged	but	
judged to be able to regain 
walking	after	treatment,	
2. Clarity of consciousness 
and ability to follow one step 
commands,	3.	Walking	speed	
<	37	m/min,	4.	Ability	to	stand	
with walking aids or slight 
assistance	of	one,	5.	Knee	
extensor	muscle	strength	>	
grade	III,	6.	Knee	flexion	
contracture	<20°,	7.	Ability	to	
sit	independently	>	2	min
1.	Any	exercise	contraindications,	
2.	Uncontrolled	BP.
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Author 
(year)
Number of 
non- 
ambulatory 
stroke 
participants 
(% of study 
participants)
Age (years) 
of study 
participants
Mean (SD) 
(unless stated 
otherwise)
Time since stroke 
of study 
 participants
Mean (SD) (unless 
stated otherwise) Inclusion criteria Exclusion criteria
Vidoni	
(2008)
Int.:	1	(100%) Int.:	61 Int.:	≥5	years 1.	Time	post	stroke	≥	
6	months,	2.	Able	to	transfer	
sit- stand with minimal 
assistance,	3.	Unable	to	walk	
independently,	4.	Without	
language or cognitive deficits 
that would impair informed 
consent,	5.	Without	a	
medical condition that would 
prevent safe participation in 
an	exercise	programme.
NR
Wang 
(2014a)
Int.:	24	(100%)
Cont.:	24	
(100%)
Int.:	57	(6.8)
Cont.:	55	
(11.5)
Int.:	30	(10.2)	days
Cont.: 
36	±	12.1	days
1.	Time	post	stroke	2–6	week,	
2.	Age	45–75	years,	3.	Unable	
to	walk	with	any	walk	aid,	
4.	Severely	impaired;	
affected	leg	score≤	3	on	the	
Chedoke-	McMaster	Stroke	
Assessment	scale,	
5.	Cardiovascular	stable,	
6.	No	orthopaedic	disease	to	
preclude	ergometer	exercise	
training,	7.	Not	taking	
medication that might 
significantly	alter	heart	rate,	
8.	Able	to	understand	study	
information.
1.	Subarachnoid	haemorrhage,	2.	TIA,	
3.	Severe	cerebral	oedema,	4.	O2 
dependence,	5.	Angina,	6.	Unstable	
cardiac	condition,	7.	Peripheral	
arterial	occlusive	disease,	
8.	Abnormal	high	fever	,9.	BP	
>200/110	mmHg,	10.	Dementia,	
11.	Aphasia	operationally	defined	as	
incapacity to follow two- point 
commands,	12.	Untreated	major	
depression. 13.Other medical 
conditions precluding participation 
in	exercise	training.
Wang 
(2014b)
Int.:	27	(100%)
Cont.: 27 
(100%)
Int.:	54	(7.2)
Cont.:	52	
(12.1)
Int.:	109	(31.2)	
days
Cont.:	86	(19.2)	
days
1. Time post stroke 
1–6	months,	2.	Stroke	
confirmed	by	CT	or	MRI,	
3.	Age	>45	years,	4.	Severely	
impaired;	affected	leg	≤3	or	
less	on	Chedoke–McMaster	
Stroke	Assessment	scale,	
5.	Unable	to	walk	even	with	
aids,	6.	Unaffected	leg	able	
to move against normal 
resistance,	7.	Fasting	glucose	
level	<	than	7	mmol/L,	7.	No	
physician- diagnosed 
diabetes,	8.	In	stroke	unit	or	
neurology	department,	
9. Never using medications 
that may significantly alter 
HR	and	blood	glucose	level,	
10.	Able	to	understand	study	
information.
1.	Subarachnoid	haemorrhage,	2.	TIA,	
3.	Severe	cerebral	oedema,	4.	O2 
dependence,	5.	Angina,	6.	Unstable	
cardiac	conditions,	7.	Peripheral	
arterial	occlusive	disease,	
8.	Abnormal	high	fever,	9.	Severe	
pneumonia,	10.	BP>	200/110	mm	
Hg,	11.Dementia,	12.	Aphasia	
operationally defined as incapacity 
to	follow	two-	point	commands,	
13.	Untreated	major	depression,	
14.	Other	medical	conditions	
precluding	participation	in	exercise	
training.
White 
(2013)a
Int.:	4	(18%) Int.:	63	
(57–80)b
Int.:	22	(9–84)	
monthsb
1.	Diagnosis	of	stroke,	
2.	Community	dwelling,	
3. Not currently accessing 
other rehabilitation services.
1. Severe cognitive or language 
impairment.
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monitored	throughout	the	sessions.	White	et	al.	(2013)	delivered	the	
Masterstroke	program,	 combining	moderate-	intensity	mixed	 train-
ing	with	health	education.	Intensity,	which	was	moderate,	was	moni-
tored throughout the training sessions. It was not clear how training 
was progressed.
3.6 | Comparisons
Twenty-	two	 studies	 included	 comparator	 groups	 (Chang	 et	al.,	
2012;	Cho	et	al.,	2015;	Dean	et	al.,	2010;	Franceschini	et	al.,	2009;	
Hesse	 et	al.,	 2012;	 Husemann	 et	al.,	 2007;	 Lennon	 et	al.,	 2008;	
Mayr	et	al.,	2007;	Morone	et	al.,	2011;	Ng	et	al.,	2008;	Ochi	et	al.,	
2015;	Potempa	et	al.,	1995;	Richards	et	al.,	1993;	Rosendahl	et	al.,	
2006;	 Stoller	 et	al.,	 2015;	 Teixeira	 da	 Cunha	 Filho	 et	al.,	 2001,	
2002;	 Tong	 et	al.,	 2006;	 Tsaih	 et	al.,	 2012;	 Wang	 et	al.,	 2014a,	
2014b;	Yagura	et	al.,	2006;	Yang	et	al.,	2014;	Table	5).	In	most	stud-
ies	(17/22),	the	comparator	was	usual	care	(Chang	et	al.,	2012;	Cho	
et	al.,	 2015;	 Dean	 et	al.,	 2010;	 Franceschini	 et	al.,	 2009;	 Hesse	
et	al.,	 2012;	 Husemann	 et	al.,	 2007;	 Lennon	 et	al.,	 2008;	 Mayr	
et	al.,	 2007;	Morone	 et	al.,	 2011;	 Ng	 et	al.,	 2008;	 Richards	 et	al.,	
1993;	Teixeira	da	Cunha	Filho	et	al.,	2001,	2002;	Tong	et	al.,	2006;	
Tsaih	et	al.,	2012;	Wang	et	al.,	2014a,	2014b;	Yang	et	al.,	2014),	but	
details	were	 patchy.	 The	 RCT	 by	Morone	 et	al.	 (2011)	 comprised	
four	 arms;	 participants	were	 stratified	 according	 to	 the	Motricity	
Index,	with	those	scoring	≤29	allocated	to	the	“low	motricity”	group	
and	 those	 scoring	 >29	 allocated	 to	 the	 “high	motricity”	 group.	 In	
this	review,	both	“low	motricity”	and	“high	motricity”	intervention	
groups were combined in the meta- analysis and the same was done 
for	the	control	groups.	The	RCT	by	Richards	et	al.	 (1993)	included	
two control groups: Control group 1 received early intensive con-
ventional	physiotherapy,	while	Control	group	2	received	usual	care.	
Only the intervention and usual care groups were included in this 
meta-	analysis.	Ng	et	al.	(2008)	and	Tong	et	al.	(2006)	incorporated	
a	second	intervention	group,	receiving	a	combination	of	functional	
electrical	stimulation	and	robot-	assisted	walking	 intervention,	but	
these combined groups were not included in this meta- analysis. The 
RCT	 by	 Rosendahl	 et	al.	 (2006)	 comprised	 four	 groups:	 strength	
training	or	sitting	activities,	combined	with	either	a	protein	or	pla-
cebo drink; only the group receiving strength training with a pla-
cebo drink and the group receiving sitting activities with a placebo 
drink were included in this meta- analysis.
The comparator intervention was dose- matched in 18/22 
studies	 (Chang	 et	al.,	 2012;	 Cho	 et	al.,	 2015;	 Dean	 et	al.,	 2010;	
Franceschini	 et	al.,	 2009;	 Hesse	 et	al.,	 2012;	 Husemann	 et	al.,	
Author 
(year)
Number of 
non- 
ambulatory 
stroke 
participants 
(% of study 
participants)
Age (years) 
of study 
participants
Mean (SD) 
(unless stated 
otherwise)
Time since stroke 
of study 
 participants
Mean (SD) (unless 
stated otherwise) Inclusion criteria Exclusion criteria
Yagura	
(2006)
Int.:	22	(100%)
Cont.:	25	
(100%)
Int.:	62.9	(7.4)
Cont.:	59.3	
(5.7)
Int.:	57.0	(11.0)	
days
Cont.:	58.4	(24.4)	
days
1. Time post stroke < 
3	months,	2.	Inpatient,	
3.	Requiring	physical	
assistance with gait after 
4	weeks	of	inpatient	
rehabilitation.
1.	Age	>80	years,	2.	Impaired	
cognitive	function,	3.	Previous	
stroke,	4.	Dependence	in	ADLs	prior	
to	stroke,	5.	History	of	MI	within	
1	year,	6.	Uncontrolled	hypertension,	
7. Symptomatic orthostatic 
hypotension,	8.	Uncontrolled	rate	
arterial fibrillation.
Yang	(2014)a Int.:	1	(7%)
Cont.:	1	(7%)
Int.:	56
Cont.:	44
Int.: 29 months
Cont.:	6	months
1.	First-	ever	stroke,	2.	Time	
post	stroke	3	months– 
3	years,	3.	Unilateral	
hemiplegia,	4.	Age	
18–70	years,	5.	Ability	to	
walk 10 m with or without 
assistance,	6.	Scores	of	three	
levels of consciousness items 
in the NIHSS = 0.
1. Patients with aphasia who could 
not	follow	instructions,	2.	Blindness	
or severe visual impairments that 
prohibit	seeing	the	faceplate,	
3.	Musculoskeletal	disorders,	
4.	Cardiac	disorders,	5.Peripheral	
neuropathy that could potentially 
interfere with study.
Notes.	ACSM:	American	College	of	Sports	Medicine.	ADL:	Activities	of	Daily	Living.	AO1/2:	Assistance	of	one/two	people.	BP:	Blood	Pressure.	CJCS:	
Cummings	Jewish	Centre	for	Seniors.	Cont.:	Control	group.	COPD:	Chronic	Obstructive	Pulmonary	Disease.	CT:	computed	tomography	scan.	DVT:	
Deep	Vein	Thrombosis.	ECG:	Electrocardiogram.	FAC:	Functional	Ambulation	Category.	Int.:	Intervention	group.	LL:	lower	limb.	MAS:	Motor	Assessment	
Scale	for	Stroke,	MCA:	Middle	cerebral	artery,	MI:	Myocardial	 Infarction.	MMSE:	Mini	Mental	Scale	Examination.	MRC:	Medical	Research	Council	
Scale.	MRI:	Magnetic	 Resonance	 Imaging.	NIHSS:	National	 Institutes	 of	Health	 Stroke	 Scale.	NR:	Not	 Reported.	 ROM:	 Range	 of	Movement.	 SD: 
Standard	Deviation.	TIA:	transient	ischaemic	attack.	RAGT:	Robot	Assisted	Gait	Training.	RATE:	Robot	Assisted	Treadmill	Exercise.	WB:	Weight	Bearing.
All	data	were	extracted	from	publications,	except	in	cases	indicated	by:	aData	supplied	by	author,	analysed	by	review	authors	(ML,	FvW).	bMedian	
(range).	cAnalysed	data	supplied	by	the	author.	dData	from	all	study	participants	including	those	who	were	not	non-	ambulatory	after	stroke,	where	data	
from the latter were not available. NR data not reported by study authors.
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TABLE  6 Overview of the outcomes of non- ambulatory participants only
Author (year) 
Study design Assessment time points and outcome measures Results
Batcho	(2013)b
Cohort study 
 
Two baseline assessments (data reported from 
baseline	2),	end	of	intervention	and	3	month	
follow up 
1.	ACTIVLIM-	stroke 
2.	6	minWT	(m) 
3.	SIAS 
4.	BBS 
5.	HADS
Median	(range)
1.	0.53	(0.39	to	0.92),	1.03(−0.36	to	1.79),	0.7	(0.41	to	1.45)
2.	134.55	m	(67.2	to	280.8),	135.9	m	(72	to	232.8),	137.5	m	
(100	to	230)
3.	51.5	(42	to	65),	60.5	(47	to	73),	55	(47	to	67)
4.	38	(29	to	48),	43.5	(35	to	50),	39	(34	to	43)
5.	13.5	(4	to	24),	14	(6	to	21),	8.5	(6	to	9)
Chang	(2012)®
RCT 
 
Baseline,	end	of	intervention 
1.	Aerobic	Capacity:
a.	 Peak	VO2	(L/min)
b.	 Peak	VO2 (ml kg
−1 min−1)
c.	 Peak	VO2	(%	predicted)
d.	RER	peak
2. Cardiovascular Response:
a.	 HR	rest,	(bpm)
b.	HR	peak	(bpm)
c. Peak O2	pulse	(ml/beat)
d.	 SBP	peak	(mmHg)
e.	 DBP	peak	(mmHg)
f.	 RPE	peak
3.	Ventilatory	Response:
a.	 VE	peak	exercise,	(L/min)
b.	VE	vs.	VCO2 slope
4.	F-M	(LL)
5.	MI	(LL)
6.	FAC
Between	group	comparisons: 
1.	Aerobic	Capacity:
a. Peak	VO2	(L/min):	A	significant	difference	in	favour	of	the	
intervention group (p	=	0.025)
b. Peak	VO2 (ml kg
−1 min−1):	A	significant	difference	in	favour	
of the intervention group (p	=	0.013)
c. Peak	VO2, percentage predicted:	A	significant	difference	in	
favour of the intervention group (p	=	0.024)
2.	A	significant	difference	in	favour	of	the	intervention	group	
(p	=	0.037)	1d,	2,	3,	5,	6:	No	significant	differences.
Cho	(2015) 
Randomised cross- over 
trial 
 
Baseline,	end	of	intervention	(i.e.,	4	w,	8	w) 
Primary: 
1.	BBS 
2.	MFRT	(cm) 
 
Secondary: 
3.	FAC 
4.	mAS 
5.	F-	M	(LL) 
6.	MI 
7.	MBI
Data	at	point	of	cross-	over	not	presented;	data	from	RAGT	
phases combined for both groups and compared with data 
from	non-	RAGT	phase	combined	for	both	groups:
1–6:	No	significant	between	group	differences
7.  	No	between	group	differences	in	total	MBI	but	significant	
difference	in	“transfer”	item	in	favour	of	the	RAGT	group	
(p	<	0.05).
Dean	(2010) 
RCT 
 
Baseline	data	NR.	Outcomes	at	6	months	after	
study entry. 
Walkers only:  
1.	Walking	speed	(m/s) 
2.	Stride	length	(cm):	10	m	walk	test	(m/s) 
3.	Distance	walked:	6	min	WT	(m) 
 
All	participants: 
4.	Walking	self-	rating	 
5.	Adelaide	Activities	Profile 
6.	Number	of	falls 
7. Percentage of fallers 
8. Number of independent walkers
1,	2,	5–7:	No	significant	differences
3.	Significant	difference	in	favour	of	intervention	group	(MD	
57,	95%	CI	1	to	113).
4.	Significant	difference	in	favour	of	intervention	group	(MD	
1.0,	95%	CI	0.1	to	1.9)
8.	Independent	walking:	Int.:	42/59	(72%),	Control:	36/60	
(60%).	
Demers	(2015)b
Mixed	Methods 
 
Pre,	post	intervention 
1.	Berg	Balance	Scale	(BBS):	week	prior	to	and	
week following intervention 
2.	Timed	Up	and	Go	(TUG) 
3.	Time	spent	exercising
a.	Balance	exercises	in	sitting
b.	Balance	exercises	in	standing
Pre,	post	(median	(range)):
1.	5	(5	to	11),	34	(24	to	40)
2.	TUG	for	3	participants	pre,	post	(median	(range)):	0	(0	to	
0),	62	(40.36	to	65)
3.	a.	42.5	(25	to	45),	22.5	(15	to	25)	min
3.	b.	1	(0	to	20),	22.5	(20	to	30)	min
(Continues)
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Author (year) 
Study design Assessment time points and outcome measures Results
Franceschini	(2009) 
RCT 
 
Baseline	(T0),	after	10	sessions	(T1),	end	of	
intervention	(T2),	2	weeks	post	intervention	
(T3)	+	6	months	post	stroke	onset	(T4) 
1.	MI 
2. Trunk Control Test 
3. modified Rankin Scale 
4.	BI 
5.	FAC 
6.	Ashworth	Scale 
7. Token Test  
8.	Albert	Test	 
9.	Proprioceptive	sensibility	LL 
10.	10	mWT	(m/s) 
11.	6	minWT	(m) 
12.	Borg	Scale	(during	6	minWT) 
13. Walking Handicap Scale
1–13.	No	significant	between-	group	difference	in	any	outcome	
measure at any time.
Hesse	(1994)	 
Cohort study 
 
Baseline,	5,	10,	15,	20,	25	days	after	start	of	
intervention.	FAC	recorded	−15,	−10,	−5	days	
before start of intervention.
1.	FAC
2. Standing balance test
3.	RMI	(Leg,	trunk	and	gross	function	subscales)
4.	Motricity	Index
5.	mAS	(ankle,	knee)
6.		10	m	walk	test:	speed	(m/s),	cadence	(steps/min),	
stride	length	(m)	
Mean	change	(range)	in	outcomes	1–5	pre	to	post	intervention:
1.	Mean	improvement	2.2	(range	1	to	4)
2.	Prior	to	intervention:	2	participants	unable	to	stand,	3	able	
to	only	stand	with	feet	apart,	4	able	to	stand	with	feet	
together. Post intervention: 8 participants able to stand 
with	feet	together	>30	s,	one	for	<30	s.
3.	Leg	and	trunk:	change	2.9	(1	to	5)	to	6.1	(4	to	8),	Gross	
function:	change	3.8	(1	to	6)	to	7.7	(5	to	12)
4.	LL	and	UL:	no	change.
5.	Ankle:	change	3.1	to	3.0	(2	to	5),	knee:	change	2.3	to	2.1	(0	
to	4)	(unclear	which	time	point	range	pertained	to).	
6.	Significant	improvements	in	all	gait	parameters	(p	<	0.01).
Hesse	(1995) 
Case study 
 
Outcome	1–4:	Baseline,	end	of	every	week,	
outcome	5:	2×	pw. 
1.	FAC 
2.	RMI	(Gross	function	+	Leg/trunk) 
3.	MI 
4.	mAS 
5.		10	mWT	(m/s):	speed	(m/s),	cadence	(steps/
min),	stride	length	(m)
Comparisons	between	each	3-	week	intervention	period	(A:	
BWSTT,	B:	PT,	A:	BWSTT) 
1.		Significant	improvements	following	each	period	of	BWSTT	
compared to PT (p	<	0.05)2–5:	No	significant	differences	
following	BWSTT	and	PT	training	periods
Hesse	(2010)®
Case study within 
observational study 
 
Case	study:	Baseline,	end	of	intervention 
1.	FAC 
2.	RMI 
3.	MI 
4.	BI
Pre- post intervention values for single case study: 
1.	1	to	4 
2. 3 to 7 
3.	22	to	59 
4.	25	to	65
Hesse	(2012) 
Non- randomised clinical 
trial 
 
Baseline,	after	2	w,	after	4	w	(intervention	end),	
3 month follow up 
Primary:
1.	FAC
Secondary:
2.	RMI
3.	10mWT	(m/s)
4.	MI	(LL	only)
5.	LL	Resistance	to	passive	movement	scale
Alpha	set	at	0.025.
1–3:		Significant	difference	in	favour	of	intervention	group	
(p	<	0.025)	but	not	at	follow	up	(p	>	0.03)
4.		Significant	difference	in	favour	of	intervention	group	
(p	=	0.002)	and	at	follow	up	(p	=	0.007)
5.		No	significant	between	group	difference	at	intervention	
end or follow up (p	value	NR).
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Author (year) 
Study design Assessment time points and outcome measures Results
Husemann	(2007) 
RCT 
 
Baseline	end	of	intervention. 
Primary:
1.	FAC
2.	10mWT	(m/s)
Secondary:
3.	Gait	parameters:	
-. cadence
-.	 stride	duration	(s)
-.	 stance	duration	(s)
-.	 single	support	time	for	both	legs	(s)
4.	Body	composition:
-.	 Body	weight	(kg)
-.	 Body	cell	mass
-. Fat mass
5.	mAS
6.	MI
7.	 BI	(German	version)
1–3,	5–7:	no	significant	between-	group	differences
4.		Significant	difference	in	favour	of	intervention	group	in	
reduction of fat mass (p	=	0.012),	no	significant	between-	
group differences in body weight or body cell mass.
Lennon	(2008)a
RCT 
 
Baseline,	end	of	intervention
1.	VO2 (ml O2 kg
−1 min−1)
2.	RPE	
3.	Peak	Wattage	(Nm)
4.	Cardiac	risk	score
5.	HR	rest	(bpm)
6.	Resting	brachial	artery	BP:	
a.	Systolic	(mmHg)
b.	Diastolic	(mmHg)
7.	Body	composition:
a. waist girth (mm × 102)	
b.	BMI	(kg/m2))
8.	Fasting	lipids	(total	cholesterol,	mmol/L)
9.	Spirometry	(FEV1	(L))
10.	HADS	
11.	Frenchay	Activities	Index
Mean	difference	(95%	CI)	baseline	-	end	of	intervention:
1.	Int.:	−1.23	(−3.53	to	1.07)|Cont.:	0.12	(−0.13	to	0.37)
2.	Int.:	−0.50	(−3.26	to	2.26)	ont.:	0.25	(−3.03	to	3.53)
3.	Int.:	−14.00	(−39.76	to	11.76)|Cont.:	3.00	(−1.11	to	7.11)
4.	Int.:	2.00	(−0.91	to	4.91)|Cont.:	−4.25	(−13.10	to	4.60)
5.	Int.:	0.00	(−13.75	to	13.75)|Cont.:	2.50	(−12.96	to	17.96)
6a.	Int.:	5.75	(−13.45	to	24.94)|Cont.:	−10.0	(−44.37	to	24.37)
6b.	Int.:	5.25	(2.24	to	8.26)|Cont.:	−6.00	(−21.15	to	9.15)
7a.	Int.:	3.25	(−34.35	to	40.85)|Cont.:	0.50	(−7.56	to	8.56)
7b.	Int.:	−1.20	(−4.67	to	2.27)|Cont.:	−0.54	(−2.19	to	1.10)
8.	Int.:	0.16	(−0.58	to	0.90)|Cont.:	−0.40	(−1.41	to	0.60)
9.	Int.:	0.07	(−0.17	to	0.30)|Cont.:	−0.14	(−0.56	to	0.29)
Median	change	(min–max)	baseline	–	intervention:
10.	Anxiety	:	Int.:	0.5	(−1.0	to	2.0)|Cont.:	−0.5	(−5.0	to	8.0)
Depression:	Int.:	1.5	(0.0	to	11.0)|	Cont.:	1.50	(−3.0	to	6.0)
11.	Int.:	−4.5	(−7.0	to	0.0)|	Cont.:	0.50	(−11.0	to	6.0)
Leroux	(2005)	 
Cohort study 
 
Baseline	+	end	of	intervention 
1.	SIAS	motor	score 
2.	BBS 
3. Step test 
4.	TUG 
5.	6	min	WT
Alpha	set	at	0.008 
1–4,	5:	Significant	improvements	(p	<	0.008) 
5.	Trend	towards	improvement	(p =	0.012)
Mayr	(2007)b
Randomised cross- over 
trial 
 
Baseline	and	at	each	point	of	crossover	at	3,	
6	weeks	+	9	weeks 
1.	Modified	EU	walking	scale 
2.	RMI	(Gross	Function) 
3.	10	mWT	(s) 
4.	6	minWT	(m) 
5.	MRC	scale 
6.	MI	(LL) 
7.	AS	(5	muscles)
Data for baseline and 1st point of crossover at 3 weeks 
(Mean	±	SD):
1.	Int.:	1.7	±	0.5	to	2.9	±	1.3|Cont.:	1.6	±	0.9	to	3.0	±	0.7
2.	Int.:	3.3	±	1.9	to	4.9	±	3.0|Cont.:	2.2	±	1.3	to	3.6	±	1.5
3.	Int.:	98.0	±	48.6	to	78.1	±	50.2|Cont.:	62.8	±	76.8	to	
77.0	±	56.9
4.	Int.:	23.8	±	32.8	to	74.1	±	66.5|Cont.:	43.0	±	44.9	to	
62.1	±	40.4
5.	Int.:	30.0	±	9.6	to	38.0	±	7.4|Cont.:38.8	±	7.9	to	41.2	±	3.1
6.	Int.:	34.7	±	25.0	to	56.4	±	21.6|	Cont.:	45.4	±	27.2	to	
70.6	±	17.5
7.	Int.:	3.6	±	4.9	to	5.1	±	6.2|Cont.:0.8	±	1.3	to	2.8	±	1.8	
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Study design Assessment time points and outcome measures Results
Mehrholz	(2006) 
Case series 
 
Baseline,	end	of	intervention	 
1.	MI	(LL) 
2.	F-	M	(UL	passive	joint	motion,	pain) 
3. modified Tardieu scale 
4.	FAC 
5.	10	m	walk	test	(m/s),	 
6.	step	length	(cm),	 
7.	Rivermead	Visual	Gait	Assessment	Score 
8.	6	minWT 
9. Repetitions per 30 s 
10.	Jump	height	(cm) 
11.	Jump	length	(cm)
1,	4–11:	Significant	improvements	(p	>	0.023)
2,	3:	No	significant	changes	(p	>	0.157)
Morone	(2011)b
 
RCT	with	4	arms:	 
Robotic	Group	(Low	
Motricity;	RGLM),	
Control	Group	(Low	
Motricity,	CGLM),	
Robot	Group	(High	
Motricity,	RGHM),	
Control	Group	(High	
Motricity,	CGHM) 
 
Outcome	1:	after	4	w	intervention	and	at	hospital	
discharge.	Outcomes	2–8:	Baseline,	4w	interven-
tion and at discharge. 
Primary: 
1.	FAC	and	number	of	independent	walkers
Secondary:
2.	Ashworth	(LL)	(3	muscle	groups) 
3.	RMI 
4.	MI 
5.	TCT 
6.	CNS 
7.	BI 
8. Rankin Scale 
9.	6	minWT 
10.	10	MWT 
11.	BMI
Low	Motricity	(LM):	MI	≤	29,	high	motricity	(HM):	MI	>	29.	
Comparison:	RGLM	versus	CGLM:
1.	At	w4	and	at	discharge:	Significant	difference	in	favour	of	
RGLM	compared	with	CGLM	(p	<	0.002).	N	(FAC	>	3	at	
discharge):	10/12	(83%)	in	RGLM,	2/12	(17%)	in	CGLM,	
9/12	(75%)	in	RGHM,	8/12	(67%)	in	CGHM.
2. No improvement in any group at any time.
3,	5,	7,	8,	9:	W4	results	NR.	At	discharge:	Significant	
difference	in	favour	of	RGLM	compared	with	CGLM	
(p	<	0.029).	No	other	significant	differences.
4,	10,	11:	w4	results	NR.	At	discharge:	no	significant	
differences (p >	0.132).
6.	Significant	between-	group	difference	(NR	in	favour	of	
which	group).
Comparison:	RGHM	versus	CGHM:
1–10:	No	significant	differences	between	RGHM	and	CGHM	
at any time (p	>	0.05).
Ng	(2008) 
RCT with 3 arms 
 
Baseline,	end	of	intervention,	6	month	follow	up 
1.	EMS 
2.	BBS 
3.	FAC 
4.	MI	(LL) 
5.	5	m	Walk	Test	(m/s) 
6.	FIM 
7.	BI 
8. Number of independent walkers
Comparison	between	intervention	group	1	(GT)	and	control	
group only: 
1. Significant improvement in favour of Int. group 1: end of 
intervention:	CT	vs.	GT	(p	=	0.017),	follow	up:	CT	vs.	GT	(p	=	0.024)
3. No significant between- group difference at intervention 
end,	significant	improvement	in	favour	of	Int.	group	1	at	
follow	up:	CT	vs.	GT	(p	=	0.018)	
5.	Significant	improvement	in	favour	of	Int.	group	1	at:	end	of	
intervention:	CT	vs.	GT	(p	=	0.027),	follow	up:	CT	vs.	GT	
(p	=	0.006)
2,	4,	6,	7:	No	significant	between	group	differences
8. N	=	5/17	in	Int.	group	1,	N	=	6/17	in	control	group.
Ochi	(2015) 
RCT 
 
Baseline,	end	of	intervention	 
1.	Fugl-	Meyer	assessment	(LL) 
2.	LL	extensor	muscle	torque	 
3.	FAC 
4.	10	mWT	(m/s)	for	those	with	FAC	≥3 
5.	FIM	mobility
1,	5:	No	significant	between	group	differences	(p	>	0.05)
2. Significant improvement in favour of Int. group in unaffected 
side (p	<	0.01)
3. Significant improvement in favour of Int. group (p	=	0.02)
4.	Trend	towards	greater	improvement	in	Int.	group	group	
(p	=	0.07)
Plummer	(2007) 
Cohort study 
 
Outcome	1.	Baseline,	sessions	12,	24,	36	(end	of	
training),	2.	Baseline,	end	of	training,	3.	Baseline,	
session	18,	end	of	training,	4.	Baseline,	sessions	
12,	24,	end	of	training,	5.	Baseline,	end	of	training,	
6–9.	Baseline,	end	of	training. 
1.	10	m	walk	test	(m/s)	 
2.	6	minWT	(m)	 
3.	Daily	steps) 
4.	Step	length,	step	width	(cm),	cadence 
5.	Ground	reaction	force 
6.	Fugl-	Meyer	(LL) 
7.	Berg	Balance	Scale 
8.	Activities	specific	Balance	Confidence	scale 
9. SIS
Results for single non- ambulatory participant (only baseline 
and	end	of	intervention	data	presented	here):
1.	0.13	to	0.15	m/s
2.	Unable	to	complete	at	baseline,	40	m	at	session	36.
3. 31 to 77
4.	Step	length	(paretic)	(cm):	32.83	to	30.74,	Step	length	
(non-	paretic)	(cm):	30.85	to	10.19,	Step	width	(cm):	9.06	to	
14.30,	Cadence	(steps/min):	41.9	to	35.0
5.	Unable	to	collect	sufficient	data
6.	15	to	18
7.	14	to	18
8. 9 to 17
9.	30	to	33	(ADL),	33	to	58	(mobility),	28	to	69	(participation).
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Potempa	(1995) 
RCT 
 
Baseline,	end	of	intervention
At	rest:
1.	Fugl-	Meyer	
2.	Weight	(kg)
3.	HR	rest	(bpm)
4.	BP:	(a)	systolic	(b)	diastolic	(mmHg)
Maximal	exercise:
5.	HR	peak	(bpm)
6.	Exercise	metabolic	parameters:	(a)	 ̇VO2 
(ml kg−1 min−1),	(b)	 ̇VCO2 (ml kg
−1 min−1),	(c)	 ̇VE 
(L/min),	and	(d)	RER)
7. Workload
8.	Exercise	time
9.	BP	submaximal	workload
1,	2,	3,	4,	5,	6d:	No	significant	between-	group	differences	
(p	=	NR)
6a–c,	7,	8:	Significant	improvements	in	favour	of	intervention	
group (p	<	0.01).
9: Significant improvement in favour of intervention group for 
SBP	(p	=	0.047)	but	not	for	DBP	(p	=	0.12).	
Richards	(1993) 
RCT with 3 arms 
 
Baseline	and	end	of	intervention	at	6	weeks	and	3,	
6	months	follow-	up	 
1.	Fugl-	Meyer:
a.	Balance
b.	Arm
c.	Leg
2.	Berg	Balance	Scale
3.	Gait	kinematics	(gait	cycle	duration,	stance,	
swing	and	double	support	phases	(s))	
4.	Gait	speed	(m/s)	
5.	Muscle	activation
6.	BI	Ambulation	Score
Gait	training	and	Conventional	Therapy	(Cont..2)	compared	
only 
1.	a,	c,	6.	No	significant	between	group	difference	(p	>	0.05)	
at	end	of	intervention	and	at	3-	month	follow-	up.	6-	month	
follow- up: NR. 
b.	Baseline	to	end	intervention:	Int.:	12.5	(12.7)	to	31.7	
(21.3)|Cont.2.	14.8	(20.0)	to	28.1	(25.3).	3-	month	follow-	up	
and	6-	month	follow-	up:	NR 
2.	Baseline	to	end	intervention:	Int.:	NR	to	33.2(18.2)|Cont.	2:	
NR	to	28.4(19.7)	(p	=	NR).	3-	month	and	6-	month	follow-	up:	
NR 
3,	5.	NR 
4.	Baseline	to	end	intervention:	Int:	not	measured	to	31.3	
(19.8)	m/s	in	N	=	9/9|Cont.	2:	NR	to	30.0	(18.7)	m/s	in	N	=	4/8	
(p	=	NR).	3-	month	and	6-	month	follow-	up:	NR
Rosendahl	(2006)b
RCT	with	4	arms 
 
Baseline,	3	months	(end	of	intervention),	6	month	
follow up 
1.	Berg	Balance	Scale 
2.	Gait	speed	(self-	paced,	m/s) 
3.	Gait	speed	(max,	m/s) 
4.	LL	strength	(1RM) 
5.	modified	Chair-	Stand	Test
Int. 2 and Cont. 2 groups compared only.
Difference	between	3	months-	baseline;	6	months-	baseline	
(median,	range):
1.	Int.:	1.5	(−5	to	17);	2.0	(1	to	24)	|	Cont.:	1	(−8	to	6);	1	(−6	to	2)
2.	Int.:	0.01	(0.00	to	0.15);	0.00	(0.00	to	0.27)	|	Cont.:	0.00	
(−0.09	to	0.00);	0.00	(−0.01	to	0.05)
3.	Int.:	0.02	(0.00	to	0.21);	0.00	(0.00	to	0.35)	|	Cont.:	0.00	
(−0.07	to	0.00);	0.00	(−0.01	to	0.08)
4.	Int.:	30	(−14	to	42);	28	(−6	to	52)	|	Cont.:	−7	(14	to	0);	−10	
(−10	to	10)
5.	NR
Shea	(2014) 
Case study 
 
PILATES
Baseline,	3	months,	6	months	,	9	months	(end	of	
intervention) 
1.	5-	repetition	Sit	To	Stand	Test	(s) 
2.	Thoracic	and	lumbar	posture	(cm) 
3.	Berg	Balance	Scale 
4.	Gait	speed	(cm/s) 
5.	Stride	length	(cm)	 
6.	SIS
Baseline	–	9	months	:	(interim	data	not	presented	here): 
1,	3:	Minimal	Detectable	Change	value	surpassed 
2,	4:	Outcomes	below	Minimal	Detectable	Change	value 
5.	Minimal	Detectable	Change	value	approached
6.	Total	SIS	did	not	surpass	Minimal	Detectable	Change	but	
items	Strength,	Mobility,	ADL	surpassed	Minimal	Clinically	
Important Difference 
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Stoller	(2015) 
RCT 
 
Primary:	at	Baseline,	end	of	intervention: 
1.	Cardiovascular	fitness	&	Cardiopulmonary	
performance:
a.	VO2peak,	(ml/min)
b. Ppeak(W)
c. VEpeak	(L/min)
d. Rfpeak	(L/min)
e. HRpeak	(bpm)
f.	(VCO2/VO2)	at	VO2peak	(RERpeak)
g. O2	cost	of	work	(∆VO2/∆P)
h. O2	pulse	at	VO2peak (O2pulse)
i.	VE	versus	VCO2	slope	(∆VE/∆VCO2)
2. Training intensity HR and HR reserve
3. Feasibility
a. Training attendance
b. Number of drop outs
c. Serious adverse events (n)
d.	Loss	of	data
1. No significant between group differences (p	>	0.35)
2. Significant between group difference in favour of interven-
tion	group	(HR	and	HR	reserve,	p	<	0.002)
3. Feasibility:
a.	100%
b.	Attrition	rates	during	familiarisation	and	baseline	30%
c. 0
d.	0%
Teixeira	da	Cunha	Filho	
(2001) 
RCT 
 
 
 
 
 
Baseline	+	end	of	intervention	at	discharge 
Cycle ergometry:
1.	VO2	max	(ml	kg
−1 min−1)	
2.	HR,	peak	(bpm)	
3.	Workload	(W)	
4.	Time	to	reach	volitional	fatigue/request	to	
stop/respiratory	exchange	ratio	greater	than	
1.0/HR within 10 beats of age predicted 
maximal	HR/	observed	signs	of	marked	
dyspnea,	pallor,	volitional	fatigue,	significant	
EKG	changes/BP	exceeding	190/110	mmHg
5.	SBP	(mmHg)
6.	DBP	(mmHg) 
7.	FIM	(Locomotor	sub	score)
1. Significant difference in favour of the intervention group 
(p	=	0.039)
2–7:	No	significant	between-	group	differences
Teixeira	da	Cunha	Filho	
(2002) 
RCT
Gait	parameters
1.	FAC
2.	5	m	walk	test	(m/s)	
3.	Distance	covered	in	5	min	(m)
4.	O2	consumption	during	5	min	walk	
(ml kg−1 min−1)
5.	O2	consumption	per	meter	during	5	min	
walk	(mLO2 kg
−1 m−1)
1–5:	No	significant	between-	group	difference	in	any	outcome.
1.	Pre	to	post	testing,	median	(range)
Int.:	1	(0	to	2),	2.5	(0	to	4)
Cont.:	1	(0	to	2),	3	(0	to	4)
2.	Effect	size	=	0.4	SD units in favour of the intervention group
3.	Effect	size	=	1.16	SD units in favour of the intervention 
group
4.	Effect	size	=	0.3	SD units in favour of the intervention group
5	Effect	size	=	0.7	SD units in favour of the intervention group
Tong	(2006) 
RCT with 3 arms 
 
Baseline,	mid	training	(after	2	weeks),	end	of	
intervention	(after	4	weeks) 
1.	5	m	walking	test	(m/s) 
2.	EMS 
3.	BBS 
4.	FAC 
5.	MI	(LL) 
6.	FIM 
7.	BI
Baseline-	end	of	intervention	(w4)	comparisons	between	Cont.	
and	Exp.	1	group	only	(all	other	data	not	presented	here): 
1,	2,	4:	Significant	improvement	in	favour	of	Exp.	1	
(p	<	0.011). 
3,	5,	6,	7:	No	significant	between-	group	differences	
(p	>	0.084)
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Tsaih	(2012)	b
RCT 
 
Baseline,	end	of	intervention	at	w4 
1.	Walking	speed	(m/s)	 
2.	6minWT(m/s) 
3.	TUG	(s) 
4.	BBS 
5.	BI
Mean	(SD) 
1.	Int.:	0.1	(0.2)	to	0.2	(0.2)|	Cont.:	0.1	(0.1)	to	0.1	(0.1) 
2.	Int.:	33.8	(40.7)	to	47.4	(42.6)|Cont.:24.7	(31.7)	to	19.4	(19.3)
3.	Int.:	128.5	(96.0)	to	88.5	(76.7)|Cont.:	156.3	(112.2)	to	
130.2	(102.7)
4.	Int.:	21	(16)	to	25.1	(18.3)|Cont.:	21.1	(14.6)	to	23.4	(15.7)
5.	Int.:	11.9	(5.7)	to	11.8	(6.9)|Cont.:	7.1	(5.4)	to	7.4	(5.8)
Vidoni	(2008) 
Case study 
 
Baseline	and	weekly	assessment. 
1.	6minWT	(m) 
2.	BBS 
3.	Timed	Parallel	Bar	Walk	(s)
4.	Manual	Muscle	Testing	(kg)	(Hip	flexion,	hip	
abduction,	knee	flexion,	knee	extension	and	
dorsiflexion)
Mean	(SD)	following	each	type	of	gait	training	in	single	case	
study:	A:	Over	ground	walking,	B:	BWSTT,	C:	Over-	ground	
walking with motor learning: 
1.	A:	16	(5),	B:	27	(4),	C:	33	(3) 
2.	A:	26	(1),	B:	27	(2),	C:	29	(2) 
3.	A:	91	(10),	B:	79	(6),	C:	62	(4) 
4.	Left	hip	flexion	:	A:	13	(5),	B:	12	(3),	C:	13	(2)
Left	hip	abduction:	A:	11	(1),	B:	11	(2),	C:	12	(3)
Left	knee	flexion:	A:	10	(2),	B:	10	(2),	C:	10	(2)
Left	knee	extension:	A:	20	(5),	B:	25	(2),	C:	25	(4)
Right	knee	extension:	A:	10	(2),	B:	13	(2),	C:	13	(3)
Left	dorsiflexion:	A:	14	(2),	B:	15	(2),	C:	16	(3)
Wang	(2014a) 
RCT 
 
Baseline,	end	of	intervention 
1.	Fugl-	Meyer	Motor	score 
3.	Exercise	Testing	(min) 
4.	Peak	Heart	Rate	(bpm) 
5.	Oral	Glucose	Tolerance	Test:
a. Fasting Insulin (μU/ml)
b.	Fasting	Glucose
c.	2-	hr	Blood	Glucose
d.	HOMA-	IR	(Homeostasis	Model	Assessment	
Insulin	Resistance	Index)
6.	Serum	lipid	profiles:
a. Total triglycerides
b.	HDL	cholesterol
c.	LDL	cholesterol
7.	BI
Intention to treat analysis:
1,	7:	Significant	between	group	differences	in	favour	of	
intervention group (p	<	0.05)
3–6:	No	between	group	differences
Wang	(2014b) 
RCT 
 
Baseline,	end	of	intervention 
1.	Oral	Glucose	Tolerance	Test	(OGTT):
a.	Fasting	Insulin	(µU/ml)
b.	Fasting	Glucose	(mmol/L)
c.	2-	hr	Blood	Glucose	(mmol/L)
d.	HOMA-	IR	(Homeostasis	Model	Assessment	
Insulin	Resistance	Index)
2.	Fugl-	Meyer	Motor	Score	(a.	total,	b.	UL,	c.	LL)
3.	BI
4.	Exercise	Test	time	(min)
5.	Peak	Heart	Rate	(bpm)
6.	Rest	Heart	Rate	(bpm)
7. Serum lipid profiles:
a.	Total	triglycerides	(mmol/L)
b.	HDL	cholesterol	(mmol/L)
c.LDL	cholesterol	(mmol/L)
8.	Weight	(kg)
1a,	c,	d,	2a,	c,	3,	4,	7a:	Significant	differences	in	favour	of	
intervention group (p	<	0.05),	including	significantly	more	
participants improving glucose tolerance in intervention 
group (N =	11/23,	48%)	compared	to	control	group	(N	=	4/22,	
18%),	(p	<	0.05). 
1b,	2b,	5,	6,	7b,	c,	8:	No	significant	between	group	differences
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2007;	 Mayr	 et	al.,	 2007;	 Ng	 et	al.,	 2008;	 Potempa	 et	al.,	 1995;	
Richards	et	al.,	 1993;	Rosendahl	 et	al.,	 2006;	Stoller	 et	al.,	 2015;	
Teixeira	da	Cunha	Filho	et	al.,	2001,	2002;	Tong	et	al.,	2006;	Wang	
et	al.,	2014a,	2014b;	Yagura	et	al.,	2006;	Yang	et	al.,	2014),	while	
the	control	group	dose	was	not	reported	 in	two	studies	 (Lennon	
et	al.,	 2008;	 Tsaih	 et	al.,	 2012).	Ochi	 et	al.	 (2015)	 provided	 their	
control group with robot- assisted arm training of the same dose 
as	robot-	assisted	lower	limb	training,	but	this	constituted	20	min’	
more	 therapy	time.	Morone	et	al.	 (2011)	matched	the	amount	of	
attention	time	in	their	groups,	but	due	to	time	required	for	getting	
in/out	of	 equipment,	 net	 training	 time	 in	 the	 intervention	group	
was less than in the control group.
3.7 | Outcome measures
A	total	of	105	different	outcome	measures	were	reported	across	the	
33	 studies,	 including	 74	 used	 in	 single	 studies	 only.	 A	 total	 of	 44	
(42%)	were	health-	related	fitness	outcomes	(Table	6).
Author (year) 
Study design Assessment time points and outcome measures Results
White	(2013)b  
Mixed	methods	cohort	
study 
 
 + 
Baseline,	end	of	intervention,3	month	follow	up 
1.	Waist	circumference	(cm) 
2.	Resting	HR	(bpm) 
3.	TUG	(s) 
4.	6minWT	(m) 
5.	SAQoL	(score) 
6.	Fat	and	Fibre	Barometer	(score) 
7. Fagerstrom test 
8.	Daily	salt	intake	(self-	reported,	score)
9.	Daily	alcohol	intake	(self-	reported,	number	of	
drinks	per	occasion)
10.	Knowledge	of	stroke	and	associated	risk	
factors	(questionnaire,	%	score)
Changes	between	End	intervention	-	baseline,	Follow-	up	
–	baseline	(Median,	range): 
1.	1.95	(−5.5	to	3.5),	1.75(1	to	6) 
2.	−1	(−12	to	8),	4	(−20	to	7) 
3.	−12.45	(−35.45	to	−3.13),	−8.68	(−39.24	to	1.62) 
4.	26	(7	to	60),	27.3	(−7	to	59) 
5.	0.22	(−0.32	to	1.18),	−0.12	(−0.3	to	1.82) 
6.	4.5	(2	to	19),	6	(−5	to	11) 
7.	N/A	(none	smoked)	 
8.	−4.5	(−8	to	−2),	−3.5	(−6	to	0) 
9.	0	(−1	to	0),	−0.5	(−1	to	0) 
10.	3.5	(−4	to	23),	14.5	(3	to	35)
Yagura	(2006) 
RCT 
 
Baseline	(admission),	4	w	post	admission	prior	to	
BWSTT	starting,	10	w	post	admission	(after	6	w	
BWSTT),	16	w	post	admission	follow-	up.	Gait	
speed and cadence measured every two weeks up 
to	16	w. 
1.	Fugl-	Meyer	(UL	and	LL)	 
2.	FIM	:
a. total
b. motor 
c. gait 
3. 10 m walk test
4.	Cadence
1,	2,	3:	No	significant	between-	group	differences	at	any	point	
in time
4.	Not	measured	in	non-	ambulatory	participants 
Yang	(2014)b  
Randomised cross- over 
Baseline,	after	4	w	(point	of	cross	over),	8	w	(end	of	
intervention) 
1.	Fugl-	Meyer	(LL) 
2.	6minWT	(m) 
3.	10mWT	(m/s) 
4.	mAS
Change	from	baseline	–	4	weeks	(single	participant	in	each	RCT	
arm).	Only	change	from	baseline	to	cross-	over	reported	here: 
1.	Cycling	+	UC,	then	UC:	+3|UC,	then	Cycling	+	UC:	+1 
2.	Cycling	+	UC,	then	UC:	+4|UC,	then	Cycling	+	UC:	−2.5 
3.	Cycling	+	UC,	then	UC:	0|UC,	then	Cycling	+	UC:	0 
4.	Data	not	provided
Notes.	1RM:	1	Repetition	Maximum,	6	minWT:	6	minute	Walk	Test,	10mWT:	10	metre	Walk	Test,	ADL:	Activities	of	Daily	Living,	AS:	Ashworth	scale,	
BBS:	Berg	Balance	Scale,	BI:	Barthel	 Index,	BMI:	Body	Mass	 Index,	BP:	Blood	Pressure,	bpm:	Beats	per	minute,	BWSTT:	Body	Weight	Supported	
Treadmill	 Training,	 CGHM:	 control	 group	 with	 high	 motricity,	 CGLM:	 control	 group	 with	 low	 motricity,	 CI:	 Confidence	 Interval,	 CNS:	 Canadian	
Neurological	Scale,	Cont.:	Control,	CT/OCGT:	Conventional	overground	gait	training,	DBP:	Diastolic	Blood	Pressure,	EKG:	electrocardiogram,	EMS:	
Elderly	Mobility	 Scale,	 Exp.:	 experimental,	 FAC:	 Functional	Ambulation	Category,	 FEV:	 Forced	Expiratory	Volume,	 FIM:	 Functional	 Independence	
Measure,	F-	M:	Fugl-	Meyer	Scale,	FES:	Functional	Electrical	Stimulation,	GT:	Electromechanical	gait	trainer,	HADS:	Hospital	Anxiety	and	Depression	
Scale,	HDL:	High	Density	Lipoprotein,	HOMA-	IR:	Homeostatic	Model	Assessment-	Insulin	Resistance,	HR:	Heart	Rate,	 Int.:	 Intervention,	LDL:	Low	
Density	 Lipoprotein,	 LL:	 Lower	 Limb,	mAS:	Modified	 Ashworth	 Scale,	MBI:	 modified	 Barthel	 Index,	MD:	Mean	 difference,	Med:	median,	MFRT:	
Modified	Functional	Reach	Test,	MI:	Motricity	Index,	MRC:	Medical	Research	Council,	NR:	Not	reported,	O2:	Oxygen,	Ppeak:	peak	work	rate,	RAGT:	
Robot	Assisted	Gait	Training,	RCT:	Randomised	Control	Trial,	RER:	Respiratory	Exchange	Ratio,	RGLM:	robot	group	with	low	motricity,	RGHM:	robot	
group	with	high	motricity,	RMI:	Rivermead	Mobility	Index,	RM:	repetition	maximum,	RPE:	Rate	of	Perceived	Exertion,	Rfpeak:	peak	respiratory	rate,	
SAQOL:	Stroke	and	Aphasia	Quality	of	Life	Scale,	SBP:	Systolic	Blood	pressure,	SD:	Standard	Deviation,	SIAS:	Stroke	Impairment	Assessment	Set,	SIS:	
Stroke	Impact	Scale,	TCT:	Trunk	Control	Test,	TUG:	Timed	Up	and	Go	Test,	VO2:	maximum	oxygen	volume,	CCO2:	maximum	carbon	dioxide	volume,	
UL:	upper	limb,	VE:	Expiratory	Volume,	w:	weeks.
All	data	were	extracted	from	publications,	except	in	cases	indicated	by:	aAnalysed	data	supplied	by	the	author.	bData	supplied	by	author,	analysed	by	
review	authors	(ML,	FvW).
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3.8 | Assessment times
Baseline	measures	were	reported	 in	all	but	one	study	 (Dean	et	al.,	
2010),	which	only	measured	outcomes	at	6	months	post-	study	entry.	
Of	 the	walking	 training	 studies,	nine	 included	a	 follow-	up	 (Batcho	
et	al.,	 2013;	 Dean	 et	al.,	 2010;	 Franceschini	 et	al.,	 2009;	 Hesse	
et	al.,	 2012;	 Morone	 et	al.,	 2011;	 Ng	 et	al.,	 2008;	 Richards	 et	al.,	
1993;	Rosendahl	et	al.,	2006;	Yagura	et	al.,	2006)	to	6	months	post-	
intervention	 end	 (Dean	 et	al.,	 2010;	 Franceschini	 et	al.,	 2009;	 Ng	
et	al.,	2008;	Richards	et	al.,	1993;	Rosendahl	et	al.,	2006)—although	
Richards	et	al.	(1993)	did	not	report	6-	month	follow-	up	data.	None	
of the studies investigating cycling included any follow- up. Of the 
other	 intervention	 types,	 only	 one	 study	 (White	 et	al.,	 2013)	 in-
cluded	a	follow-	up,	undertaken	at	3	months.
3.9 | Setting
Twenty- three of the 33 included studies were based in healthcare 
settings	 (Chang	 et	al.,	 2012;	 Cho	 et	al.,	 2015;	 Dean	 et	al.,	 2010;	
Demers	&	McKinley,	 2015;	 Franceschini	 et	al.,	 2009;	Hesse	 et	al.,	
1994,	1995,	2012;	Husemann	et	al.,	2007;	Lennon	et	al.,	2008;	Mayr	
et	al.,	 2007;	Mehrholz	 et	al.,	 2006;	Morone	 et	al.,	 2011;	 Ng	 et	al.,	
2008;	 Ochi	 et	al.,	 2015;	 Richards	 et	al.,	 1993;	 Teixeira	 da	 Cunha	
Filho	et	al.,	2001,	2002;	Tong	et	al.,	2006;	Wang	et	al.,	2014a,	2014b;	
White	et	al.,	2013;	Yagura	et	al.,	2006;	Yang	et	al.,	2014),	three	took	
place	in	community	settings	(Batcho	et	al.,	2013;	Leroux,	2005;	Shea	
&	Moriello,	 2014),	 one	 in	 a	 laboratory	 (Potempa	 et	al.,	 1995),	 and	
two	in	care	homes	(Rosendahl	et	al.,	2006;	Tsaih	et	al.,	2012).	Four	
studies	 did	 not	 report	 study	 setting	 (Hesse	 et	al.,	 2010;	 Plummer	
et	al.,	2007;	Stoller	et	al.,	2015;	Vidoni	et	al.,	2008).	Only	six	studies	
(Batcho	et	al.,	2013;	Demers	&	McKinley,	2015;	Lennon	et	al.,	2008;	
Leroux,	2005;	Rosendahl	et	al.,	2006;	White	et	al.,	2013)	delivered	
training in a group setting.
3.10 | Effects of interventions
Outcomes	from	all	studies	are	reported	in	Table	6.	Five	RCTs	could	
not be included in some meta- analyses: Some or all data were pre-
sented	as	medians	(Franceschini	et	al.,	2009;	Husemann	et	al.,	2007;	
Ochi	et	al.,	2015),	end-	of-	study	data	were	only	presented	in	graphi-
cal	 form	 (Yagura	et	al.,	2006),	 and	only	one	nonambulatory	 stroke	
survivor	was	 included	 in	each	group	 (Yang	et	al.,	 2014),	while	one	
randomized crossover study did not report data at crossover point 
(Cho	et	al.,	2015).
3.10.1 | Effects on primary outcomes
Alpha	was	set	at	0.10	instead	of	the	conventional	0.05,	for	reasons	
explained	in	the	Section	2.
Case fatality
Out	 of	 33	 studies	 involving	 910	 participants,	 29	 studies	 includ-
ing	 739	 participants	 reported	 case	 fatality.	Within	 these,	 10/739	
deaths	 (1.35%)	were	 reported	over	 the	entire	 study	period:	7/400	
(1.75%)	 in	 all	 intervention	groups	 and	3/339	 (0.88%)	 in	 all	 control	
groups	(Table	7).	There	were	no	deaths	in	any	of	the	cycling	or	other	
intervention-	type	 studies—although	 two	 studies	 (Potempa	 et	al.,	
1995;	 White	 et	al.,	 2013)	 did	 not	 report	 fatality.	 At	 intervention	
end,	data	from	the	13	walking	training	RCTs	reporting	case	fatality	
showed	that	2/272	(0.74%)	deaths	took	place	in	intervention	groups,	
compared	with	3/270	(1.11%)	in	control	groups	(Chang	et	al.,	2012;	
Dean	et	al.,	2010;	Franceschini	et	al.,	2009;	Husemann	et	al.,	2007;	
Morone	 et	al.,	 2011;	Ng	 et	al.,	 2008;	Ochi	 et	al.,	 2015;	 Rosendahl	
et	al.,	2006;	Stoller	et	al.,	2015;	Teixeira	da	Cunha	Filho	et	al.,	2001,	
2002;	 Tong	 et	al.,	 2006;	 Tsaih	 et	al.,	 2012;	 Yagura	 et	al.,	 2006;	
Table	7).	Both	deaths	occurred	in	one	study	(Dean	et	al.,	2010),	but	
it was unclear whether this occurred during the intervention itself 
or just within the intervention period. The difference in case fatality 
between	 groups	was	 not	 statistically	 significant	 (OR	 0.69,	 95%	CI	
0.13	 to	 3.78,	p	=	0.67,	 I2	=	0%;	 Figure	2).	 There	were	 no	 deaths	 in	
any	of	the	10	other	walking	studies	(Batcho	et	al.,	2013;	Hesse	et	al.,	
1994,	1995,	2010,	2012;	Leroux,	2005;	Mayr	et	al.,	2007;	Mehrholz	
et	al.,	2006;	Plummer	et	al.,	2007;	Vidoni	et	al.,	2008),	while	two	did	
not	report	case	fatality	(Cho	et	al.,	2015;	Richards	et	al.,	1993).
Between	 end	 of	 intervention	 and	 follow-	up,	 5/133	 (3.76%)	
deaths	occurred	in	the	walking	groups	across	four	RCTs	(Dean	et	al.,	
2010;	Franceschini	et	al.,	2009;	Morone	et	al.,	2011;	Rosendahl	et	al.,	
2006),	compared	to	0/134	in	the	control	groups.	This	higher	risk	of	
death in the intervention groups was borderline statistically signif-
icant	 (OR	 4.75,	 95%	CI	 0.75	 to	 30.13,	 p	=	0.10,	 I2	=	0%;	 Figure	3).	
Two	other	walking	studies	 (Batcho	et	al.,	2013;	Hesse	et	al.,	2012)	
reported no deaths.
Cardiovascular and respiratory functions [ICF domain b4]
Cardiac risk score None of the RCTs on assisted walking measured 
cardiac risk score. One cycle ergometer study measured cardiac risk 
score;	Lennon	et	al.	 (2008)	reported	changes,	but	due	to	the	small	
number	of	participants,	only	descriptive	data	are	presented	(Table	6).
Heart rate One walking study measured resting heart rate (Chang 
et	al.,	2012);	however,	there	was	no	effect	compared	with	the	control	
group.	At	the	end	of	walking	training,	there	was	a	significant	increase	
in peak heart rate in the intervention compared to the control group 
(MD	9.3,	95%	CI	−0.7	to	19.2,	p	=	0.07,	I2	=	32%;	Figure	4)	in	three	
studies	 (Chang	et	 al.,	 2012;	Stoller	et	 al.,	 2015;	Teixeira	da	Cunha	
Filho	et	al.,	2001).	Stoller	et	al.	(2015)	found	a	significant	difference	
in	favor	of	the	intervention	group	in	terms	of	training	intensity,	heart	
rate,	and	heart	rate	reserve	(p	<	0.002).
Cycling did not alter resting heart rate compared to control inter-
ventions	in	three	studies	(MD	1.33	bpm,	95%	CI	−3.89	to	6.55,	p	=	0.62,	
I2	=	5%;	Lennon	et	al.,	2008;	Potempa	et	al.,	1995;	Wang	et	al.,	2014a,	
2014b.	However,	peak	heart	rate	was	significantly	increased	in	the	cy-
cling	compared	to	control	groups	(MD	8.39	bpm,	95%	CI	1.90	to	14.87,	
p	=	0.01,	I2	=	35%;	Figure	5;	Potempa	et	al.,	1995;	Wang	et	al.,	2014a,	
2014b).	There	were	no	follow-	up	data.
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TABLE  7 Overview	of	dropouts	involving	non-	ambulatory	participants	only	(intervention	period,	follow up period—where included)	and	
adverse events
Author (year) Group
Drop outa (number of non- ambulatory stroke participants) during  
intervention period and follow up period (where included)
Adverse eventsb (number of 
non- ambulatory stroke participants 
experiencing event, and event 
description as stated by authors)
Possibly 
interven-
tion related
General 
health/
death
Logistical/
refusal Unknown
Not 
reported
Total entire 
study 
period (%)
Batcho	
(2013)
N/A 0 0,0,	1/0 0/0,	1/0 0, 0 0,	0 2	(33%) N	=	1	(ankle	injury,	also	reason	for	
dropout)
Chang  
(2012)
Int. 0 1/0 0/0 0 0 1	(5%) N	=	1	(aspiration	pneumonia—also	
reason	for	dropout)
Cont. 3 3/0 0/1 0 0 7	(29%) N	=	1	(low	back	pain).	N = 1 (recurrent 
stroke)	and	N = 1 (uncontrolled 
seizure):	also	reasons	for	dropout
Cho  
(2015)
Int. NR NR NR NR NR NR N	=	NR,	however	authors	reported	a	
“high	dropout	rate”	including	the	
following reasons: health status 
aggravation,	“adverse	dermatological	
effects”c
Cont. NR NR NR NR NR NR
Dean  
(2010)
Int. 2 0/2,	0/1 0/0, 0/0 0, 0 0, 0 5	(8%) N	=	2	(anxiety	due	to	treadmill	
training,	also	intervention	related	
reason	for	drop	out)
Cont. 0 0/2,	0/0 0/0, 0/0 0, 0 0, 0 2	(3%) NR
Demers 
(2015)d
N/A 0 1/0 0/0 0 0 1	(20%) Increased	fatigue	in	all	4	non-	
ambulatory participants but this was 
not a reason to stop
Franceschini 
(2009)
Int. 2 4c/0,	0/1 
(Int.. 
group)
6c/0,	0/0 0,	0 0,0 10	(19%) N	=	2	(discomfort	from	harness,	also	
intervention related reason for drop 
out)
Cont. 0 5/0,	0/0 3,	0 0,	0 8	(18%)
Hesse	(1994) N/A 0 0/0 0/0 0 0 0 NR
Hesse	(1995) N/A 0 0/0 0/0 0 0 0	(0%) NR
Hesse	(2010) N/A 0 0/0 0/0 0 0 0	(0%) None observed
Hesse  
(2012)
Int. 0 0/0,	0/0 0/0,	0/0 0,	0 0,	0 0	(0%) N	=	1	(aggravation	of	knee	OA)
Cont. 0 0/0,	0/0 0/0,	0/1 0,	0 0,	0 1	(7%) NR
Husemann 
(2007)
Int. 0 1/0 0/0 0 0 1	(6%) N	=	2	(skin	lesions),	N = 1 (ankle 
distortion	,	N =	1	(enteritis,	also	
reason	for	health-	related	dropout)
Cont. 0 0/1 0/0 0 0 1	(6%) N	=	3	(DVT),	N = 1 (pulmonary artery 
embolism,	also	cause	of	drop-	out	
and	death)
Lennon	
(2008)d
Int. 0 0/0 0/0 0 0 0	(0%) N/A
Cont. 0 0/0 0/0 0 0 0	(0%) N/A
Leroux	
(2005)
N/A 0 0/0 0/0 0 0 0	(0%) NR
Mayr	 
(2007)d
Int. 0 1/0 0/0 0 0 1	(14%)* N	=	1	(Tumour	)
Cont. NR NR/0 NR 0 0 3	(60%)* N	=	NR	(Bad	general	condition,	quit	
study	without	reason)
Mehrholz	
(2006)
N/A 0 0/0 0/0 0 0 0	(0%) N	=	1	(shoulder	pain)
Morone	
(2011)
Int. Figures NR Figures 
NR/0
Figures NR 0 0 12	(50%) N	=	3	(severe,	symptomatic	hypoten-
sion),	N	=	1	(paretic	leg	knee	pain),	
N	=	NR	(perceived	weakness,	
uncontrolled	blood	pressure,	fever,	
urinary	tract	infection)
Cont. Figures NR Figures 
NR/0
0/0 0 0 9	(38%) N	=	3	(details	NR)
(Continues)
     |  37 of 55LLOYD et aL.
Author (year) Group
Drop outa (number of non- ambulatory stroke participants) during  
intervention period and follow up period (where included)
Adverse eventsb (number of 
non- ambulatory stroke participants 
experiencing event, and event 
description as stated by authors)
Possibly 
interven-
tion related
General 
health/
death
Logistical/
refusal Unknown
Not 
reported
Total entire 
study 
period (%)
Ng  
(2008)e
Int. 0,	0 0/0,	
Figures 
NR per 
group
0/0,	
Figures 
NR
2,	Figures 
NR
0,	0 2	(6%) None	observed	during	treatment.	AE	
during follow upc: N	=	1	(died),	N = 3 
(recurrent	stroke)
Cont. 0,	0 2/0,	
Figures 
NR per 
group
2/0,	
Figures 
NR
3,	Figures 
NR
0,	0 7	(33%) N	=	1	(hospital	admission),	N = 1 
(deteriorating	medical	condition)
Ochi  
(2015)
Int. 0 0/0 0/0 0 0 0	(0%) None observed
Cont. 0 0/0 0/0 0 0 0	(0%) NR
Plummer 
(2007)
N/A 0 0/0 NR 0 0 NR None observed
Potempa 
(1995)
Int. NR NR NR NR NR NR NR
Cont. NR NR NR NR NR NR NR
Richards 
(1993)e
Int. NR NR NR 1 0 1	(10%) NR
Cont. NR NR 0/1 0 0 1	(11%) NR
Rosendahl 
(2006)d,e
Int. 0, 0 0/0,	0/3 0/0,	0/1 0, 0 0, 0 4	(50%) 6	AE	among	3	participants	(3	
musculoskeletal,	2	respiration/
circulation,	1	psychological)
Cont. 0, 0 0/0,	0/0 1/0,	0/0 0, 0 0, 0 1	(13%) 3	AE	among	3	participants	(2	
unknown,	1	psychological)
Shea	(2014) N/A 0 0/0 0 0 0 0	(0%) None observed
Stoller 
(2015)c
0 5/0 0 1 0 6	(33%) None	observed	during	training.	AE	
after recruitment but prior to 
randomisation: N = 1 (uncontrollable 
spasticity),	N	=	1	(skin	lesion),	N = 1 
(severe	groin	pain),	N = 1 (suspected 
cerebrospinal	fluid	leak),	N = 1 
(respiratory	infection)	(all	reasons	for	
dropout)
Teixeira	da	
Cunha Filho 
(2001,	
2002)
Int. 0 0/0 0/0 1 0 1	(14%) N/A
Cont. 0 1/0 1/0 0 0 2	(25%) N	=	1	(pulmonary	complication)
Tong	(2006)e Int. 0 0/0 0/0 0 0 0	(0%) None observed
Cont. 0 2/0 2/0 0 0 4	(20%) N	=	1	(hospital	admission),	N = 1 
(deteriorating	medical	condition)
Tsaih	(2012)d Int. NR NR /0 NR/NR NR 0 NR None Observed. Participants 
attended all intervention sessions
Cont. NR NR /0 NR/NR NR 0 NR None Observed. Participants 
attended all intervention sessions
Vidoni	
(2008)
N/A 0 0/0 0/0 0 0 0	(0%) Chronic	back	pain,	discomfort	during	
BWSTT	and	respiratory	infection
Wang 
(2014a)
Int. 0 0/0 3/2 0 0 5	(21%) N	=	2	(hospital	admission,	incl.	N = 1 
DVT),	N = 3 (discomfort or unpleas-
ant	feelings	after	training)	N = NRc 
(General	fatigue,	pain	and	discomfort	
in	affected	leg,	psychological	
reasons
Cont. 0 5/0 0/0 0 0 5	(21%)
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Blood pressure At	the	end	of	walking	training,	there	was	no	effect	on	
systolic	(MD	9.54	mmHg,	95%	CI	−17.72	to	36.80,	p	=	0.49,	I2	=	80%)	
or	diastolic	blood	pressure	 (MD	−0.55	mmHg,	95%	CI	−5.98	 to	4.89,	
p	=	0.84,	I2	=	0%;	Chang	et	al.,	2012;	Teixeira	da	Cunha	Filho	et	al.,	2001).
At	 the	 end	 of	 cycling	 training,	 there	was	 no	 significant	 differ-
ence	in	systolic	(MD	−3.16	mmHg,	95%	CI	−13.49	to	7.18,	p	=	0.55,	
I2	=	0%)	or	diastolic	blood	pressure	(MD	0.93	mmHg,	95%	CI	−3.87	
to	 5.74,	 p	=	0.70,	 I2	=	1%)	 compared	 to	 the	 control	 groups	 in	 two	
RCTs	(Lennon	et	al.,	2008;	Potempa	et	al.,	1995).
There were no follow- up data.
Oxygen (VO2)  uptake At	 the	 end	 of	 walking	 training,	 peak	 oxygen	
uptake was significantly increased compared to control interventions 
(MD	2.73	ml/kg/min,	95%	CI	0.64	to	4.89,	p	=	0.01,	I2	=	0%;	Figure	6;	
Chang	et	al.,	2012;	Stoller	et	al.,	2015;	Teixeira	da	Cunha	Filho	et	al.,	2001).
Chang	et	al.	(2012)	found	a	significant	improvement	in	the	walk-
ing compared to the control group at the end of the intervention 
in	 the	 percentage	 predicted	 peak	 VO2 (p	=	0.024).	 Another	 RCT	
(Teixeira	 da	 Cunha	 Filho	 et	al.,	 2002)	 found	 an	 effect	 size	 of	 0.7	
SD	units	 in	the	amount	of	oxygen	consumed	per	meter	during	the	
5MWT	in	favor	of	the	intervention	group.
F IGURE  2 Comparison	assisted	walking	training	versus	control—end	of	intervention.	Outcome:	case	fatality
Author (year) Group
Drop outa (number of non- ambulatory stroke participants) during  
intervention period and follow up period (where included)
Adverse eventsb (number of 
non- ambulatory stroke participants 
experiencing event, and event 
description as stated by authors)
Possibly 
interven-
tion related
General 
health/
death
Logistical/
refusal Unknown
Not 
reported
Total entire 
study 
period (%)
Wang 
(2014b)
Int. 2 0/0 0/0 2 0 4	(15%) N	=	2	(discomfort	in	affected	leg,	also	
intervention related reason for drop 
out)
Cont. 0 3/0 0/0 2 0 5	(19%) N	=	4	(pain	and	discomfort	in	lower	
limb)c
White	(2013) N/A NR NR NR NR NR NR NR
Yagura	
(2006)
Int. 1 0 0 0 0 1	(4%) N = 1 (harness discomfort - also 
intervention related reason for drop 
out)
Cont. 1 0 0 0 0 1	(4%) N = 1 (harness discomfort - also 
intervention related reason for drop 
out)
Yang	(2014) Int. 0 0/0 0 0 0 0	(0%) None observed
Cont. 0 0 0 0 0 0	(0%) None observed
AE:	adverse	event,	BWSTT:	body	weight	supported	treadmill	training,	Cont.:	Control,	DVT:	Deep	Vein	Thrombosis,	Int.:	Intervention,	N: number of 
participants	affected,	N/A:	Not	applicable,	NR:	Not	reported,	OA:	Osteoarthritis,	SAE:	Serious	Adverse	Event.
aDrop	out	categorisation	assessed	by	review	authors,	based	on	description	in	published	article.	bAE	as	described	by	study	authors	in	publication.	cGroup	
allocation not specified. dData supplied by study authors. eData	presented	only	for	group(s)	included	in	this	review.
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After	 cycling	 training,	 there	 was	 no	 significant	 difference	 be-
tween	 intervention	and	control	 groups	 in	peak	VO2	 (MD	1.84	ml/
kg/min,	95%	CI	−1.06	to	4.73,	p	=	0.21,	I2	=	73%;	Lennon	et	al.,	2008;	
Potempa	et	al.,	1995).	There	were	no	follow-	up	data.
Respiratory exchange ratio  (RER) At	 the	end	of	walking	 training,	
there was no significant difference between intervention and 
control	groups	in	peak	RER	(MD	0.01,	95%	CI	−0.01	to	0.03,	p	=	0.34,	
I2	=	0%;	Chang	et	al.,	2012;	Stoller	et	al.,	2015).
At	the	end	of	one	cycling	training	RCT	(Potempa	et	al.,	1995),	no	
significant	difference	was	found	in	peak	RER;	however,	there	was	a	sig-
nificant improvement in peak CO2 production in the intervention com-
pared to the control group (p	<	0.01).	There	were	no	follow-	up	data.
Peak ventilation  (VE peak) At	 the	 end	 of	walking	 training,	 there	
was	no	significant	difference	in	peak	VE	between	intervention	and	
control	 groups	 (MD	 0.87	 L/min,	 95%	 CI	 −4.75	 to	 6.49,	 p	 =	 0.76,	
I2	=	0%;	Chang	et	al.,	2012;	Stoller	et	al.,	2015).
At	the	end	of	one	cycle	ergometer	training	RCT,	Potempa	et	al.	
(1995)	 found	 a	 significant	 improvement	 in	 peak	 ventilation	 in	 the	
intervention compared with the control group (p	<	0.01).	There	were	
no follow- up data.
Other cardiorespiratory functions After	walking	training,	Stoller	et	al.	
(2015)	found	no	significant	difference	in	any	of	their	cardiorespiratory	
performance	measures	(Table	6)	compared	with	the	control	intervention.	
These	findings	were	echoed	in	the	RCT	by	Chang	et	al.	(2012).
After	 cycling	 training,	 one	 RCT	 (Lennon	 et	al.,	 2008)	 reported	
changes	in	forced	expiratory	volume;	however,	only	descriptive	data	
could	be	presented	(Table	6).
Workload One	walking	training	RCT	(Teixeira	da	Cunha	Filho	et	al.,	
2001)	 found	no	 significant	 difference	 in	workload	during	 exercise	
testing between walking and control groups at intervention end.
At	the	end	of	one	cycle	training	RCT	(Potempa	et	al.,	1995),	a	signif-
icant	improvement	in	workload	was	found	during	maximal	exercise	in	
the intervention compared to the control group (p	<	0.0001).	Lennon	
et	al.	(2008)	reported	changes	in	peak	wattage	following	their	cycling	
intervention,	 but	 due	 to	 the	 small	 number	 of	 participants,	 only	 de-
scriptive	data	are	presented	(Table	6).	There	were	no	follow-	up	data.
F IGURE  3 Comparison	assisted	walking	training	versus	control—follow-	up.	Outcome:	case	fatality
F IGURE  4 Comparison	assisted	walking	training	versus	control—end	of	intervention.	Outcome:	peak	heart	rate	(bpm)
F IGURE  5 Comparison	cycle	ergometer	training	versus	control—end	of	intervention.	Outcome:	peak	heart	rate	(bpm)
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Rate of perceived exertion Rate	of	perceived	exertion	 (RPE)	was	
assessed in two walking training RCTs: No significant differences 
between intervention and control groups were found at the 
intervention	end	(Chang	et	al.,	2012;	Franceschini	et	al.,	2009)	or	at	
follow-	up	(Franceschini	et	al.,	2009).
One	cycle	training	RCT	(Lennon	et	al.,	2008)	assessed	RPE,	but	
due	 to	 the	small	numbers	of	nonambulatory	participants,	only	de-
scriptive	data	are	presented	(Table	6).	There	were	no	follow-	up	data.
Exercise  tolerance One walking training RCT measured the 
total	 time	pedaling	during	 the	 testing	protocol	 (Teixeira	 da	Cunha	
Filho	 et	 al.,	 2001),	 but	 found	 no	 significant	 difference	 between	
intervention and control groups at intervention end.
At	the	end	of	cycle	ergometer	interventions,	there	was	no	signif-
icant	difference	in	exercise	time	between	groups	(MD	83.61	s,	95%	
CI	−22.30	to	189.51,	p	=	0.12,	I2	=	43%;	Potempa	et	al.,	1995;	Wang	
et	al.,	2014a,	2014b).	There	were	no	follow-	up	data.
Metabolic functions [ICF domain b5]
Body  weight At	 the	 end	 of	 robot-	assisted	 walking,	 one	 RCT	
(Husemann	 et	 al.,	 2007)	 found	 a	 significant	 reduction	 of	 fat	mass	
compared with conventional walking rehabilitation (p	 =	 0.012);	
however,	 there	 were	 no	 significant	 between-	group	 differences	 in	
body	weight	 or	 body	 cell	 mass.	 There	was	 no	 follow-	up.	Morone	
et	 al.	 (2011)	 was	 the	 only	 study	 on	 walking	 to	 measure	 BMI	 at	
baseline	 and	 discharge	 (but	 not	 end	 of	 intervention);	 however,	 no	
significant between- group difference was found.
At	the	end	of	cycle	ergometer	interventions,	there	was	no	signif-
icant	difference	in	body	weight	between	groups	(MD	−0.58	kg,	95%	
CI	−8.12	to	6.97,	p	=	0.88,	 I2	=	48%;	Potempa	et	al.,	1995;	Wang	et	
al.,	2014a).	Lennon	et	al.	(2008)	measured	waist	girth	and	BMI,	but	
as	there	were	only	four	ambulatory	participants	in	each	group,	only	
descriptive	data	are	presented	(Table	6).
There were no follow- up data.
Serum lipid profiles None of the walking training RCTs measured 
any serum lipid levels.
One	 cycle	 training	 RCT	 measured	 total	 cholesterol	 (Lennon	
et	al.,	2008);	however,	due	 to	 the	small	number	of	nonambulatory	
participants,	 only	 descriptive	 data	 are	 presented	 (Table	6).	 Two	
cycle	 training	 RCTs	 (Wang	 et	 al.,	 2014a,	 2014b)	 measured	 total	
triglycerides:	 Following	 the	 end	 of	 the	 intervention,	 there	was	 no	
significant	difference	between	intervention	and	control	groups	(MD	
−0.18	mmol/L,	95%	CI	−0.59	to	0.23,	p	=	0.39,	I2	=	98%).
Two	cycle	training	RCTs	 (Wang	et	al.,	2014a,	2014b)	measured	
high-	density	 lipoprotein	 (HDL)	 and	 low-	density	 lipoprotein	 (LDL):	
Following	 the	 end	 of	 the	 intervention,	 HDL	 levels	 had	 improved	
significantly	in	the	intervention	compared	to	the	control	group	(MD	
0.06	mmol/L,	95%	CI	0.00	to	0.13,	p	=	0.07,	I2	=	0%;	Figure	7).
In	contrast,	the	same	two	studies	(Wang	et	al.,	2014a,	2014b)	found	
no	difference	in	LDL	levels	between	intervention	and	control	groups	
at	the	end	of	intervention	(MD	−0.04	mmol/L,	95%	CI	−0.29	to	0.21,	
p	=	0.77,	I2	=	0%).
Blood glucose and insulin levels None of the walking training RCT 
included any measures of glucose tolerance or insulin resistance.
At	 the	 end	 of	 the	 intervention,	 cycle	 ergometer	 training	 did	
not	 significantly	 alter	 2-	hr	 blood	 glucose	 (MD	 −1.06	mmol/L,	
95%	 CI	 −2.87	 to	 0.76,	 p	=	0.25,	 I2	=	93%)	 or	 Homeostatic	 Model	
Assessment—Insulin	Resistance	(HOMA-	IR;	MD	−0.08,	95%	CI	−0.45	
to	0.29,	p	=	0.68,	I2	=	0%)	compared	to	control	interventions	(Wang	
et	 al.,	 2014a,	 2014b).	 In	 contrast,	 fasting	 insulin	 (MD	 0.75	μU/ml,	
95%	CI	0.15	to	1.34,	p	=	0.01,	I2	=	2%;	Figure	8)	and	fasting	glucose	
levels	 (MD	−0.11	mmol/L,	95%	CI	−0.22	to	0.00,	p	=	0.04,	 I2	=	0%;	
Figure	9)	were	significantly	improved	in	the	intervention	compared	
to	control	groups	(Wang	et	al.,	2014a,	2014b).	Furthermore,	by	com-
bining	data	on	fasting	glucose	and	2-	hr	plasma	glucose,	Wang	et	al.	
(2014a)	found	that	significantly	more	participants	in	the	intervention	
(48%)	compared	to	the	control	group	(18%)	improved	their	glucose	
tolerance (p	<	0.05).
Movement- related functions [ICF domain b7]
Walking endurance A	mix	of	5MWT	and	6MWT	was	used	across	
studies;	therefore,	the	average	distance	per	minute	walking	during	
these	 tests	 was	 calculated.	 At	 the	 end	 of	 walking	 interventions,	
there was a borderline statistically significant improvement in 
distance walked in the intervention compared with control groups 
(MD	7.22	m/min	95%	CI	−1.42	to	15.87,	p	=	0.10,	I2	=	57%;	Figure	10;	
Mayr	et	al.,	2007;	Teixeira	da	Cunha	Filho	et	al.,	2002;	Tsaih	et	al.,	
2012).	 However,	 Franceschini	 et	 al.	 (2009)	 found	 no	 significant	
between- group differences at intervention end.
Three RCTs undertook follow- up assessment; data from two 
RCTs	(Dean	et	al.,	2010;	Morone	et	al.,	2011)	demonstrated	a	signif-
icant	improvement	in	the	6MWT	in	favor	of	the	intervention	group	
F IGURE  6 Comparison	assisted	walking	training	versus	control—end	of	intervention.	Outcome:	peak	VO2	(ml/kg/min)
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(MD	45.3	m,	95%	CI	11.3	to	79.3,	p	=	0.009,	I2	=	0%),	while	one	RCT	
(Franceschini	et	al.,	2009)	found	no	significant	difference.
Only	one	cycling	study	measured	walking	endurance	(Yang	et	al.,	
2014);	however,	there	was	only	one	nonambulatory	stroke	survivor	
in	each	group	(Table	6).
Muscle  strength Muscle	 strength	 was	 measured	 using	 a	 range	
of	 tools,	 including	1	 repetition	maximum	 (RM)	and	modified	Chair	
Stand	Test	 (Rosendahl	et	al.,	2006),	MRC	scale	(Mayr	et	al.,	2007),	
and	 the	Motricity	 Index	 (MI;	Chang	et	 al.,	 2012;	Cho	et	 al.,	 2015;	
Franceschini	et	al.,	2009;	Husemann	et	al.,	2007;	Mayr	et	al.,	2007;	
Morone	et	al.,	2011;	Ng	et	al.,	2008;	Tong	et	al.,	2006)—although	not	
all	authors	used	the	full	MI.
At	the	end	of	walking	training,	there	was	no	change	in	the	MI-	
lower	 limb	subscale	between	groups	 (MD	1.8,	95%	CI	−5.9	 to	9.5,	
p	=	0.65,	 I2	=	20%;	Chang	 et	al.,	 2012;	Mayr	 et	al.,	 2007;	Ng	 et	al.,	
2008).	Three	further	studies	found	no	significant	differences	in	the	
MI	at	 intervention	end	 (Franceschini	et	al.,	2009;	Husemann	et	al.,	
2007;	Tong	et	al.,	2006).	Mayr	et	al.	(2007)	used	the	MRC	scale,	but	
due	 to	 the	 small	 numbers	 involved,	 only	 descriptive	 data	 are	 pre-
sented	(Table	6).	Rosendahl	et	al.	 (2006)	used	the	1RM	to	measure	
leg	strength;	however,	due	 to	 the	small	number	of	nonambulatory	
participants,	 only	 descriptive	 data	 are	 presented	 (Table	6),	 while	
modified	Chair	 Stand	Test	data	were	not	 available.	Muscle	 torque	
was	measured	in	one	RCT;	Ochi	et	al.	(2015)	found	a	significant	im-
provement in the unaffected leg only in the walking compared with 
the control group at intervention end (p	<	0.01).
Three	studies	conducted	a	follow-	up	(Franceschini	et	al.,	2009;	
Morone	et	al.,	2011;	Ng	et	al.,	2008);	there	was	no	significant	effect	
of	walking	 compared	 to	 control	 interventions	 on	 the	MI.	 Findings	
from	 the	 meta-	analysis	 (MD	 6.5,	 95%	 CI	 −1.9	 to	 14.9,	 p	=	0.13,	
I2	=	0%)	agreed	with	those	by	Franceschini	et	al.	(2009).
None of the cycle training studies included any measures of mus-
cle strength or power.
3.10.2 | Effects on secondary outcomes
Mobility [ICF domain d4]
Measuring	walking	outcomes	in	a	nonambulatory	population	was	
challenging,	and	different	studies	used	different	protocol	adapta-
tions	(although	they	were	not	always	described);	for	example,	in	
some studies participants were allowed to use devices (includ-
ing	 parallel	 bars)	 and	 assistance	 from	 staff,	while	 in	 others	 this	
was	not	permitted.	In	some	studies,	walking	was	only	evaluated	in	
those	able	to	walk,	while	in	other	studies	outcomes	were	scored	
as	 “zero”	 if	 participants	 were	 unable	 to	 walk	 independently	 or	
without	 aids,	walk	 continuously,	 or	 complete	 the	 required	 time	
or	distance.	In	other	studies	again,	if	participants	were	unable	to	
F IGURE  7 Comparison	cycle	ergometer	training	versus	control—end	of	intervention.	Outcome:	high-	density	lipoprotein	(mmol/L)
F IGURE  8 Comparison	cycle	ergometer	training	versus	control—end	of	intervention.	Outcome:	fasting	insulin	(μU/m/L)
F IGURE  9 Comparison	cycle	ergometer	training	versus	control—end	of	intervention.	Outcome:	fasting	glucose	(mmol/L)
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complete	 the	walking	 test,	 data	were	 inserted	 to	 avoid	missing	
data.
Walking  independence At	 the	 end	 of	 the	 intervention,	 assisted	
walking interventions resulted in a borderline significant improvement 
in	the	Functional	Ambulation	Category	(FAC)	compared	with	control	
interventions	 (MD	0.36,	95%	CI	−0.07	to	0.78,	p	=	0.10,	 I2	=	39%;	
Figure	11;	Chang	et	al.,	2012;	Morone	et	al.,	2011;	Ng	et	al.,	2008;	
Teixeira	da	Cunha	Filho	et	al.,	2002).
Two further RCTs showed significant improvements in the 
FAC	 compared	 to	 control	 interventions	 (Ochi	 et	al.,	 2015;	 Tong	
et	al.,	 2006);	 however,	 two	 other	 RCTs	 (Franceschini	 et	al.,	 2009;	
Husemann	et	al.,	2007)	found	no	significant	between-	group	differ-
ences at the end of the intervention. Three walking RCTs conducted 
a	follow-	up	using	the	FAC;	Ng	et	al.	 (2008)	 found	a	significant	 im-
provement	in	the	FAC	in	favor	of	the	intervention	group	(p	=	0.018).	
FAC	data	in	the	study	by	Morone	et	al.	(2011)	were	not	presented	in	
a	format	that	could	be	used	for	this	meta-	analysis.	In	that	study,	four	
groups	were	 compared	 (Table	5)	 and	 the	only	 significant	 improve-
ment found was in the walking compared to the control subgroups 
that included participants with more severe paresis (p	=	0.001).	
Franceschini	et	al.	(2009)	did	not	find	any	benefit	of	walking	training	
compared to the control group at follow- up.
None	of	the	cycling	studies	evaluated	the	FAC.
Odds  of  gaining  walking  independence Two RCTs of assisted 
walking	either	reported	data	(Ng	et	al.,	2008)	or	enabled	the	odds	
of achieving independent walking at the end of the intervention 
to	be	established	(Teixeira	da	Cunha	Filho	et	al.,	2001).	Teixeira	da	
Cunha	Filho	et	al.	(2001)	did	not	report	a	criterion	for	independent	
walking,	while	Ng	 et	 al.	 (2008)	 used	 an	 FAC	 score	 ≥4,	which	was	
used by the review authors for both studies. There was no significant 
difference between groups in achieving independent ambulation at 
intervention	end	(OR	0.80,	95%	CI	0.22–2.95,	p	=	0.74,	I2	=	0%).	In	
addition,	Yagura	et	al.	 (2006)	reported	that	achieving	 independent	
indoor	walking	(Functional	Independence	Measure	(FIM)	gait	score	
6	or	7)	was	not	associated	with	treatment	group	(hazard	ratio	0.53,	
95%	CI	0.12	to	2.25).
At	the	end	of	follow-	up,	two	further	walking	training	RCTs	(Dean	
et	al.,	2010;	Morone	et	al.,	2011)	reported	the	percentage	of	 inde-
pendent	walkers;	however,	they	used	different	criteria:	Dean	et	al.	
(2010)	used	the	Motor	Assessment	Scale	for	Stroke	(item	Walking,	
score	0	or	1),	while	Morone	et	al.	 (2011)	used	 the	FAC	 (score	>3).	
This showed that the odds of becoming an independent walker at 
the end of a walking intervention increased 2.73- fold compared with 
the	 control	 group	 (OR	 2.73,	 95%	 CI	 0.97–7.71,	 p	=	0.06,	 I2	=	51%;	
Figure	12).
None of the cycling interventions reported the odds of regaining 
independent walking.
Walking  speed After	 assisted	 walking	 interventions	 (Husemann	
et	al.,	2007;	Mayr	et	al.,	2007;	Ng	et	al.,	2008;	Richards	et	al.,	1993;	
Rosendahl	 et	 al.,	 2006;	Teixeira	da	Cunha	Filho	et	 al.,	 2002;	Tong	
et	al.,	2006;	Tsaih	et	al.,	2012),	there	was	a	significant	improvement	
in	maximum	walking	speed	 in	 the	 intervention	compared	with	 the	
control	group	(MD	0.10	m/s,	95%	CI	0.01	to	0.18,	p	=	0.02,	I2	=	67%).	
Rosendahl	et	al.	(2006)	also	measured	self-	paced	walking	speed,	but	
there	was	virtually	no	change	in	either	intervention	or	control	group,	
both at the end of intervention and follow- up.
Of	 the	 remaining	walking	 RCTs,	 Franceschini	 et	al.	 (2009)	 and	
Yagura	et	al.	(2006)	found	no	significant	between-	group	differences	
in	 speed	 during	 the	 intervention	 period,	 while	 Ochi	 et	al.	 (2015)	
found a trend toward improvement in the intervention compared 
with the control group (p	=	0.07).	 Six	 RCTs	 on	 walking	 training	
F IGURE  10 Comparison	assisted	walking	training	versus	control—end	of	intervention.	Outcome:	walking	endurance	(m/min)
F IGURE  11 Comparison	assisted	walking	training	versus	control—end	of	intervention.	Outcome:	FAC
     |  43 of 55LLOYD et aL.
included	a	follow-	up;	however,	Richards	et	al.	(1993)	did	not	report	
data.	Meta-	analysis	including	four	RCTs	(Dean	et	al.,	2010;	Morone	
et	al.,	2011;	Ng	et	al.,	2008;	Rosendahl	et	al.,	2006)	showed	no	sig-
nificant	 difference	between	 intervention	 and	 control	 groups	 at	 6-	
month	follow-	up	(MD	0.11,	95%	CI	−0.05	to	0.27,	p	=	0.19,	I2	=	71%),	
and	neither	did	Franceschini	et	al.	(2009).
Only	 one	 cycling	 study	 measured	 walking	 speed	 (Yang	 et	al.,	
2014);	however,	there	was	only	one	nonambulatory	stroke	survivor	
in	each	group,	whose	outcomes	did	not	change	(Table	6).
Gait kinematics At	the	end	of	the	walking	intervention,	Husemann	
et	 al.	 (2007)	 found	 no	 significant	 between-	group	 differences	 in	
cadence,	 stride	 duration,	 stance	 duration,	 or	 single	 support	 time.	
This	 study	 did	 not	 include	 a	 follow-	up.	 At	 follow-	up,	 Dean	 et	 al.	
(2010)	 found	 no	 significant	 differences	 in	 stride	 length	 between	
intervention	and	control	groups,	measured	in	participants	who	had	
become	able	 to	walk.	The	study	by	Richards	et	al.	 (1993)	 included	
gait	 kinematics,	 but	 data	 were	 not	 reported,	 while	 Yagura	 et	 al.	
(2006)	did	not	measure	cadence	in	nonambulatory	participants.
None of the cycle interventions measured gait kinematics.
Self- rated  walking Using	 the	 modified	 EU	 Walking	 Scale,	 Mayr	
et	al.	(2007)	found	that	average	scores	in	both	groups	had	improved	
at	the	end	of	the	walking-	based	 intervention,	but	due	to	the	small	
number	 of	 nonambulatory	 participants,	 only	 descriptive	 data	 are	
presented	 (Table	 6).	 There	 was	 no	 follow-	up.	 At	 the	 end	 of	 the	
walking	intervention,	nor	at	follow-	up,	did	Franceschini	et	al.	(2009)	
find any between- group difference in the Walking Handicap Scale. 
In	contrast,	Dean	et	al.	(2010)	found	a	significant	improvement	on	a	
self-	rated	walking	questionnaire	 in	the	walking	compared	with	the	
control	group	at	6-	month	follow-	up	(MD	1.0,	95%	CI	0.1	to	1.9).
None of the cycling interventions assessed self- reported walking 
ability.
Mobility At	 the	 end	 of	 walking	 training,	 Elderly	 Mobility	 Scale	
scores significantly improved in the walking compared to the control 
group	in	two	RCTs	(Ng	et	al.,	2008;	Tong	et	al.,	2006),	as	well	as	at	
follow-	up	(Ng	et	al.,	2008).
The	average	time	for	the	Timed	Up	and	Go	improved	in	one	RCT	
(Tsaih	et	al.,	2012)	in	both	intervention	and	control	groups	following	
walking	training;	however,	due	to	the	small	sample,	no	further	analy-
sis	was	undertaken	(Table	6).	At	the	end	of	walking	training,	average	
Rivermead	Mobility	 Index	 (Gross	 function)	 scores	 improved	 in	 the	
RCT	by	Mayr	et	al.	(2007),	but	due	to	small	numbers,	no	further	anal-
ysis	was	undertaken.	Morone	et	al.	(2011)	did	not	report	data	at	the	
end	of	their	intervention,	but	at	follow-	up,	they	noted	a	significant	
improvement in the walking compared to the control subgroups that 
included participants with more severe paresis (p	=	0.001).	 There	
were no significant between- subgroup differences between those 
with less severe paresis.
None of the cycling studies included any mobility measures.
Movement- related functions [ICF domain b7]
Voluntary  movement  control At	 the	 end	 of	 walking	 training,	 a	
significant	 improvement	 was	 seen	 in	 the	 Fugl-	Meyer	 (lower	 limb)	
scores	 compared	 with	 control	 interventions	 (Chang	 et	 al.,	 2012;	
Richards	 et	 al.,	 1993;	 MD	 3.19,	 95%	 CI	 −0.17	 to	 6.55,	 p	 =	 0.06,	
I2	=	0%;	Figure	13).	However,	 two	 further	walking	RCTs	 found	no	
significant	 between-	group	 differences	 in	 Fugl-	Meyer	 scores	 (Ochi	
et	al.,	2015;	Yagura	et	al.,	2006).	At	follow-	up,	Richards	et	al.	(1993))	
found no significant difference between intervention and control 
groups	in	the	Fugl-	Meyer	(lower	limb	and	balance)	scores.
Across	 cycle	 ergometer	 interventions,	 different	 sections	 of	 the	
Fugl-	Meyer	were	used;	therefore,	the	SMD	instead	of	the	MD	was	
computed.	Following	training,	no	significant	differences	were	seen	in	
three	studies	(Potempa	et	al.,	1995;	Wang	et	al.,	2014a,	2014b;	SMD	
0.59,	95%	CI	−0.26	to	1.43,	p	=	0.17,	I2	=	82%),	while	in	the	study	by	
Yang	et	al.	(2014),	only	one	nonambulatory	stroke	survivor	took	part	
in	each	group,	both	of	whom	showed	minimal	improvement	(Table	6).
Trunk control Two walking training RCTs used the Trunk Control 
Test	 (Franceschini	 et	 al.,	 2009;	Morone	 et	 al.,	 2011).	 Franceschini	
et	al.	(2009)	found	no	significant	difference	between	the	intervention	
and	control	groups,	either	at	the	end	of	intervention	or	at	follow-	up.	
Morone	et	al.	(2011)	did	not	report	end-	of-	intervention	results,	but	
at	 discharge,	 there	was	 a	 significant	 improvement	 only	within	 the	
subgroup of participants with severe paresis who had undertaken 
walking	training,	compared	with	the	control	group	(p	=	0.001).
Balance At	 the	 end	 of	 walking	 training,	 there	 was	 no	 significant	
difference	 between	 intervention	 and	 control	 groups	 in	 the	 Berg	
Balance	Scale	(BBS;	MD	3.97,	95%	CI	−1.28	to	9.21,	p	=	0.14,	I2	=	0%;	
Ng	et	al.,	2008;	Richards	et	al.,	1993;	Rosendahl	et	al.,	2006;	Tsaih	
et	 al.,	 2012).	 One	 further	 RCT	 (Tong	 et	 al.,	 2006)	 also	 found	 no	
significant between- group difference in balance.
F IGURE  12 Comparison	assisted	walking	training	versus	control—follow-	up.	Outcome:	independent	walking
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In	contrast,	at	follow-	up,	RCTs	by	Ng	et	al.	(2008)	and	Rosendahl	
et	al.	(2006)	showed	a	significant	improvement	in	BBS	in	favor	of	the	
walking	training	group	(MD	6.09,	95%	CI	−0.63	to	12.81,	p	=	0.08,	
I2	=	0%)—although	Richards	et	al.	(1993)	found	no	significant	differ-
ence	 between	 intervention	 and	 control	 groups	 in	 the	 Fugl-	Meyer	
(balance)	score	at	follow-	up.
None of the cycling RCTs included any balance outcomes.
Falls Only one study assessed the number of falls and the percentage 
of	fallers;	although	no	data	were	available	for	the	intervention	end,	
Dean	 et	 al.	 (2010)	 reported	 no	 significant	 differences	 between	
walking	training	and	control	groups	at	6-	month	follow-	up.
Resistance to passive movement Resistance to passive movement 
was	 assessed	with	 the	 Ashworth	 (Franceschini	 et	 al.,	 2009;	Mayr	
et	al.,	2007;	Morone	et	al.,	2011)	or	modified	Ashworth	(Cho	et	al.,	
2015;	Husemann	et	al.,	2007)	scales	in	five	walking	training	RCTs.
At	 the	 end	 of	 walking	 training,	 two	 RCTs	 (Franceschini	 et	al.,	
2009;	Husemann	et	al.,	2007)	found	no	significant	between-	group	
difference	in	resistance	to	passive	movement.	Morone	et	al.	(2011)	
did	 not	 report	 data	 at	 intervention	 end,	 and	 the	 number	 of	 par-
ticipants	 in	 the	 study	 by	Mayr	 et	al.	 (2007)	was	 too	 small	 for	 fur-
ther	 analysis	 (Table	6).	At	 follow-	up,	Franceschini	 et	al.	 (2009)	 and	
Morone	et	al.	(2011)	found	no	significant	difference	between	groups	
in this outcome.
One	 cycling	 study	 indicated	 that	 the	modified	Ashworth	 scale	
had	been	used,	but	data	were	not	reported	(Yang	et	al.,	2014).
Body functions [ICF domain b]
Morone	 et	al.	 (2011)	 was	 the	 only	 study	 to	 use	 the	 Canadian	
Neurological	Scale	at	baseline	and	at	discharge,	but	not	at	interven-
tion	end.	All	groups	improved,	but	between-	group	differences	were	
not specified.
Sensory functions [ICF domain b2]
Proprioceptive sensibility of the lower limb was assessed in one 
walking	 training	RCT	 (Franceschini	 et	al.,	 2009);	 no	 significant	dif-
ferences were found between the intervention and control groups 
at the end of intervention or follow- up.
One	 study	 used	 the	 Albert’s	 Test	 for	 perceptual	 neglect	
(Franceschini	et	al.,	2009),	but	no	significant	between-	group	differ-
ences were found at the end of the walking training intervention or 
at follow- up.
Mental functions [ICF domain b1]
Anxiety and depression None of the walking RCTs assessed effects 
of	training	on	psychological	function,	including	cognition	or	mood.
Only	 one	 cycle	 training	 RCT	 (Lennon	 et	al.,	 2008)	 used	 the	
Hospital	 Anxiety	 and	Depression	 Scale	 (HADS).	However,	 as	 only	
four	nonambulatory	participants	were	included	in	each	group,	only	
descriptive	data	are	presented	(Table	6).
Activities and Participation [ICF domain d]
The	Barthel	 Index	 (BI)	 or	modified	BI	was	 used	 in	 eight	walking	
RCTs	 including	 a	 crossover	 study	 (Cho	 et	al.,	 2015;	 Franceschini	
et	al.,	2009;	Husemann	et	al.,	2007;	Morone	et	al.,	2011;	Ng	et	al.,	
2008;	Richards	et	al.,	1993;	Tong	et	al.,	2006;	Tsaih	et	al.,	2012);	
however,	 only	 data	 from	Ng	 et	al.	 (2008),	 Richards	 et	al.	 (1993),	
and	Tsaih	et	al.	(2012)	could	be	entered	into	the	meta-	analysis,	as	
Morone	et	al.	(2011)	only	reported	a	p	value	(<0.029),	and	reasons	
for not including other studies were stated above. No significant 
difference between intervention and control groups was found at 
the	end	of	intervention	(SMD	0.20,	95%	CI	−0.28	to	0.67,	p	=	0.42,	
I2	=	0%).	The	remaining	RCTs	also	found	no	significant	difference	
in	 BI	 between	 intervention	 and	 control	 groups	 at	 intervention	
end	(Franceschini	et	al.,	2009;	Husemann	et	al.,	2007;	Tong	et	al.,	
2006).
The	 Functional	 Independence	Measure	 (FIM)	 was	 used	 in	 five	
walking	training	RCTs	(Ng	et	al.,	2008;	Ochi	et	al.,	2015;	Teixeira	da	
Cunha	Filho	et	al.,	 2001;	Tong	et	al.,	 2006;	Yagura	et	al.,	 2006),	 al-
though	different	 sections	were	used:	Teixeira	da	Cunha	Filho	et	al.	
(2001)	used	the	locomotor	subscale	and	Ochi	et	al.	(2015)	used	the	
mobility	subscale,	while	Ng	et	al.	(2008)	and	Tong	et	al.	(2006)	used	
the	full	FIM	instrument	and	the	paper	by	Yagura	et	al.	(2006)	included	
graphs	of	the	FIM	total,	motor,	and	gait	subscales.	There	was	no	sig-
nificant	difference	between	intervention	and	control	groups,	both	at	
the	end	of	the	intervention	(Ng	et	al.,	2008;	Tong	et	al.,	2006;	Yagura	
et	al.,	2006)	and	at	 follow-	up	 (Ng	et	al.,	2008),	 in	any	of	 these	out-
comes.	One	walking	training	RCT	used	the	Adelaide	Activities	Profile	
(Dean	et	al.,	2010).	Baseline	data	were	not	reported,	and	outcomes	
were	only	measured	at	6	months	after	study	entry.	At	that	point,	no	
significant differences between the intervention and control groups 
were	 found.	 At	 follow-	up,	 Franceschini	 et	al.	 (2009)	 and	 Ng	 et	al.	
(2008)	found	no	significant	between-	group	differences	in	the	BI.	This	
was	in	contrast	to	Morone	et	al.	(2011),	who	did	find	a	significant	dif-
ference—but	only	in	favor	of	the	subgroup	of	participants	with	the	low	
F IGURE  13 Comparison	assisted	walking	training	versus	control—end	of	intervention.	Outcome:	Fugl-	Meyer	(lower	limb)
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motricity intervention group compared to those in the control group 
(p	=	0.006).	Richards	et	al.	(1993)	found	no	significant	difference	be-
tween	 intervention	 and	 control	 groups	 in	 the	 Barthel	 Ambulation	
score,	both	at	the	end	of	the	intervention	and	at	follow-	up.
Two	walking	training	RCTs	used	the	Rankin	(Morone	et	al.,	2011)	
or	modified	Rankin	Scale	(Franceschini	et	al.,	2009).	Franceschini	et	al.	
(2009)	found	no	significant	difference	between	the	intervention	and	
control	groups	either	at	the	end	of	the	intervention	or	at	follow-	up.	At	
discharge,	Morone	et	al.	(2011)	only	found	a	significant	improvement	
in favor of the subgroup of participants with low motricity partaking 
in the intervention compared to the control group (p	<	0.029).
At	the	end	of	the	intervention,	cycle	ergometer	training	resulted	
in significant improvements in favor of the intervention groups in 
the	BI	 in	two	studies	 (MD	19.5,	95%	CI	13.8	to	25.2,	p	<	0.00001,	
I2	=	8%;	Wang	et	al.,	2014a,	2014b)	by	the	same	author.	There	were	
no follow- up data.
One	cycle	ergometer	study	(Lennon	et	al.,	2008)	used	the	Frenchay	
Activities	Index.	However,	due	to	the	small	number	of	nonambulatory	
participants,	only	descriptive	data	are	provided	(Table	6).
3.11 | Feasibility
3.11.1 | Recruitment rates
Only	17/33	studies	(52%)	reported	the	number	of	people	assessed	for	
eligibility	(Batcho	et	al.,	2013;	Chang	et	al.,	2012;	Dean	et	al.,	2010;	
Franceschini	et	al.,	2009;	Hesse	et	al.,	2012;	Morone	et	al.,	2011;	Ng	
et	al.,	2008;	Ochi	et	al.,	2015;	Rosendahl	et	al.,	2006;	Stoller	et	al.,	
2015;	Teixeira	da	Cunha	Filho	et	al.,	2001,	2002;	Tong	et	al.,	2006;	
Tsaih	 et	al.,	 2012;	Wang	 et	 al.,	 2014a,	 2014b;	Yagura	 et	al.,	 2006;	
Yang	 et	al.,	 2014).	 Across	 these	 studies,	 a	 total	 of	 6,019	 patients	
were	 screened,	 of	whom	 1,271	 (mean	 36%	 per	 study,	 range	 2%–
100%)	were	randomized	or	allocated	otherwise	to	an	intervention.	
Of	these,	910	(72%	of	all	patients	screened)	were	nonambulatory.
3.11.2 | Attendance
Nineteen	of	the	33	studies	(58%)	recorded	attendance	(Batcho	et	al.,	
2013;	Dean	et	al.,	2010;	Demers	&	McKinley,	2015;	Lennon	et	al.,	
2008;	 Leroux,	 2005;	 Mayr	 et	al.,	 2007;	 Morone	 et	al.,	 2011;	 Ng	
et	al.,	2008;	Plummer	et	al.,	2007;	Richards	et	al.,	1993;	Rosendahl	
et	al.,	2006;	Shea	&	Moriello,	2014;	Stoller	et	al.,	2015;	Teixeira	da	
Cunha	Filho	et	al.,	2001,	2002;	Tong	et	al.,	2006;	Tsaih	et	al.,	2012;	
Vidoni	et	al.,	2008;	Wang	et	al.,	2014a,	2014b).	Where	reported,	at-
tendance	in	the	exercise	intervention	groups	varied	between	65.5%	
(Rosendahl	et	al.,	2006)	and	100%	(Lennon	et	al.,	2008;	Mayr	et	al.,	
2007;	Ng	et	al.,	2008;	Plummer	et	al.,	2007;	Stoller	et	al.,	2015;	Tong	
et	al.,	2006;	Tsaih	et	al.,	2012).
3.11.3 | Adverse events and dropouts
Adverse	 events	 and	 dropouts	 were	 fully	 reported	 by	 16/33	 (48%)	
studies	 (Batcho	 et	al.,	 2013;	 Chang	 et	al.,	 2012;	 Dean	 et	al.,	 2010;	
Demers	&	McKinley,	2015;	Hesse	et	al.,	2010,	2012;	Husemann	et	al.,	
2007;	 Lennon	 et	al.,	 2008;	Mehrholz	 et	al.,	 2006;	 Rosendahl	 et	al.,	
2006;	 Shea	&	Moriello,	 2014;	 Teixeira	 da	Cunha	 Filho	 et	al.,	 2001,	
2002;	Tong	et	al.,	2006;	Vidoni	et	al.,	2008;	Yagura	et	al.,	2006;	Yang	
et	al.,	2014),	while	16/33	(48%)	studies	provided	unclear/incomplete	
information	(Cho	et	al.,	2015;	Franceschini	et	al.,	2009;	Hesse	et	al.,	
1994,	1995;	Leroux,	2005;	Mayr	et	al.,	2007;	Morone	et	al.,	2011;	Ng	
et	al.,	 2008;	Ochi	 et	al.,	 2015;	Plummer	et	al.,	 2007;	Richards	et	al.,	
1993;	Stoller	et	al.,	2015;	Tsaih	et	al.,	2012;	Wang	et	al.,	2014a,	2014b)	
and	one	(3%)	provided	no	information	(Potempa	et	al.,	1995;	Table	7).	
Most	reasons	for	dropout	were	associated	with	logistics	(e.g.,	patients	
being	transferred	to	other	hospitals),	while	those	related	to	general	
health	included	recurrent	strokes	and	seizures,	enteritis,	and	aspira-
tion	pneumonia	(Table	7).
Where	 reported,	 there	were	41/354	 (12%)	dropouts	 in	 the	 in-
tervention	groups	across	all	walking	 interventions,	 compared	with	
47/299	 (16%)	 in	 the	control	groups,	with	another	 six	nonallocated	
adverse	events	reported	by	Stoller	et	al.	 (2015).	Reasons	for	drop-
out,	considered	by	the	review	authors	to	be	exercise	intervention-	
related,	 included	 anxiety	 associated	 with	 treadmill	 training	 (Dean	
et	al.,	2010)	and	discomfort	from	wearing	the	harness	(Franceschini	
et	al.,	2009;	Yagura	et	al.,	2006).	Cho	et	al.	(2015)	did	not	report	any	
specific	figures	but	attributed	a	“high	dropout	rate”	to	deteriorating	
health	status	and	“adverse	dermatological	effects.”	Across	all	cycling	
interventions,	 there	were	9/49	 (18%)	dropouts	 in	 the	 intervention	
and	10/49	 (20%)	 in	 the	control	 groups.	Reasons	 for	dropout,	 con-
sidered	 to	be	exercise	 intervention-	related	by	 the	 review	authors,	
included	discomfort	in	the	affected	leg	(Wang	et	al.,	2014a).	In	the	
other	intervention	category,	White	et	al.	(2013)	did	not	specify	the	
ambulatory status of their only dropout. In the remaining two studies 
(Demers	&	McKinley,	2015;	Shea	&	Moriello,	2014),	one	of	six	partic-
ipants	(17%)	had	an	adverse	event	in	the	intervention	groups	(there	
were	no	control	groups	in	this	category)	and	there	were	no	dropouts	
from adverse events considered to be intervention- related.
3.11.4 | Acceptability of the interventions
There	 were	 no	 qualitative	 studies,	 and	 only	 two	 cohort	 stud-
ies	 (Demers	&	McKinley,	 2015;	White	 et	al.,	 2013)	 incorporated	 a	
qualitative	element,	 exploring	participants’	 views	on	 the	 interven-
tion	provided.	During	their	dance	intervention,	the	instructor	kept	a	
journal	containing	participant	feedback	(Demers	&	McKinley,	2015),	
but there was no feedback from any of the nonambulatory stroke 
survivors.	Following	Masterstroke,	a	mixed	exercise	and	education	
program	 (White	et	al.,	2013),	 semistructured	 interviews	were	con-
ducted,	in	which	three	of	four	nonambulatory	participants	took	part.	
The	themes	and	quotes	described	below	were	all	linked	to	nonambu-
latory participants by the study authors.
3.11.5 | Perceived benefits
All	participants	in	the	Masterstroke	program	(White	et	al.,	2013)	
valued	 the	 exercise	 component.	 One	 of	 the	 nonambulatory	
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participants highlighted how perceived improvements in strength 
and	stamina	helped	with	getting	up	and	down	off	a	chair,	while	
another	 expressed	how	 they	 benefited	 from	encouragement	 by	
health professionals. Participants also reported improved bal-
ance	 and	 mobility	 following	 the	 dance	 intervention	 (Demers	 &	
McKinley,	2015).	The	benefits	of	group	exercise	were	expressed	
in	 both	 cohort	 studies	 (Demers	&	McKinley,	 2015;	White	 et	al.,	
2013),	 as	expressed	by	participants	 feeling	 less	 isolated	and	 re-
assured by peer support. Participants reported feeling more 
positive	 following	 a	 group-	based	dance	 intervention	 (Demers	&	
McKinley,	2015).	Music	was	also	expressed	as	an	important	social	
factor for reminiscing and enjoyment of the intervention. In ad-
dition	 to	 health	 benefits,	 psychosocial	 benefits	 from	 being	 in	 a	
group included vicarious learning and sharing empathy with other 
stroke	 survivors	 (White	 et	al.,	 2013).	 In	 the	 dance	 intervention	
(Demers	 &	McKinley,	 2015),	 all	 participants	 derived	 a	 sense	 of	
pride	 from	 performing	 in	 front	 of	 a	 small	 audience,	which	 they	
indicated as their favorite component.
3.11.6 | Goal attainment
Goal	 setting	was	 a	 central	 component	of	 the	Masterstroke	program	
(White	et	al.,	2013),	and	although	not	everyone	achieved	theirs,	partici-
pants	appreciated	that	the	exercises	were	aimed	at	their	personal	goals.
3.11.7 | Lifestyle modification
One	nonambulatory	participant	expressed	that	knowing	staff	at	the	
gym	was	a	key	element	in	maintaining	motivation	to	exercise	after	
completing	the	Masterstroke	program	(White	et	al.,	2013).	The	same	
participant also reported that information on diet was important to 
maintain body weight following study end.
4  | DISCUSSION
To	 the	 authors’	 knowledge,	 this	 is	 the	 first	 systematic	 review	 of	
fitness interventions for nonambulatory stroke survivors. This in-
cluded 33 studies with 910 nonambulatory participants (includ-
ing	 18	 RCTs	with	 638	 nonambulatory	 participants),	 compared	 to	
58	RCTs	with	2,797	mostly	ambulatory	participants	 in	the	review	
by	Saunders	et	al.	 (2016).	 In	 summary,	 compared	with	control	 in-
terventions,	assisted	walking	and	cycle	ergometry	training	signifi-
cantly	improved	a	range	of	outcomes.	Effectiveness	of	other	types	
of	 training	 could	 not	 be	 established,	 however,	 due	 to	 a	 paucity	
of	 data.	 Except	 for	 two	mixed-	methods	 studies,	 all	 studies	were	
quantitative.	 As	 a	 result,	 there	were	 insufficient	 qualitative	 data	
to draw firm conclusions on the acceptability of the interventions 
provided,	but	where	reported,	participants’	experiences	were	posi-
tive.	Reporting	of	adverse	events	varied	across	studies,	but	based	
on	 the	 low	number	of	 intervention-	related	adverse	events,	 a	 low	
dropout	 rate,	 and	similarity	 in	case	 fatality	between	 intervention	
and	control	groups	over	the	intervention	period,	most	intervention	
procedures included in this review could reasonably be considered 
to be feasible.
Other	 key	 findings	 related	 to	 study	quality,	 participants,	 inter-
ventions	and	comparisons,	outcome	measures,	settings,	and	effects,	
feasibility,	and	acceptability	will	be	discussed	below.
4.1 | Study quality
Study	 quality	 varied;	 most	 studies	 were	 rated	 as	 “moderate.”	
Selection	bias	affected	all	studies,	with	few	reporting	the	proportion	
of	participants	agreeing	to	participate,	or	sufficient	 information	to	
judge the representativeness of the study population. These aspects 
could be better reported in future.
4.2 | Participants
The lack of clear and standardized descriptors of ambulatory abil-
ity levels made it difficult to select and compare relevant studies. 
Despite	utilizing	the	criterion	of	FAC	score	≤2,	a	clinically	diverse	
group	was	 included	 in	 this	 review,	 which	might	 have	 led	 to	 het-
erogeneity	in	intervention	effects	(Higgins	&	Green,	2011).	Future	
studies should attempt to specify participants’ walking ability using 
a	 standardized	 scale	 (e.g.,	 the	FAC),	 to	 enable	 better	 comparison	
of studies.
Only	 a	 few	 studies	 included	 participants	 more	 than	 6	months	
poststroke.	In	this	population,	it	is	particularly	important	to	prevent	
recurrent	stroke,	which	accounts	for	approximately	30%	of	all	stroke	
(Hankey,	2014),	through	physical	activity	where	possible	(O’Donnell	
et	al.,	2016).
4.3 | Interventions and settings
Most	 studies	 used	 walking	 interventions,	 assisted	 by	 therapists,	
BWST,	and/or	robotic	equipment.	As	most	participants	were	within	
3	months	poststroke,	the	emphasis	on	walking	seemed	appropriate,	
as this is an important rehabilitation goal at this stage (Jørgensen 
et	al.,	 1995).	 The	 use	 of	 electromechanical	 devices	may	 be	 feasi-
ble within a rehabilitation setting (although none of the studies 
reported	costs);	however,	within	community	settings,	cost,	 space,	
and	 staff	 training	 requirements	 may	 pose	 barriers.	 Importantly,	
this type of training precludes the opportunity for social interac-
tion	with	peers,	which	 is	an	 important	motivator	for	stroke	survi-
vors	(Nicholson	et	al.,	2013).	Only	six	studies	(Batcho	et	al.,	2013;	
Demers	 &	 McKinley,	 2015;	 Lennon	 et	al.,	 2008;	 Leroux,	 2005;	
Rosendahl	 et	al.,	 2006;	 White	 et	al.,	 2013)	 used	 group	 training,	
and	 only	 five	 were	 undertaken	 in	 the	 community	 Batcho	 et	al.,	
2013;	Leroux,	2005;	Shea	&	Moriello,	2014)	including	care	homes	
(Rosendahl	 et	al.,	 2006;	 Tsaih	 et	al.,	 2012).	 This	 highlights	 an	 im-
portant	gap,	as	guidelines	 recommend	the	continuation	of	 fitness	
training—preferably	 in	 group	 format—after	 hospital	 discharge	
(Best	et	al.,	2010;	Billinger	et	al.,	2014;	Royal	College	of	Physicians	
Intercollegiate	Stroke	Working	Party,	2016;	Scottish	Intercollegiate	
Guidelines	Network,	2010).
     |  47 of 55LLOYD et aL.
Most	 interventions	 were	 of	 a	 short	 duration,	 except	 for	 one	
walking	(Rosendahl	et	al.,	2006)	and	one	Pilates	intervention	(Shea	
&	Moriello,	2014).	Therefore,	the	limited	effects	found	in	this	review	
may partially be due to the short training duration.
All	interventions	were	tailored	to	individuals,	but	methods	were	
not	always	described	sufficiently	to	enable	replication—with	the	ex-
ception	of	the	study	by	Shea	&	Moriello	(2014).
4.4 | Comparisons
Most	studies	that	included	a	comparison	group	comprised	usual	care,	
but	without	 sufficient	 detail	 to	 enable	 replication	 (Table	5).	 Some	
variation is unavoidable due to the individualized nature of stroke 
care;	however,	more	detailed	reporting	(Hoffmann	et	al.,	2014;	Slade	
et	al.,	2016)	will	increase	reproducibility	and	comparability	of	usual	
care.	Most	 studies	with	 usual	 care	 as	 the	 comparator	were	 dose-	
matched;	however,	some	of	the	electromechanical	gait	studies	were	
confounded by preparation time.
4.5 | Outcome assessment
A	 total	 of	 105	 different	 outcome	measures	were	 used	within	 the	
included	 studies,	 of	which	42	 (40%)	were	 skill-	related	 fitness	out-
comes	and	19	 (18%)	were	general	 stroke	outcomes,	which	caused	
difficulty in pooling results. The majority were used in single studies 
only,	which	precluded	any	comparison.
Of	some	of	the	more	commonly	used	measures	(e.g.,	the	Barthel	
Index,	Fugl-	Meyer),	different	sections	were	used	 in	different	stud-
ies,	which	prevented	a	mean	difference	from	being	computed.	The	
three	most	commonly	used	measures	(i.e.,	10-	meter	walk	test,	FAC,	
6-	min	walk	test)	all	reflected	walking	ability.	This	is	clearly	relevant	
in	the	acute	stage;	however,	for	some	chronic	stroke	survivors	who	
have	 not	 regained	 independent	 walking,	 this	 may	 no	 longer	 be	 a	
priority	and	other	measures	 (e.g.,	 around	participation	and	quality	
of	life)	may	be	more	relevant.	Most	measures	were	classified	under	
the	 ICF	body	 functions	domain,	with	very	 few	capturing	activities	
and	 participation—a	division	 also	 reflected	 in	 the	 ICF	 core	 set	 for	
stroke	(Geyh	et	al.,	2004).	The	predominantly	biomedical	approach	
to	research	on	fitness	training	after	stroke,	which	emerges	from	this	
review,	is	also	demonstrated	by	the	lack	of	psychosocial	outcomes,	
with	 only	 one	 study	 (White	 et	al.,	 2013)	 evaluating	 quality	 of	 life.	
Given	 the	 high	 prevalence	 of	 anxiety	 and	 depression	 after	 stroke	
(Hackett	&	Pickles,	2014),	further	research	on	the	effects	of	fitness	
training	on	mood	is	warranted	(Sims	et	al.,	2009).
Importantly,	none	of	the	studies	included	any	measure	of	costs.	
A	recent	study	demonstrated	the	cost-	effectiveness	(Collins,	Clifton,	
van	Wijck,	&	Mead,	2018)	of	a	clinically	effective	community-	based	
fitness	 training	 program	 for	 ambulatory	 stroke	 survivors	 (Mead	
et	al.,	2007),	but	more	health-	economic	evidence	is	required	for	ser-
vice development.
Taken	together,	this	review	indicates	that	studies	using	assisted	
walking interventions primarily assessed skill- related and only few 
health-	related	 fitness	outcomes,	whereas	 the	 reverse	seems	to	be	
the case in studies evaluating cycling interventions. This pattern of-
fers limited opportunity for comparing assisted walking and cycling 
intervention	categories.	Therefore,	in	order	to	strengthen	this	body	
of	evidence,	an	agreed	standardized	toolkit	of	outcome	measures	is	
required	that	are	valid	and	meaningful	to	service	users	and	provid-
ers,	reflect	a	biopsychosocial	paradigm,	and	include	health	econom-
ics measures.
4.6 | Effects
4.6.1 | Effects on primary outcomes
The	majority	of	RCTs	used	an	ITT	analysis,	but	in	those	that	did	not,	
treatment	effects	may	have	been	subject	to	bias	(Higgins	&	Green,	
2011).
Case fatality
Fatalities were rare; deaths only occurred in walking intervention 
groups,	 but	 these	 comprised	 the	 majority	 of	 participants.	 There	
was no suggestion that fatalities occurred during the intervention 
itself.	 Between	 intervention	 end	 and	 follow-	up,	 risk	 of	 death	was	
increased	4.75-	fold	for	participants	in	walking-	based	interventions,	
but this was only borderline significant. Case fatality in the review by 
Saunders	et	al.	(2016)	was	even	lower;	0.46%	of	all	participants	died	
before	intervention	end	and	0.72%	before	follow-	up.	The	low	num-
ber	of	deaths	may	relate	to	stringent	criteria,	whereby	participants	
with	contraindications	to	exercise	were	excluded.	It	is	also	likely	that	
participants	were	self-	selected,	with	only	those	feeling	able	agreeing	
to	take	part.	Together,	these	points	question	the	external	validity	of	
the	findings,	but	underline	the	importance	of	thorough	screening	as	
one of the factors underpinning low case fatality.
Cardiovascular and respiratory functions
Assisted	 walking	 training	 improved	 peak	 heart	 rate,	 peak	 oxygen	
uptake	capacity,	and	oxygen	consumed	during	walking,	suggesting	
better	aerobic	fitness.	However,	this	evidence	was	based	on	three	
RCTs	 of	 moderate-	to-	strong	 methodological	 quality	 only	 (Chang	
et	al.,	2012;	Stoller	et	al.,	2015;	Teixeira	da	Cunha	Filho	et	al.,	2001,	
2002).	Medication	and	age	may	influence	heart	rate	within	this	pop-
ulation,	and	therefore,	results	may	not	represent	the	actual	cardiac	
training	effect.	The	improvement	in	peak	oxygen	uptake	was	below	
the	 minimal	 clinically	 important	 difference	 (MCID)	 of	 10	ml/kg/
min	(Puente-	Maestu	et	al.,	2016).	As	there	were	no	follow-	up	data,	
longer- term benefits of assisted walking training remain unknown. 
Measures	 of	 peak	 cardiopulmonary	 performance	 were	 collected	
by	two	high-	quality	walking	training	RCTs	only	(Chang	et	al.,	2012;	
Stoller	et	al.,	2015).	Stoller	et	al.	(2015)	noted	that	despite	their	in-
tervention group reaching a significantly higher training intensity 
than	the	control	group,	they	did	not	manage	to	maintain	their	target	
because	of	fatigue.	Chang	et	al.	(2012)	attributed	the	limited	effect	
of	training	to	the	short	intervention	period,	which	was	only	2	weeks.	
These observations suggest that the training dose may not always 
have been sufficient to reach an effect.
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Cycle	ergometer	 training	 improved	peak	heart	 rate,	work	 load,	
peak	 ventilation,	 and	 maximum	 carbon	 dioxide	 production	 com-
pared	with	controls	at	intervention	end,	but	the	evidence	was	more	
limited	than	in	the	walking-	based	studies.	Evidence	for	benefits	on	
peak	heart	rate	was	based	on	three	RCTs	including	one	low-	quality	
(Potempa	 et	al.,	 1995)	 and	 two	 high-	quality	 RCTs	 (Wang	 et	 al.,	
2014a,	2014b),	but	evidence	for	the	remaining	outcomes	was	based	
on	one	low-	quality	RCT	only	(Potempa	et	al.,	1995).	As	there	were	
no	follow-	ups,	any	carryover	effects	remain	unknown.	 In	contrast,	
in	 mostly	 ambulatory	 stroke	 survivors,	 cardiorespiratory	 training	
did	 improve	peak	oxygen	uptake	and	exercise	tolerance	 (Saunders	
et	al.,	2016),	suggesting	that	these	effects	cannot	be	generalized	to	
nonambulatory stroke survivors.
Metabolic functions
There was a paucity of data on the effects of assisted walking on risk 
factors for stroke.
Cycle	ergometer	training,	compared	with	control	 interventions,	
resulted	 in	 a	 significant	 improvement	 in	HDL	 cholesterol,	 but	 the	
clinical	 significance	 of	 these	 findings	 is	 unclear,	 as	 all	 participants	
remained	within	the	average	level,	average	risk	category	for	this	pa-
rameter	 (American	Association	for	Clinical	Chemistry,	2017a)	from	
baseline to study end. Other authors have recommended the use 
of	 ratios	 (e.g.,	 total/HDL	or	 LDL/HDL	 cholesterol),	 as	 they	 confer	
greater	 predictive	 value	 than	 each	 index	 in	 isolation	 (Millan	 et	al.,	
2009).
Fasting insulin and fasting glucose were also significantly im-
proved in the intervention compared with control groups. The 
clinical	 significance	 of	 these	 findings	 is	 unclear,	 however,	 as	 both	
groups were already within the normal range of fasting glucose 
(American	Association	for	Clinical	Chemistry,	2017b;	World	Health	
Organization,	2006)	at	baseline.	Furthermore,	these	findings	came	
from	only	two	high-	quality	RCTs	and	from	the	same	author	(Wang	
et	al.,	2014a,	2014b),	so	would	need	to	be	replicated	before	any	con-
clusions	can	be	drawn.	Impaired	glucose	tolerance,	a	measure	recog-
nized	by	the	World	Health	Organization	(World	Health	Organization,	
2006),	may	be	more	clinically	 relevant	 than	 fasting	glucose	per	 se	
in	future	studies,	as	it	is	a	known	risk	factor	for	atherosclerosis	and	
stroke.
As	these	findings	show	potential	for	fitness	training	to	contrib-
ute	to	secondary	stroke	prevention—a	recognized	research	priority	
(Pollock	 et	al.,	 2012)—future	 studies	 should	 include	 measures	 of	
serum	lipids,	insulin	sensitivity,	or	glucose	tolerance.
Movement- related functions: walking endurance and strength
Assisted	walking	 resulted	 in	 a	 borderline	 significant	 improvement	
in walking endurance at intervention end and a significant improve-
ment	 at	 follow-	up,	 compared	 to	 control	 interventions.	When	 con-
verted	 to	 the	 distance	walked	 in	 6	minutes,	 the	 effect	might	 also	
be	clinically	significant,	exceeding	the	MCID	of	34.4	m	 (Tang,	Eng,	
&	Rand,	2012)—however,	 challenges	 in	undertaking	walking-	based	
outcomes in a nonambulatory population complicate interpretation. 
This	evidence	was	based	on	five	RCTs,	comprising	one	low-	quality	
(Tsaih	 et	al.,	 2012)	 and	 four	 moderate-	quality	 (Dean	 et	al.,	 2010;	
Mayr	et	al.,	2007;	Morone	et	al.,	2011;	Teixeira	da	Cunha	Filho	et	al.,	
2001,	2002)	studies.	However,	one	high-	quality	RCT	(Franceschini	
et	al.,	2009)	that	could	not	be	 included	 in	the	meta-	analysis	 found	
no significant effect at the end of intervention or follow- up. These 
findings align with the review including mostly ambulatory stroke 
survivors	(Saunders	et	al.,	2016).
Mixed	 training	 in	 the	 cohort	 study	 by	White	 et	al.	 (2013)	 re-
sulted in patient- reported improvements in strength and stamina. 
However,	 it	 was	 difficult	 to	 corroborate	 these	 perceptions	 in	
other	 studies	 using	 more	 objective	 measures	 (Chang	 et	al.,	 2012;	
Franceschini	et	al.,	2009;	Husemann	et	al.,	2007;	Mayr	et	al.,	2007;	
Ng	et	al.,	2008;	Tong	et	al.,	2006).	These	findings	align	with	 those	
from	 Saunders	 et	al.	 (2016),	 where	 effects	 of	 fitness	 training	 on	
strength were inconsistent.
4.6.2 | Effects on secondary outcomes
Mobility
The	effect	of	assisted	walking	on	walking	 independence,	assessed	
with	 the	 FAC,	was	 uncertain,	 both	 at	 the	 end	 of	 the	 intervention	
and	 at	 follow-	up.	 This	 evidence	 is	 based	 on	 eight	 RCTs,	 including	
four	high-	quality	 (Chang	et	al.,	2012;	Franceschini	et	al.,	2009;	Ng	
et	al.,	 2008;	Ochi	et	al.,	 2015),	 three	moderate-	quality	 (Husemann	
et	al.,	2007;	Morone	et	al.,	2011;	Teixeira	da	Cunha	Filho	et	al.,	2001,	
2002),	and	one	low-	quality	RCT	(Tong	et	al.,	2006).	There	was	no	sig-
nificant benefit from walking compared with control interventions 
in terms of the percentage of independent walkers at the end of the 
study.	However,	at	follow-	up,	two	medium-	quality	RCTs	(Dean	et	al.,	
2010;	Morone	et	al.,	2011)	showed	a	significant	2.73-	fold	increase	in	
the odds of achieving independent walking in the intervention com-
pared to the control group. This effect may be due to an increase in 
habitual	walking	 following	discharge	 from	hospital,	and	 this	would	
be	useful	to	examine	with	activity	monitors	in	future.
These	 findings	 concur	 to	 some	 extent	 with	 the	 Cochrane	
systematic	 review	 (Mehrholz,	 Thomas,	 Werner,	 et	al.,	 2017)	 on	
electromechanical-	assisted	gait	training,	which	found	that	this	tech-
nology increased the chance of independent walking in dependent 
walkers.	This	comparison	needs	to	be	interpreted	with	caution,	how-
ever,	as	“dependent	walkers”	were	defined	as	those	with	an	FAC	<4	
(which	includes	those	requiring	supervision	but	able	to	walk	without	
mechanical	assistance),	while	data	were	analyzed	at	intervention	end	
only.	A	comparison	with	the	Cochrane	systematic	review	on	tread-
mill	training	and	body	weight	support	(Mehrholz,	Thomas,	&	Elsner,	
2017)	could	not	be	undertaken,	however,	as	this	did	not	differentiate	
between outcomes in ambulatory and nonambulatory participants. 
The effects of walking training on self- reported walking ability com-
pared	with	control	interventions	were	based	on	two	medium-	quality	
studies	 (Mayr	et	al.,	 2007;	Dean	et	al.,	 2010)	 and	one	high-	quality	
RCT	(Franceschini	et	al.,	2009).
It was challenging to obtain reliable measures of gait kinematics 
in	this	population,	and	any	changes	need	to	be	interpreted	with	cau-
tion.	For	example,	an	increase	in	speed	may	have	been	the	result	of	
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fewer	participants	scoring	“zero”	 in	some	studies.	Walking	training	
significantly	improved	maximum	walking	speed	in	intervention	com-
pared	to	control	groups,	but	effects	were	lost	after	the	intervention	
end.	This	evidence	is	based	on	eight	RCTs,	including	one	high-	quality	
(Ng	 et	al.,	 2008),	 four	 moderate-	quality	 (Husemann	 et	al.,	 2007;	
Mayr	 et	al.,	 2007;	 Rosendahl	 et	al.,	 2006;	 Teixeira	 da	Cunha	 Filho	
et	al.,	 2002),	 and	 three	 low-	quality	 studies	 (Richards	 et	al.,	 1993;	
Tong	 et	al.,	 2006;	 Tsaih	 et	al.,	 2012).	 In	 the	 systematic	 review	 by	
Saunders	et	al.	(2016),	effects	of	fitness	training	on	walking	endur-
ance	and	speed	did	carry	over	after	the	intervention,	which	suggests	
that training for nonambulatory stroke survivors might need to con-
tinue,	possibly	because	it	may	be	more	difficult	for	this	population	to	
practice safely and independently. Walking training did not improve 
any	gait	kinematics	at	the	end	of	the	intervention	or	at	follow-	up,	but	
only	three	RCTs	(two	medium-	quality	(Dean	et	al.,	2010;	Husemann	
et	al.,	2007)	and	one	 low-	quality	RCT	 (Richards	et	al.,	1993))	were	
able	to	measure	a	selection	of	these.	Effects	of	walking	training	on	
mobility	were	mixed,	with	 significant	 improvements	 in	 the	Elderly	
Mobility	Scale	shown	in	one	low-	quality	(Tong	et	al.,	2006)	and	one	
high-	quality	RCT	(Ng	et	al.,	2008)	at	the	end	of	the	intervention	and	
in	one	RCT	at	follow-	up	(Ng	et	al.,	2008),	but	inconclusive	findings	
in	the	Rivermead	Mobility	Index	and	TUG	due	to	a	paucity	of	data	
(Mayr	et	al.,	2007;	Morone	et	al.,	2011;	Tsaih	et	al.,	2012).
Movement- related functions
Evidence	 for	 the	 effects	 of	 fitness	 training	 on	 voluntary	 move-
ment	control,	trunk	control,	balance,	falls,	and	resistance	to	passive	
movement was limited. The effect of assisted walking training on 
voluntary	motor	control,	assessed	with	the	Fugl-	Meyer,	was	uncer-
tain.	This	evidence	is	based	on	two	high-	quality	(Chang	et	al.,	2012;	
Ochi	et	al.,	2015)	and	 two	 low-	quality	RCTs	 (Richards	et	al.,	1993;	
Yagura	et	al.,	2006).	Walking	training	did	not	improve	trunk	control	
compared	with	 controls	 at	 intervention	 end,	while	 data	 at	 follow-
	up	were	inconclusive.	Evidence	for	trunk	control	was	based	on	one	
high-	quality	 (Franceschini	 et	al.,	 2009)	 and	 one	 moderate-	quality	
(Morone	et	al.,	2011)	RCT.	Walking	training,	compared	to	control	in-
terventions,	had	no	significant	impact	on	balance	at	the	end	of	the	
intervention,	but	between	end	of	intervention	and	follow-	up,	there	
was	an	indication	of	improvement.	This	is	perhaps	to	be	expected,	
as	during	the	intervention,	participants	would	have	been	supported	
by	 therapists	and/or	equipment,	but	afterward,	without	such	sup-
port,	participants’	balance	would	have	been	challenged	more	often	
during	habitual	daily	activities.	This	evidence	is	based	on	five	RCTs,	
including	 one	 high-	quality	 (Ng	 et	al.,	 2008),	 one	moderate-	quality	
(Rosendahl	et	al.,	2006),	and	three	low-	quality	RCTs	(Richards	et	al.,	
1993;	 Tong	 et	al.,	 2006;	 Tsaih	 et	al.,	 2012).	 The	 effect	 of	 walking	
training	on	falls	could	not	be	established,	due	to	a	paucity	of	data.	
As	falls	prevention	is	an	important	clinical	consideration	in	nonam-
bulatory	stroke	survivors	(Bernhardt,	Ellis,	Denisenko,	&	Hill,	1998),	
future studies should include valid measures of balance and falls.
Walking training did not seem to have any differential impact on 
resistance to passive movement. This evidence is based on one high- 
quality	 (Franceschini	 et	al.,	 2009)	 and	 four	moderate-	quality	 (Cho	
et	al.,	2015;	Husemann	et	al.,	2007;	Mayr	et	al.,	2007;	Morone	et	al.,	
2011)	studies,	suggesting	that	fitness	training	does	not	exacerbate	
hypertonia.
Cycling resulted in no significant benefit in voluntary motor con-
trol,	assessed	with	the	Fugl-	Meyer,	compared	with	control	 interven-
tions.	This	evidence	came	from	two	high-	quality	(Wang	et	al.,	2014a,	
2014b)	and	one	low-	quality	(Potempa	et	al.,	1995)	RCT.	This	is	perhaps	
not	surprising,	as	the	Fugl-	Meyer	does	not	comprise	any	cyclical	ac-
tions.	The	effects	of	cycling	training	on	balance,	trunk	control,	and	re-
sistance	to	passive	movement	are	not	known,	as	these	measures	were	
not included or reported.
Body and Sensory functions
Effects	 of	 walking	 training	 on	 neurological	 function	 (CNS),	 lower	
limb	proprioception,	and	perceptual	neglect	were	inconclusive	due	
to a paucity of data.
Mental functions
The	effects	of	walking	on	mood	are	not	known,	as	none	of	the	walk-
ing RCTs included an outcome to this effect. One cycle training RCT 
assessed	mood,	but	findings	were	inconclusive	due	to	a	paucity	of	
data. The systematic review on fitness training by Saunders et al. 
(2016),	 which	 included	 mostly	 nonambulatory	 stroke	 survivors,	
found inconsistent effects on mood. The impact of fitness training 
on	mood	is	an	important	gap	in	the	evidence,	as	many	stroke	survi-
vors	experience	depression	and/or	anxiety	(Kim,	2017).	Participants	
in	 a	 mixed	 training/education	 program	 (White	 et	al.,	 2013)	 ex-
pressed	psychosocial	benefits	from	group-	based	training,	including	
enhanced	motivation	to	exercise	and	benefits	from	seeing	how	oth-
ers had learned to cope with a similar condition. These findings are 
worthy of further investigation.
None of the studies assessed the effects of fitness training on 
cognition	(the	top	research	priority	selected	by	stroke	survivors,	car-
ers,	and	health	professionals	(Pollock	et	al.,	2012),	which	should	be	
explored	in	future	studies,	especially	as	other	reviews	have	shown	
benefits	 of	 exercise	 after	 stroke	 on	 cognition	 (Cumming,	 Tyedin,	
Churilov,	Morris,	&	Bernhardt,	2012;	Garcia-	Soto,	Lopez	de	Munain,	
&	Santibanez,	2013)).
Activities and participation
Most	of	the	walking	training	RCTs	showed	no	significant	benefits	for	
activity	and	participation	compared	to	control	interventions,	as	as-
sessed	with	the	FIM,	BI,	or	Adelaide	Activities	Profile.	This	evidence	
is	based	on	12	RCTs,	including	three	high-	quality	(Franceschini	et	al.,	
2009;	Ng	et	al.,	2008;	Ochi	et	al.,	2015),	five	moderate-	quality	(Cho	
et	al.,	2015;	Dean	et	al.,	2010;	Husemann	et	al.,	2007;	Morone	et	al.,	
2011;	Teixeira	da	Cunha	Filho	et	al.,	2001),	and	four	low-	quality	stud-
ies	(Richards	et	al.,	1993;	Tong	et	al.,	2006;	Tsaih	et	al.,	2012;	Yagura	
et	al.,	2006).	Two	walking	RCTs	(one	high	quality	(Franceschini	et	al.,	
2009)	 and	 one	 moderate	 quality	 (Morone	 et	al.,	 2011))	 examined	
the	effects	of	training	on	stroke-	related	disability,	assessed	with	the	
(modified)	Rankin	Scale,	but	found	no	difference	compared	with	con-
trols.	It	is	plausible	that	walking	training,	which	comprises	repetitive	
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practice	of	a	specific	cyclical	task,	does	not	carry	over	to	tasks	that	
are	discrete	and	complex.	The	 lack	of	effect	of	 fitness	 training	on	
disability	(other	than	walking-	related)	was	echoed	in	the	systematic	
review	by	Saunders	et	al.	(2016).
Cycling	resulted	in	a	significant	improvement	in	the	Barthel	Index	
(BI)	 at	 the	end	of	 training,	based	on	 two	high-	quality	RCTs	by	 the	
same	 author	 (Wang	 et	 al.,	 2014a,	 2014b).	 Changes	 in	 the	 BI,	 fol-
lowing	cycle	ergometer,	were	clinically	 important,	 as	 the	detected	
mean	 difference	was	 19.4	 points,	 much	 higher	 than	 the	MCID	 of	
1.85	points	 (Hsieh	 et	al.,	 2007).	 These	 promising	 findings	 need	 to	
be	replicated	in	other	studies,	however,	before	any	conclusions	can	
be drawn.
4.7 | Feasibility
Reporting	 of	 recruitment	 rates,	 dropouts,	 adverse	 events,	 and	 at-
tendance	 varied;	 only	 just	 under	 50%	 of	 studies	 included	 in	 this	
review	fully	reported	this	information.	However,	it	must	be	acknowl-
edged that many studies were published before the CONSORT 
guidelines	(Schulz,	Altman,	&	Moher,	2010).	Across	studies	reporting	
this	information,	on	average	22%	of	all	patients	screened	were	eligi-
ble,	but	for	planning	future	studies,	more	consistent	reporting	of	this	
number	is	required.
Attendance,	although	only	reported	in	just	over	50%	of	studies,	
was	generally	high,	which	supports	feasibility.	However,	better	re-
porting	of	attendance,	which	is	also	poorly	reported	in	exercise	stud-
ies	for	older	people	(Hawley-	Hague,	Horne,	Skelton,	&	Todd,	2016),	
is	required	in	future	studies.
Dropout	 from	 studies	 was	 relatively	 low	 (12%–20%),	 espe-
cially given a vulnerable population with a high prevalence of co-
morbidities.	Adverse	events	 reflected	the	complex	health	status	
of	 this	population,	 including	pulmonary	complications,	 recurrent	
stroke,	 and	 deteriorating	medical	 conditions,	 demonstrating	 the	
need	 for	 careful	monitoring	 by	 qualified	 staff.	Where	 reported,	
there	were	very	 few	 intervention-	related	adverse	events,	which	
included	 anxiety	 associated	 with	 treadmill	 training	 (Dean	 et	al.,	
2010),	 discomfort	 from	wearing	 the	harness	 (Franceschini	 et	al.,	
2009;	 Yagura	 et	al.,	 2006)	 and	 “adverse	 dermatological	 effects”	
(Cho	et	al.,	2015)	in	walking	interventions,	and	discomfort	in	the	
affected	leg	during	cycling	(Wang	et	al.,	2014a).	Fatigue	was	com-
monly	 reported,	 but	 did	 not	 necessarily	 lead	 to	dropout.	 In	 this	
review,	 only	 dropouts	 in	 the	 period	 between	 intervention	 start	
and	end	of	study	were	noted,	but	between	randomization	and	in-
tervention	start,	29	additional	dropouts	occurred,	in	many	cases	
because	participants	were	not	able	 to	 tolerate	 the	 study’s	exer-
cise testing protocol.
Experiences	 from	 only	 three	 nonambulatory	 stroke	 survivors	
could	be	 included	 in	 this	 systematic	 review,	which	were	 generally	
positive:	 Participants	 reported	 benefits	 from	 the	 exercise	 compo-
nent	 that	was	 tailored	 to	 their	 goals,	 helped	 to	 increase	 strength	
and	stamina,	and	provided	a	supportive	group	atmosphere	providing	
mutual	 support	 from	 peers	 and	 professionals	 (White	 et	al.,	 2013).	
However,	it	is	clear	that	more	research	is	required	to	gain	a	deeper	
understanding of participants’ perceptions of fitness interventions 
in order to optimize their uptake and maintenance.
4.8 | Strengths and limitations
In	terms	of	the	evidence	included	in	this	review,	there	was	a	paucity	
of	high-	quality	quantitative—and	particularly	qualitative—evidence,	
as discussed above. These limitations impact on the conclusions that 
can	be	drawn	in	this	review,	and	recommendations	for	strengthening	
the evidence base will be discussed below.
In	terms	of	review	methodology,	a	systematic	and	comprehen-
sive	literature	search	was	conducted.	However,	despite	best	efforts,	
other relevant studies may have been overlooked. Reporting of 
ambulatory	 status	was	 generally	 poor,	 and	 although	authors	were	
contacted	 where	 required,	 data	 were	 not	 always	 available,	 and	
therefore,	 some	 studies	 had	 to	 be	 excluded.	 Studies	 in	 languages	
other	than	English	also	had	to	be	excluded,	due	to	resource	limita-
tions.	Taken	together,	these	limitations	mean	that	not	all	potentially	
relevant literature could be included in this review.
4.9 | Implications for practice
This review provides evidence that assisted walking and cycle er-
gometer	 training	may	 improve	 health-	 and	 skill-	related	 fitness,	 as	
well as functional outcomes in carefully selected nonambulatory 
stroke	survivors,	but	no	firm	conclusions	could	be	drawn.	Training	
did	not	 carry	over	 into	 activity	 and	participation,	 however;	 there-
fore,	if	these	domains	were	to	be	among	the	participant’s	personal	
goals,	they	would	require	more	targeted	interventions.
Adverse	 event	 reporting	 was	 patchy;	 however,	 the	 low	 inci-
dence of intervention- related adverse events and similarity in case 
fatality over the intervention period suggest that the adapted in-
terventions,	delivered	by	qualified	staff,	were	safe	 for	 those	who	
had	been	selected.	Although	the	evidence	requires	strengthening,	
postponing implementation until such time would mean that this 
population remains sedentary and at high risk of further cardiovas-
cular	disease.	Therefore,	health	and	exercise	professionals,	as	well	
as	 policymakers,	 should	 be	 encouraged	 to	 create	 more	 opportu-
nities where this emerging body of evidence can be implemented 
judiciously	by	suitably	trained	professionals,	to	enable	nonambula-
tory stroke survivors to become less sedentary and more physically 
active	(Ezeugwu	&	Manns,	2017;	Kerr,	Dawson,	Robertson,	Rowe,	
&	Quinn,	2017).
4.10 | Implications for future research
Descriptions of different levels of walking ability after stroke need 
to be agreed and standardized to enable better comparison be-
tween studies. One of the strengths of this review is the attempt 
to	 use	 a	 standardized	 tool	 to	 describe	 the	 term	 “nonambulatory,”	
that	is,	the	FAC	(Holden	et	al.,	1984).	This	may	facilitate	comparison	
across studies in future and enable further research to build upon 
this review.
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To	 strengthen	 the	 evidence	 and	 facilitate	 trial	 planning,	 fu-
ture studies should improve their reporting of a number of as-
pects,	 especially	 the	 number	 of	 participants	 initially	 approached,	
as	 per	 CONSORT	 guidelines	 (Schulz	 et	al.,	 2010).	 Reporting	 of	
intervention- related adverse events should be improved to provide 
a more accurate estimate of safety. Future studies should also re-
port	all	components	of	fitness	interventions	and	comparisons,	as	per	
TIDieR	(Hoffmann	et	al.,	2014)	and	CERT	(Slade	et	al.,	2016)	guide-
lines,	to	enable	replication	of	interventions	demonstrating	effective-
ness.	 Finally,	 future	 studies	 should	 incorporate—and	 report	 (Slade	
et	al.,	 2016)—behavior	 change	 strategies	 aimed	 at	maintenance	 of	
physical activity behavior in order to optimize retention of training 
benefits	 (Fjeldsoe,	 Neuhaus,	 Winkler,	 &	 Eakin,	 2011;	 Kwasnicka,	
Dombrowski,	 White,	 &	 Sniehotta,	 2016),	 together	 with	 adequate	
follow- up to measure this.
One limitation of this body of evidence was the limited dose 
and	 intensity	 in	 a	 number	 of	 studies.	 A	 recent	 systematic	 review	
(Hendrey,	Holland,	Mentiplay,	Clark,	&	Williams,	 2017)	 found	 that	
only	 a	 third	 of	 included	 studies	 adhered	 to	 the	 ACSM	 intensity	
guidelines,	and	therefore,	this	requires	attention	in	future	studies.
Outcomes	should	address	the	risk	of	recurrent	stroke,	 impair-
ment	and	function,	psychosocial	aspects,	participation,	and	quality	
of	 life,	 as	 prioritized	 by	 stroke	 survivors	 and	 other	 stakeholders	
(Pollock	 et	al.,	 2012),	 as	 well	 as	 costs.	 To	 facilitate	 comparison	
and	 synthesis	of	 findings	 across	 studies,	 the	number	of	outcome	
measures needs to be reduced. The need for a core dataset for 
stroke	 rehabilitation	 research	 in	 general	 was	 highlighted	 by	 Ali,	
English,	Bernhardt,	Sunnerhagen,	&	Brady	(2013),	and	this	review	
echoes this recommendation for stroke- related fitness research in 
particular.
More	qualitative	or	mixed-	methods	studies	are	required	to	gain	
deeper	insight	into	participants’	experiences	of	interventions,	to	en-
sure	these	are	acceptable,	aimed	at	what	matters	most	to	them,	and	
encourage maintenance of physical activity.
5  | CONCLUSION
This	 mixed-	methods	 systematic	 review	 and	 meta-	analysis	 on	 the	
case	fatality,	effects,	experiences,	and	feasibility	of	physical	fitness	
interventions for nonambulatory stroke survivors showed emerging 
evidence	 that	assisted	walking	and	cycle	ergometer	 training,	com-
pared	with	control	 interventions,	 improved	a	range	of	fitness-	and	
function-	related	 outcomes.	 Benefits	 generally	 did	 not	 carry	 over	
into	activities	of	daily	 living	or	participation;	however,	this	may	re-
flect the specificity of training provided. The effects of other types 
of fitness training are still to be determined. The effects of any type 
of	fitness	training	on	risk	factors	for	stroke,	anxiety	and	depression,	
fatigue,	 quality	 of	 life,	 and	 participation	 in	 this	 population	 remain	
unknown.	 Low	 case	 fatality	 and	 incidence	 of	 intervention-	related	
adverse	 events	 and	 dropout	 rates	 suggest	 that	 fitness	 training,	
adapted to stroke and tailored to carefully screened and monitored 
nonambulatory	 individuals,	 is	 feasible	 and	 safe.	 There	 were	 very	
limited	 findings	 about	 the	 acceptability	 of	 interventions	 provided,	
but	where	reported,	participants’	experiences	were	positive.
Most	studies	examined	the	effects	of	short	 training	periods	of	
individual,	assisted	walking	interventions	using	complex	technology	
in acute settings. To provide nonambulatory stroke survivors with 
appropriate	 evidence-	based	 fitness	 training,	 further	 studies	 need	
to focus on the clinical and cost- effectiveness of a wider range of 
fitness	interventions	of	a	sufficient	dose,	especially	of	group-	based	
interventions in the community.
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